





UNDERSTANDING THE MOLECULAR MECHANISM ON CELL SURFACE 





















Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Biochemistry 
in the Graduate College of the  










 Professor Steven R. Blanke, Chair 
 Professor Brenda A. Wilson 
Professor James H. Morrissey 








Chronic infection with the human specific gastric pathogen Helicobacter pylori (H. 
pylori) is a risk factor for the development of gastric ulcer disease and gastric 
adenocarcinoma. The vacuolating cytotoxin (VacA) is a secreted toxin of H. pylori, 
initially discovered as the proteinacious factor within H. pylori culture filtrates that 
intoxicates epithelial cells and induces vacuole biogenesis. Throughout 25 years of 
VacA research, several interesting and important properties of VacA have become 
apparent; the gene encoding VacA (vacA) is characterized by a high degree of genetic 
variation, and experimental evidence strongly supports the idea that VacA promotes 
colonization and persistence of H. pylori, and the pathophysiology associated with H. 
pylori infection. At cellular level, VacA functions as an endomembrane channel 
subsequent to internalization into a host cell and targets the mitochondria to modulate 
host cell physiology. An abundant cell surface membrane sphingolipid, sphingomyelin 
(SM), functions as a cell surface receptor, mediating cellular activity of VacA. However, 
major gaps in knowledge include the molecular detail on the interaction between VacA 
and its cell surface receptor, and the contribution of the VacA-receptor interaction to the 
high degree of genetic variation on vacA. In this dissertation, I report that three VacA 
residues, arginine 552 (Arg-552), tryptophan 603 (Trp-603), and arginine 647 (Arg-647), 
are the active receptor-interacting residues important for VacA-mediated cellular activity 
and SM-interaction. A mutant form of VacA with alanine substitution on the three VacA 
residues, VacA (R552A/W603A/R647A), showed dramatic attenuation of vacuole 
biogenesis on human epithelial-derived cells, suggesting the importance of the three 
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VacA residues for cellular activity. VacA (R552A/W603A/R647A) binding to SM-coated 
plates was attenuated relative to wildtype VacA, demonstrated the importance of the 
three VacA residues for SM interaction. Binding of VacA (R552A/W603A/R647A) to the 
plasma membrane of the epithelial-derived cells was reduced relative to wildtype VacA, 
suggesting the importance of the three VacA residues for cell surface binding. A larger 
fraction of total membrane bound wildtype VacA than VacA (R552A/W603A/R647A) 
bound to a specific component or components on the surface of cultured cells, 
suggesting the importance of the three VacA residues for receptor-mediated plasma 
membrane binding of VacA on the cells. Also, a smaller fraction of total membrane 
bound VacA (R552A/W603A/R647A) than wildtype VacA partitioned to detergent 
resistant membranes (DRMs), suggesting that the three VacA residues are important for 
VacA association into specialized microdomains on the cell surface called lipid rafts. In 
order to understand the contribution of the active receptor-interacting residues in the 
high degree of genetic variation on vacA, I examined two variant forms of VacA from 
two H. pylori strains; a toxic form of VacA from H. pylori strongly associated with gastric 
disease and a less toxic form of VacA from H. pylori less associated with the gastric 
disease. By generating a chimeric form of VacA, I observed that the difference on the 
central region with the most heterogeneity mediates VacA cellular activity. Mapping the 
central region by smaller subdomain substitution between the toxic form and the less 
toxic form of VacA revealed that chimeric forms of VacA lacking the active receptor-
interacting residues showed attenuation in cellular activity of the toxin. It was 
demonstrated that the difference on the region that contains the active receptor-
interacting residues contribute to the difference in the cytotoxicity between toxic variant 
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and less toxic variant form of VacA. In Chapter 4, I described the importance of the 
oligomerization state of VacA for its cellular activity. In Chapter 5, I discuss the current 
model on how VacA interacts and becomes anchored onto the membrane by a 
mechanism involving the active receptor-interacting residues. My finding of the active 
receptor-interacting residues sheds a new insight in designing inhibitors to block the 
VacA-receptor interaction, which can supplement current H. pylori eradication strategy 
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Chapter 1: Introduction 
 
1.1  Helicobacter pylori and human health 
 
Since the first discovery of Helicobacter pylori (Figure 1.1) in human stomach in 
1984 1, the thirty years of research demonstrated that H. pylori colonize over half of the 
world’s population 2-5. Among the H. pylori infected individuals, approximately 20% of 
them have shown a strong association with clinical disease such as peptic ulcers, gastric 
adenocarcinoma, or mucosa-associated lymphoid tissue (MALT) lymphoma 6-9. Indeed, 
the discovery on strong correlation of H. pylori infection with both gastric adenocarcinoma 
and MALT lymphoma, which are early stages of development of gastric cancer, led H. 
pylori classified as class I carcinogen by the World Health Organization. Without antibiotic 
intervention, H. pylori infection persists within the harsh acidic condition within the human 
stomach (Figure 1.2). Thus, understanding the mechanism and strategies of H. pylori 
infection within the human stomach for its survival and colonization is important to better 
understand the effects of H. pylori infection in human health. 
 
1.2  Helicobacter pylori and vacuolating cytotoxin (VacA) 
 
The vacuolating cytotoxin of Helicobacter pylori was first identified in 1988 when 
culture supernatants from the H. pylori were used to treat cultured cells10. Exposure 
resulted in the formation of large, membrane bound vacuolar structures10 Through further 
isolations and genetic analyses, VacA was identified and purified. VacA is the only known 
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exotoxin produced by H. pylori. The purified VacA solely can induce the vacuolation onto 
the sensitive cells (Figure 1.3). VacA has been demonstrated to be important for in the 
development of gastric and duodenal ulcers. Introducing VacA orally into mice could 
generate ulcerative lesions like those found following H. pylori infection11. VacA has been 
demonstrated to be important for H. pylori colonization. H. pylori colonization was greatly 
attenuated in isogenic VacA knockout strains, compared to wildtype H. pylori strains, 
underlining the importance of VacA in H. pylori pathogenesis12. However, the detailed 
physiological role of VacA production and its importance in Helicobacter pylori infection 
remains poorly understood. 
 
1.3 Allelic diversity of vacuolating cytotoxin (VacA) and its relevance to human 
health 
 
H. pylori is demonstrated to be one of the most variable species of bacteria 2. This 
heterogeneity has been used as a classification system to discriminate among strains 
13,14. vacA gene, a virulent H. pylori gene responsible for secreting pore-forming protein 
Vacuolating cytotoxin A, has been utilized for developing such a classification system. 
vacA gene is virtually found in all H. pylori strains. To examine the role of VacA in human 
disease, the severity of gastric disease from clinical isolates to the different alleles of 
VacA present in the H. pylori infected human was compared. Genetic analysis has shown 
VacA to have two regions of allelic diversity, termed the s-region (s1a, s1b, and s2 alleles) 
and m-region (m1, m2a, and m2b alleles)15,16 (Figure 1.4B). Studies have shown that 
humans infected with strains of H. pylori harboring the s1/m1 alleles are at a higher risk 
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for peptic ulceration and gastric epithelial damage compared to s2/m2 strains17. The data 
thus far indicate that VacA with more toxic alleles is associated with more severe gastric 
disease, perhaps by perturbing host cell responses to limit the infection. 
 
1.4 VacA structure 
 
VacA is a secreting exotoxin, where its pro-toxin forms are made within the 
bacteria with approximately 140kDa in size (Figure 1.4A). Upon an N-terminal signal 
sequence is cleaved, VacA starts release out from bacteria through the C-terminal 
autotransporter16. After the release, the C-terminal autotransporter system is removed, 
generating the processed VacA with a size of 88kDa. The full length secreted form of 
VacA is comprised of effectively 2 putative domains, termed p33 and p5516. 
Based on many structure analysis of VacA, it is now generally accepted that the 
overall shape of active form of VacA is a hexamer with anion-selective channel in the 
middle (Figure 1.5). The image of cryo electron microscopy of VacA showed that the 
most common form of the toxin was a hexamer in shape18-20. The oligomers were 
approximately 25-30 nm in diameter, with a center cavity about 12 – 14 nm in width18. 
The pores formed by VacA are anion-selective, bidirectional channels21, and it is currently 






1.5 Cellular activity of VacA 
 
VacA is a paradigm for multi-functional intracellular-acting toxins16. The cellular 
effects of VacA intoxication has been reported ranging from disruption of mitochondria22,23, 
perturbation autophagy mechanism24,25, and induction of vacuolation26-28. At the level of 
the mitochondria, the centric organelle for energy generation within the cell, VacA 
intoxication induces cytochrome C release22. Cytochrome C is an inner membrane 
hemeprotein involved in the electron transport chains, and is a potent activator of 
apoptosis if released from the mitochondria into the cytosol. In addition, mitochondrial 
damages were observed upon VacA intoxication, measured by the potential sensitive 
fluorescent dye TMRE (tetramethylrhodamine ethyl ester perchlorate)22. While healthy 
mitochondria take up TMRE, depolarized mitochondria do not uptake TMRE, leading to 
defect the healthiness of mitochondria. VacA intoxication shows less TMRE uptake, 
suggesting the defect on the mitochondria’s health. In addition, VacA has been shown to 
induce mitochondrial fragmentation by activating the mitochondria fission regulator Drp123. 
The mitochondrial damage has direct effects on cellular metabolism, where it was shown 
that VacA treatment results in lower levels of cellular ATP, an inhibition of oxygen 
consumption. These data suggest that VacA intoxication can lead cells to have less 
metabolic homeostasis, facilitating the ability of Helicobacter pylori to establish an 
infection.  
VacA intoxication affects autophagy mechanism of the cells25,29. Autophagy is a 
physiological process where cells can degrade its own components, and is an innate 
immune response to pathogen infection. VacA has been reported to both induce and 
	 5	
disrupt the self-eating mechanism in the toxin-exposed cells25,29. Upon VacA intoxication, 
lipidation on LC 3 is activated leading to the accumulation of LC 3 II within the cells. LC 3 
is a ubiquitous protein that is recruited to autophagosomes upon autophagy induction29. 
Autophagy induction eventually leads to accumulation of p6229, an indicator for disruption 
of metabolic homeostasis. These data suggest that VacA perturbs a physiological 
response to pathogen exposure, to disrupt the host epithelial barrier. 
The most striking phenotype of VacA exposure is the vacuolation formation within 
the VacA intoxicated cells. Decades of research have been studied the physiological role 
of the vacuolation14,27,30-35. Regardless of the physiological role of vacuole formation, this 
phenotype has served as a reliable indicator of VacA entry into toxin-exposed cells. In 
conclusion, the cellular activity of VacA is important for mitochondrial dysfunction, 
autophagy induction, as well as vacuolation. Understanding the mechanisms of these 




1.6 Cell membrane interaction of VacA: Sphingomyelin as the novel VacA receptor 
 
  In order to modulate host cells, intracellular-acting exotoxins must breach the 
plasma membrane barrier as a requisite step for accessing their intracellular targets 36. 
Toxin internalization generally involves binding to one-or-more specific toxin receptors on 
the surface of host cells, which, in part, is critical for positioning the toxin in close 
juxtaposition to existing cellular uptake machinery 36. VacA internalization has been 
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demonstrated to occur by a Cdc42-dependent pinocytic mechanism that localizes the 
toxin initially into a class of early uptake vesicles called GPI-anchored protein enriched 
compartments (GEECs) 37,38. Although a number of cell surface components have been 
reported as VacA receptors 24,39-42, the fate of VacA within cells is dependent, in part, on 
an abundant lipid component of the plasma membrane outer leaflet, sphingomyelin (SM) 
43. SM has been demonstrated to be important for binding of the toxin to the plasma 
membrane, and subsequent VacA cellular activity. In addition, a fraction of total 
membrane-bound VacA partitions into SM-enriched membrane rafts 43, which is important 
for toxin uptake and cellular activity. Finally, using an ELISA-based, lipid-binding assay, 
VacA was demonstrated to bind SM directly and highly preferentially over other common 
lipids with non-phosphorylcholine headgroups 43. These data support a model that SM 
functions as a VacA receptor on the surface of sensitive cultured cells.  
 
1.7 Known SM-interacting proteins 
 
In order to study how VacA interacts with SM, I took advantage of previous 
published efforts to understand protein-SM interactions.  Although specific, conserved 
sequence motifs for SM interactions have not been identified, structural 44-46 and 
biochemical 44,47-49 approaches revealed a potential role for aromatic residues, and 
tryptophan residues, in mediating protein-SM interactions. Sphingomyelinase C from 
Bacillus cereus contains a binding pocket composed of a tryptophan and an arginine that 
can accommodate the interacting of phosphatidylcholine headgroup of sphingomyelin45. 
The X-ray crystallography containing the phosphocholine headgroup of SM identified a 
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SM-binding pocket to accommodate the headgroup of SM. The SM-binding pocket 
facilitate the enzymatic activity of SM by stabilizing the headgroup of SM onto the protein. 
The most well studied SM interacting proteins are equinatoxin II (EqtII) and sticholysins I 
(StI) from the sea anemones, Actinia equine and Stichodactyla helianthus, respectively 
50-52. Each actinoporin is known to bind individual SM molecules through a motif 
containing two tryptophan residues, Trp-112 and Trp-133. Tryptophan to alanine 
substitution on EqtII suggests the importance of Trp-112 and Trp-133 for its channel 
activity as well as the SM-liposome binding activity 52. In addition, X-crystal structure also 
demonstrated that the one SM molecule can interact with the tryptophan containing motif 
that were predicted to interact with SM 51. Lysenin, a pore-forming protein from earthworm 
Eisenia foetida, is yet another well characterized SM interacting protein. Biochemical, 
molecular biological as well structural evidence supports strongly that lysenin is only 
specific for SM 48,53-56. Currently, lysenin has been used as the SM specific recognition 
marker. The SM binding motif of lysenin contains tryptophan residues based on alanine 
screening on tryptophan residues.48 In addition, structural evidence suggests lysenin is 
capable of differentiate SM from PC, another lipid containing phosphocholine headgroup, 
with additional motif for the tail of SM48. Lysenin was demonstrated to recognize SM-
enriched microdomain on the plasma membrane57. One conclusion from these SM-
interacting protein is that tryptophan residues are crucial for SM interacting, even though 
additional molecular determinants for sphingomyelin specificity are unique to the 




1.8 p55 structure of VacA and the importance of its subdomain called m region 
 
Based on the crystal structure of the p55 domain, it is well-accepted that the overall 
structure of p55 is a right-handed β-helix58 (Figure 1.6). The crystal structure of p33 has 
not been solved yet. p55 structure has been perhaps studied the most in the context of 
membrane interaction. Specifically, the m region, the most heterogeneous region located 
within p55 domain, was demonstrated to be important for its membrane interaction activity 
15,16,59,60. m region can categorize H. pylori into m1 and m2 strains, based on the toxicity 
of VacA. The non-toxic C-terminus domain of VacA p55 purified from the engineered H. 
pylori strain to contain the partial vacA gene responsible for the C-terminus domain of 
VacA, showed similar cell binding pattern as the holotoxin. This suggests the importance 
of C-terminus of VacA for membrane interaction59. When individual subunits of VacA, N-
terminus and C-terminus forms of VacA, were examined for VacA internalization into the 
cells using fluorescent labeled recombinant VacA subunits purified from E. coli, the 
internalization only happens in when C-terminus subunit of VacA was present, further 
suggesting the importance of p55 domain for membrane interaction 60.  
m region has been suggested to be responsible for cell specificity via possible 
receptor interaction, even though the molecular evidence was still not well understood. 61-
64. When culture filtrates of several H. pylori strains, both m1 and m2 strains, were 
examined for vacuolation activity on HeLa cells, the most well-studied immortalized 
laboratory epithelial cell lines for VacA activity, the culture filtrates of m1 strains, but not 
that of m2 strains, showed cytotoxicity 64. When RK-13 cells, a distinct epithelial cell line 
derived from rabbit kidney epithelial cells, were examined for cytotoxicity, however, the 
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culture filtrates of m2 H. pylori strains, but not that of m1 strains, showed extensive 
cytotoxicity, suggesting the difference on m region may utilize different host cell surface 
molecules as cell receptor for cell specificity. In addition, the difference on m region 
showed two distinctive cell binding pattern depending on the heterogeneity of m region 
65. Examination of VacA binding affinity using a soluble GST-VacA fusion system with m1 
showed very high binding affinity, while m2 VacA showed distinctive binding pattern with 
lower binding affinity. This examination further supports the importance of m region for 
cell specificity: difference on m region confers different binding pattern.  
 
1.9 Gaps in knowledge 
 
VacA utilizes sphingomyelin as the cell surface receptor. However, two underlying 
gaps in knowledge remain. First, the molecular basis of VacA-SM interaction is unclear. 
Based on other SM-interacting proteins, it is reasonable to hypothesize VacA utilizes 
tryptophan with additional molecular determinants for SM interaction in SM-interacting 
binding pocket. I hypothesized that VacA has a distinct SM-binding site. I predict the 
disruption of SM-binding site would lead to disrupt biological activity, membrane 
interaction as well as direct SM-interaction. A second gap in knowledge is the molecular 
basis of the allelic dependent cytotoxicity. Based on the observation in VacA literature, it 
is reasonable to hypothesize that the difference on membrane interaction domain, 
specifically the receptor interacting region, between alleles is important for VacA 
cytotoxicity. I hypothesized that VacA from less toxic alleles has a dysfunctional receptor 
binding site, which induce less cellular cytotoxicity. I predicted that reconstitution of 
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dysfunctional receptor binding site on VacA from nontoxic alleles will restore cellular 
cytotoxicity. 
 
1.10 Significance of this study 
 
Altogether, these studies will address fundamental gaps in knowledge in the study 
of VacA and its interactions with its receptor. By understanding the mechanisms 
governing VacA interacting with SM, not only will a previously undescribed mechanism 
be elucidated, but the knowledge of this molecular mechanism will be the first 
characterized in SM-interacting bacterial toxin. Given that VacA and plasma membrane 
interaction is the most targetable step, our data can be beneficial for inhibitor design in 
the future, which can be used in current H. pylori eradication strategy of antibiotic 
treatment. In addition, understanding the molecular basis of the allelic dependent 
cytotoxicity will be the first molecular evidence to such an important clinical observation 
made almost 25 years ago. Given that the genetic difference of VacA is referred as a 
biomarker for gastric disease, molecular evidence of the allelic dependent cytotoxicity will 














                 
 
Figure 1.1 Graphic representation of Helicobacter pylori 
10,000X magnification scaled CAD drawing of Helicobacter pylori depicting its 























Figure 1.2 H. pylori in a gastric pit.  
This photomicrograph of a section of a biopsy of a 35-year-old man stained with Genta 
stain shows a gastric pit filled with H. pylori. Pictures taken by Robert M. Genta and David 












                   
Figure 1.3. VacA induced vacuolation in HeLa cells.  
Monolayers of mammalian epithelial-derived cells, HeLa cells, were incubated at 37 ˚C in 
the absence or presence of VacA(250 nM). After 16 h, phase contrast images of HeLa 
cells incubated in the absence or presence of wildtype VacA (250 nM) were collected 
(scale bar, 10 µm). The images are representative of those collected during three 






Figure 1.3. VacA induced vacuolation in HeLa cells. 
Monolayers of mammalian epitheial-derived cells, HeLa cells, were incubated at 37 ˚C in the absence or presence of 
VacA(250 nM). After 16 h, phase contrast images of HeLa cells incubated in the a sence or 
presence of wildtype VacA (250 nM) were collected (scale bar, 10 μm). The images are representative of those 
collected during three independent experiments, each performed with three technical replicates (n = 3). 
- VacA + VacA wildtype











Figure 1.4 vacA  gene structure and allelic diversity  
(A) The amino-terminal signal sequence and carboxyl-terminal domain are cleaved from 
the 140-kDa VacA protoxin to yield an 88-kDa mature toxin that is secreted into the 
extracellular space via an autotransporter mechanism. p33 and p55 domains are 
indicated. (B) The structure of the vacA gene and the secretion and proteolytic processing 










                                    
Figure 1.5. A representative cryo-EM image of VacA oligomer 
The image of cryo electron microscopy of VacA showed that the most common form of 
the toxin was a hexamer in shape. The oligomers were approximately 25-30 nm in 
diameter, with a center cavity about 12 – 14 nm in width. The pores formed by VacA are 
anion-selective, bidirectional channels. 







Figure 1.5. A representative cryo-EM image of VacA oliomger
The image of cryo electron microscopy of V cA showed that the mo t common form of the toxin was a hexamer 
in shape. The oligomers were approximately 25-30 nm in diameter, with a center cavity about 12 – 14 nm in 






    
Figure 1.6 The three-dimensional structure of the VacA C-terminal domain 
The structure of the C-terminal domain of VacA (residues 355 - 811; PDB : 2QV3) was 
rendered using PyMol ver.1.8. (open source; www.pymol.org) . The site of tryptophan 603 








Figure 1.7  The three-dimentional structure of the VacA C-terminal domain. 
The structure of the C-terminal domain of VacA (residues 355 - 811; PDB : 2QV3) was rendered using 
PyMol ver.1.8. (open source; www.pymol.org) . The site of tryptophan 603 on the structure is indicated with 
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Chapter 2. Identification of a SM-binding site important for VacA-mediated cellular 





  Vacuolating cytotoxin (VacA) is an intracellular-acting exotoxin secreted from the 
human specific pathogen Helicobacter pylori, which persistently colonizes the gastric 
epithelium. Without medical intervention, chronic colonization by H. pylori increases the 
risk of developing gastric ulcer disease and gastric adenocarcinoma 3. VacA is an 
important factor for H. pylori colonization and disease pathogenesis 11,12,66. Intoxication of 
gastric cells with VacA results in modulation of cellular homeostasis, resulting in several 
consequences, including vacuolation, mitochondrial dysfunction, and cell death 15,16.  
  In order to modulate host cells, intracellular-acting exotoxins must breach the 
plasma membrane barrier as a requisite step for accessing their intracellular targets 36. 
Toxin internalization generally involves binding to one-or-more specific toxin receptors on 
the surface of host cells, which, in part, is critical for positioning the toxin in close 
juxtaposition to existing cellular uptake machinery 36. VacA internalization has been 
demonstrated to occur by a Cdc42-dependent pinocytic mechanism that localizes the 
toxin initially into a class of early uptake vesicles called GPI-anchored protein enriched 
compartments (GEECs) 37,38. Although a number of cell surface components have been 
reported as VacA receptors 24,39-42, the fate of VacA within cells is dependent, in part, on 
an abundant lipid component of the plasma membrane outer leaflet, sphingomyelin (SM) 
43. SM has been demonstrated to be important for binding of the toxin to the plasma 
membrane, and subsequent VacA cellular activity. In addition, a fraction of total 
membrane-bound VacA partitions into SM-enriched membrane rafts 43, which is important 
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for toxin uptake and cellular activity. Finally, using an ELISA-based, lipid-binding assay, 
VacA was demonstrated to bind SM directly and highly preferentially over other common 
lipids with non-phosphorylcholine headgroups 43. These data support a model that SM 
functions as a VacA receptor on the surface of sensitive cultured cells. However, these 
earlier studies did not address the molecular details underlying VacA-SM interactions. 
  Here, we describe studies to identify the VacA SM-binding site. Although the 
identification of a conserved sequence or structural motif for protein-SM interactions has 
remained elusive, several studies have indicated the importance of aromatic residues, 
and tryptophan, in particular, for promoting protein interactions with the exposed 
phosphorylcholine headgroup of plasma membrane embedded SM 44-46,48,67-69. Using 
bioinformatics, scanning mutagenesis, computational simulations, and biochemical 
characterization, we identified three residues in the carboxyl-terminal domain of VacA, 
R552, W603, and R647 that, together, function in a synergistic manner to promote VacA 
cellular activity, VacA partitioning into SM-enriched membrane rafts, and VacA-SM 
interactions. These studies advance our understanding of the molecular basis underlying 
VacA interactions with gastric cells, and, provide the framework for developing measures 
to block these interactions.  
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2.2 Methods and Materials 
2.2.1 Bacterial strains and growth conditions 
 
 H. pylori 60190 (49503; ATCC, Manassas, VA) and all other H pylori strains, listed in 
Table S1, were cultured under biphasic conditions at 37 ºC under 5% CO2 and 10% O2 
within a humidified environment, using bisulfite- and sulfite-free Brucella broth (BSFB) 
broth (dextrose; 0.1%, β -cyclodextrin; 0.2%, NaCl; 0.5%, Sigma-Aldrich, St. Louis, MO, 
and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2%, BD Biosciences, Sparks, MD) 
containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, MO) on Ham F-12 plates 
supplemented with fetal bovine serum (FBS, 10%; Atlanta Biologicals Inc., Flowery 
Branch, GA) 70. For genetic manipulation, H. pylori VM022 (∆vacA) was utilized 30. H. 
pylori VM022 was cultured at 37 ºC under 5% CO2 and 10% O2 within a humidified 
environment on Columbia blood agar (CBA) plates supplemented with vancomycin (10 
µg / mL; Oxoid, Hampshire, UK), trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; 
Oxoid), and amphotericin B (5 µg / mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, 
MO) with 10% defibrinated sheep blood (Hemostat Laboratories, Dixon, CA). For 
selection of H. pylori transformants, the CBA plates supplemented with sucrose (100 mg 
/ mL; Sigma-Aldrich) were used in place of kanamycin.   
 
2.2.2 DNA manipulation and plasmid construction 
 
Genomic DNA was extracted from H. pylori 60190 using Wizard genomic DNA 
purification kit (Promega Corp., Madison, WI). A 4513-bp fragment of the vacA gene was 
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amplified from the genomic DNA by polymerase chain reaction (PCR) using the 
oligonucleotides, BamHI-vacA-F (5´-CGCGCGGATCCAACTGCTTGGCATCGGG-3´) 
and vacA-BamHI-R (5´- GCGCGCGGATCCATTTCAAACCCATGCTTTGAGC-3´) 
(ordered from IDTDNA, Coralville, IA). The 4513-bp fragment of the amplified vacA gene 
was digested with BamHI and ligated with BglII digested pHel2 71, a chloramphenicol 
resistant plasmid (kindly gifted by Dr. Ritesh Kumar, the University of Illinois at Urbana-
Champaign, IL), to generate vacA gene containing plasmid, named pHel2-vacA. 
Alteration of vacA gene on pHel2-vacA was performed with the QuikChange site-directed 
mutagenesis kit (Strategene, San Diego, CA) using the oligonucleotides listed in Table 
S2. The resulting constructs were fully sequenced at the Roy J. Carver Biotechnology 
Center at the University of Illinois at Urbana-Champaign and were compared with wildtype 
sequence using nucleotide BLAST of NIH (https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
2.2.3 Alteration on vacA gene of H. pylori by allelic-exchange strategy  
 
pHel2-vacA and its derived plasmids, listed in Table S3, were introduced into 
naturally-competent H. pylori VM022 30, by using natural transformation 72. The H. pylori 
transformants were obtained by sacB-based counter selection 73. Briefly, fresh growing 
cultures of H. pylori VM022 were prepared by incubating the H. pylori culture at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment on Columbia blood agar 
(CBA) plates supplemented with vancomycin (10 µg / mL; Oxoid, Hampshire, UK), 
trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; Oxoid), and amphotericin B (5 µg 
/ mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, MO) with 10% defibrinated sheep 
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blood (Hemostat Laboratories, Dixon, CA). After 3 days, the culture of H. pylori was 
transferred to a fresh cold CBA plate with kanamycin. After 6 h, pHel2-vacA and its 
derivatives (concentration: 3–10 µg) were dropped on the top of H. pylori culture and 
mixed using a spreader. After 6 h, H. pylori was scraped from the plate and transferred 
to a cold CBA plate supplemented with sucrose (100 mg / mL; Sigma-Aldrich), allowing 
homologous recombination to occur between the endogenous vacA and the vacA gene 
on the plasmid. After 8 -10 days, H. pylori transformants were picked on both a new CBA 
plates supplemented with sucrose (100 mg / mL; Sigma-Aldrich) and a new CBA plates 
supplemented with kanamycin (30 µg / mL; Sigma-Aldrich, MO). Colonies formed on the 
sucrose CBA plates, but not on the kanamycin CBA plates, were assumed to be 
successful H. pylori transformants. vacA gene from the possibly successful H. pylori 
transformants were fully sequenced at Roy J. Carver Biotechnology Center at the 
University of Illinois at Urbana-Champaign and were compared with the wildtype 
sequence using nucleotide BLAST of NIH (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Yield 
of obtaining successful H. pylori transformants by this method was about 30%. 
Replication of pHEL2 or its derivatives in H. pylori was not observed, based on multiple 
trials to extract the plasmids from log-phase growth of H. pylori culture (8-10 h incubation) 
using Miniprep plasmid extraction kit (Qiagen Inc., Valencia, CA). 
 
2.2.4 Purification of VacA  
 
VacA and its derived version of toxins were purified, as previously described 20. 
Briefly, H. pylori 60190 and all of its derived strains were cultured on biphasic conditions 
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using BSFB broth (dextrose; 0.1%, β-cyclodextrin; 0.2%, sodium chloride; 0.5%, Sigma-
Aldrich, St. Louis, MO, and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2 %, BD 
Biosciences, Sparks, MD) containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, 
MO) on Ham F-12 plates supplemented with FBS (10%, Atlanta Biologicals Inc.) at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment. After 48 h, the liquid phase 
containing H. pylori growth was transferred to a fresh BSFB liquid culture and further 
incubated at 37 ºC under 5% CO2 and 10% O2 within a humidified environment.  After 48 
h, the supernatant of the H. pylori culture was collected by centrifugation at 8000 xg for 
15 min at 4 ºC. The supernatant was then precipitated 4 ºC with ammonium sulfate (Fisher 
Scientific, Fair Lawn, NJ) to 90% saturation (662 g / L). After 16 h, the precipitates were 
dissolved in the wash buffer (10 mM sodium phosphate dibasic, pH 7.0; Sigma-Aldrich) 
and dialyzed in the same buffer using a dialysis membrane (Spectra/PorTM RC/MWCO; 
50kDa, Spectrum Labs, Rancho Dominquez, CA). After removing the insoluble fractions 
by centrifugation at 8000xg for 15 min at 4 ºC followed by filtration using a filtered funnel 
(Stericup©, MWCO; 0.22 μm; EMD Millipore, Billerica, MA), the VacA containing soluble 
fraction was loaded into a column embedded with an anion exchange resin (DEAE 
Sephacel™, GE healthcare, Little Chalfont, UK). After washing the column with 3 bed 
volumes of the wash buffer, VacA was eluted with the wash buffer supplemented with 0.2 
M sodium chloride, and collected into small fractions (1.5 mL each). The fractions 
collected were checked for purity by SDS-PAGE gel separation and Coomassie Brilliant 
Blue staining. Fractions with visibly pure VacA were dialyzed in PBS (pH7.4, 4 ºC) using 
a dialysis cassette (Slide-A-LyzerTM, MWCO; 20kDa, Thermo Fisher Scientific, Walthan, 
MA). The final concentration of VacA was determined by measuring the total protein 
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concentration using the BCA assay, using bovine serum albumin (BSA) to generate a 
standard curve (0.025 – 1.5 mg / mL). 
2.2.5 Western blot analysis of VacA 
 Protein lysates for western blot analysis were prepared by mixing protein samples, 
or cell lysates, with the equivalent volume of 2X Laemmli sample buffer (Bio-Rad 
Laboratories Inc, CA) and then incubated at 100 ºC  for 10 min for protein denaturation. 
After the standard SDS-PAGE gel separation and transfer to PVDF membrane 
(Immobilon®-P, Pore size; 0.45 μm, Merck Millipore, Tullagreen, Ireland), the blots were 
incubated overnight at 4 °C with primary antibodies diluted in Tris-buffered (pH 7.4) saline 
with 0.1% Tween 20 (TBS-T), supplemented with 5% skim milk (blocking buffer), and then 
for 1 h at room temperature with HRP-conjugated secondary antibodies (1:10000 dilution; 
Cell Signaling, Danvers, MA) diluted in the blocking buffer. After washing 4 times with 
TBS-T for 5 min each, the blots were incubated with HRP substrates (SuperSignal® West, 
Pico and Femto mixed at 4:1 ratio; Thermo Scientific, Rockford, IL). The luminescent 
signals from the blots were imaged using ChemiDoc™ XRS+ imaging system (Bio-Rad, 
Hercules, CA), and, analyzed using Image Lab™ software (Version 4.1; Bio-Rad, 
Hercules, CA) for quantification of the relative band intensities. 
2.2.6 Incubation of VacA with N-bromosuccinimide (NBS) 
 Tryptophan modification by incubating proteins with N-bromosuccinimide (NBS; 
Sigma-Aldrich), a tryptophan specific oxidizing agent, was well-described previously 74-77. 
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Briefly, purified VacA was incubated with NBS (in PBS, pH 7.4) at room temperature in 
the dark. After 5 min, 100-molar excess of L-tryptophan (Sigma-Aldrich, MO), towards the 
concentration of NBS, was added at room temperature in the dark to prevent further 
oxidizing reaction of NBS on VacA. To remove free L-tryptophan from purified VacA, the 
NBS-reacted solution was dialyzed in PBS using a dialysis cassette (Slide-A-LyzerTM, 
MWCO; 20kDa, Thermo Fisher Scientific, Walthan, MA). In order to demonstrate the 
tryptophan modification by NBS incubation, Bovine Serum Albumin (BSA; Sigma-Aldrich, 
MO), a 66 kDa protein containing two tryptophan residues (Trp-134 and Trp-213), was 
incubated with NBS using the method described above. The fluorescence of tryptophan 
(absorbance at 295 nm / fluorescence emission at 350 nm) in BSA incubated with NBS, 
was reduced by 4-fold at 1: 10 molar ratios between BSA and NBS. NBS incubation on 
BCA did not seem to degrade the protein, based on the visible analysis of the treated 
BSA on the Coomassie Brilliant Blue staining. The final concentration of VacA was 
determined by measuring the total protein concentration using BCA assay, using bovine 
serum albumin (BSA) to generate a standard curve (0.025 – 1.5 mg / mL).  
2.2.7 Mammalian cell culture 
All cultured mammalian cell lines were maintained at 37 °C and under 5% CO2 
within a humidified environment. AZ-521 cells (3940; RIKEN, Japan) and HeLa (CCL-2; 
ATCC) were maintained in Minimum Essential Medium (MEM; Corning Life Sciences, 
Tewksbury, MA) with 10% FBS (Atlanta Biologicals Inc., GA). AGS cells (CRL-1739; 
ATCC) were grown in Dulbecco’s Modified Eagle Medium (DMEM; Corning Life Sciences, 
MA) supplemented with 10% FBS (Atlanta Biologicals Inc.). Tissue culture media were 
	 36	
supplemented with glutamine (2 mM; Corning), penicillin (100 U / mL; Corning), and 
streptomycin sulfate (1 mg / mL; Corning). Unless otherwise indicated, cells were seeded 
in 96 well plates at a confluency not exceeding 90% (2.5 x 104 cells / well).  
2.2.8 Preparation of primary gastric epithelial cells from mice 
 All experiments involving the use of live vertebrate animals were conducted with the 
approval of the University of Illinois at Urbana-Champaign Institutional Animal Care and 
Use Committee (IACUC) under Protocol #15238.  Animal populations were composed of 
male and female C57BL/6J (Jackson Laboratories) mice bred within the School of 
Molecular and Cellular Biology Animal Care Unit. Animals were housed with 12 h light-
dark cycles, mean temperature of 22.1 °C, humidity of 50%, and allowed food and water 
ab litum. 
 Cultures of primary gastric epithelial cells were prepared as previously described 78,79 
with modification 80. Briefly, mice stomachs were obtained from 12–17 week-old C57BL / 
6J mice following euthanasia by CO2 asphyxiation. After removing the light-colored 
portion that represents forestomach, the stomachs were opened with surgical scissors 
through the high curvature side, across from esophagus to duodenum, and rinsed 
thoroughly with PBS (pH 7.4, 4 °C). After removing the forestomach, the stomachs were 
roughly minced using scissors, and incubated at 37 °C and under 5% CO2 within a 
humidified environment in the cell dissociation medium consisting of DMEM/ F-12 (Sigma) 
supplemented with FBS (2.5%; Atlanta Biological Inc., GA), collagenase type IV (125 U / 
ml; Sigma), dispase II (2 U / ml; Sigma), CaCl2 (5 mM; Sigma), MgCl2 (2 mM; Sigma), Y-
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27632 dihydrochloride (10 nM; Selleck Chemicals, Houston, TX), and N-acetyl-L-cysteine 
(NAC) (2 mM; Sigma). After 1 h, the large chunks of tissue debris were removed by 
filtrating the dissociated cells through a cell strainer (Corning® cell strainer, size; 100 µm, 
Sigma-Aldrich, St. Louis, MO). The collagenase and dispase activities within the filtrate 
containing the dissociated cells were neutralized by adding EDTA (5 mM, pH 8.0; 
Invitrogen, Eugene, OR) solution diluted in PBS (pH 7.4, 4 °C). The dissociated cells 
within the filtrate were pelleted by centrifugation at 100 g for 7 min at 4 °C, and 
resuspended in EDTA free PBS (pH 7.4, 4 °C). The non-epithelial cells within the cell 
suspension were removed by filtrating the dissociated cells through a cell strainer 
(Corning® cell strainer, size; 70 µm, Sigma-Aldrich, St. Louis, MO). The epithelial cells 
within the filtrates were pelleted by centrifugation at 100 xg for 7 min at 4 °C, and then 
resuspended in the culture medium consisting of DMEM / F-12 supplemented with FBS 
(2.5%; Sigma-Aldrich, St. Louis, MO), amphotericin B (125 mg/mL; Sigma-Aldrich, St. 
Louis, MO), penicillin/streptomycin (1%; Sigma-Aldrich, St. Louis, MO), ITS (1%; Gemini 
Bio-Products, San Diego, CA), mouse derived EGF (10 µg/mL; Gemini Bio-Products, San 
Diego, CA), Y-27632 dichloride (10 nM; Selleck chemicals, Houston, TX), and NAC (2 
mM; Sigma-Aldrich, St. Louis, MO), and then seeded on 96 well plates (3 x 104 cells / 
mL), which were pre-coated with an extracellular matrix (ECM) (Corning® Matrigel ®, 2%, 
Sigma-Aldrich, St. Louis, MO). The seeded cells were maintained at 37 °C and under 5% 
CO2 within a humidified environment. The seeded cells were confirmed positive for the 
epithelial cellular markers ZO-1 (for tight junction, N-term; ThermoFisher, CA), E-cadherin 
(for adherent junction, DECMA-1; Sigma-Aldrich, MO), cyto18 (for cytokeratin 18, RGE53; 
Santa Cruz Biotechnology, Dallas, TX), and, negative for both mesenchymal (vimentin 
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for intermediate filaments, V9; Santa Cruz Biotechnology) and endothelial / fibroblast 
cellular markers (for smooth muscle actin, SMA; Santa Cruz Biotechnology). After 48 h, 
the cells that established attachment to the well bottoms were washed once with, and 
incubated in the pre-warmed intoxication medium (the culture medium lacking 
amphotericin B, Y-27632 dichloride, and NAC) for 1 h, before commencing the 
experiment. 
2.2.9 Qualitative and quantitative analysis of vacuole biogenesis on cells.  
 Monolayers of AZ-521, AGS, HeLa or primary gastric epithelial cells from mice, were 
cultured in 96 well plates and allowed to adhere at 37 ºC, 5% CO2, in humidified 
atmosphere. After 16 h, the cells were incubated at 4 °C to prevent toxin uptake from the 
cell surface to occur. The cells then received experimental treatment in cell culture 
medium containing ammonium chloride (5 mM; Sigma-Aldrich, MO) with a duplicate 
experimental set on the same plate, one for vacuolation measurement and the other for 
total protein measurement. Following experimentation, cells were imaged for qualitative 
vacuole biogenesis by light microscopy. Cells with more than 4-5 visible vacuoles 
observed throughout the cytosol of the cells were qualified as VacA-mediated vacuolated 
cells. 
 After cell imaging, the monolayers were washed twice with PBS (pH 7.4) for 
quantitative analysis. To measure vacuole biogenesis on cells, one experimental set was 
incubated at 37 ºC with Neutral Red solution (Sigma-Aldrich) (100 µL / well, diluted 1:5 
with PBS, pH 7.4). After 4 min, cells were washed three times with PBS (pH 7.4, 4 ºC) to 
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remove residual neutral red. The cells within the wells were lysed by adding acid alcohol 
(100 µL / well, 3.7% hydrochloride, 70% ethanol, in diH2O) and the colorimetry of the 
neutral red on the plates was measured at 530 nm and 410 nm using a microplate reader 
(BioTek, Winooski, VT). To measure total protein concentration, another experimental set 
was lysed in RIPA buffer (30 µL / well, Thermo Fisher), followed by incubation at 37 ºC 
with BCA reagent (200 µL / well, Thermo Fisher). After 30 min, total protein was measured 
at 562 nm using a microplate reader (BioTek, Winooski, VT). The total protein 
concentration was determined by BCA assay, using bovine serum albumin (BSA) to 
generate a standard curve (0.025 – 1.5 mg / mL). The neutral red uptake data were 
normalized to the respective total protein measurement under the same experimental 
treatment and relativized to the respective untreated control. 
2.2.10 SM quantification  
 Cellular SM levels were measured using the Amplex Red Sphingomyelinase Assay kit 
(Invitrogen; Eugene, OR), adapted from this publication 81. Monolayers of cells, AZ-521, 
AGS, HeLa, or primary gastric epithelial cells from mice at 37 ºC, 5% CO2, and in a 
humidified atmosphere, were incubated in the presence of SMase C (200 mU / mL in PBS 
pH 7.4, 37 °C; Sigma-Aldrich, MO), or sphingomyelin (SM, 35  µM in PBS pH 7.4, 37 °C; 
Avanti Lipids, AL). After 1 h, the plates were place on ice. After 30 min, cells were washed 
with PBS (pH 7.4, 4 °C) three times. The cells in each well were lysed by rotating on a 
rocker at 4 °C with 2% Triton X-100 (200 µL / well, in PBS, pH 7.4, 4 °C; Sigma-Aldrich, 
MO). After 30 min, the lysates were collected and spun at 13,000 g for 10 min at 4 °C. To 
quantify cellular SM in lysates, the lysates (50 µl each) were incubated at 4 °C with 
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Amplex Red reagent (50 µl each), as described in manufacturers’ manual. After 30 min, 
the fluorescence of resorufin (absorbance at 571 nm / fluorescence emission at 583 nm), 
a byproduct of reaction between SM and Amplex Red reagent, was measured by a 
fluorescence microplate reader (BioTek, Winooski, VT). For total cellular SM contents of 
the cells, a set of standards from 100 µmol of sphingomyelin (SM) to 0 µmol were used.  
To measure total protein concentration in lysates, the lysates (10 µl each) were incubated 
at 37 ºC for 30 min with BCA reagent (100 µl each, Thermo Fisher). The total protein 
concentration was determined by BCA assay, using bovine serum albumin (BSA) to 
generate a standard curve (0.025 – 1.5 mg / mL). The cellular SM content were 
normalized to the respective total protein measurement under the same experimental 
treatment and relativized to the respective untreated control. 
2.2.11 Lipid binding assay 
 A solid state ELISA assay was used to quantify VacA binding to lipids as previously 
described 43,55,82. 96 well Immulon 1B microtiter plates (Thermo Scientific, Rockford, IL) 
were incubated with the indicated concentrations of SM (860062p; Avanti, AL), 
phosphatidylcholine (PC, 840053p; Avanti), ceramide (Cer, 860518p; Avanti), 
phosphatidylinositol (PI, 840042p; Avanti), phosphatidylethanolamine (PE, 840022p; 
Avanti), or mock control at room temperature. After 2h or the lipids were visibly dried, the 
wells were blocked using 3% BSA diluted in PBS (pH 7.4) at room temperature. After 1.5 
h, each well was incubated with VacA in 3% BSA diluted in PBS (pH 7.4) at 4 °C. After 
16 h, the wells were washed out with PBS (pH 7.4) to remove unbound toxins from the 
wells. The wells were then incubated at room temperature with polyclonal rabbit α-VacA 
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antibody for 2 h, followed by HRP-conjugated α-rabbit antibody (Cell Signaling 
Technology, Danvers, MA). After 40 min, the wells were washed with PBS (pH 7.4) six 
times. Degree of VacA binding on the lipid-coated plates was determined by colorimetric 
method using Ultra TMB-ELISA substrate (50 µl / well; Thermo Fisher, IL). After 10 min, 
the color development was stopped by adding sulfuric acid (2M, 50 µl / well; Thermo 
Fisher) and the colorimetry was measured by using a microplate reader (BioTek, 
Winooski, VT).  
2.2.12 Computational model of VacA-SM interactions 
 MD simulation of VacA was performed in a 90 Å ´ 90 Å ´ 130 Å rectangular cube 
(106,450 atoms total) in which the p55 domain of VacA solvated with 32,674 TIP3P water 
molecules, neutralized and ionized with 200 mM NaCl. The VacA structure was obtained 
from PDB entry 2QV3 resolved by X-ray crystallography at 2.4 Å resolution 58. The 
solvated and ionized VacA complex was equilibrated for 20 ns to allow for the relaxation 
of the crystal structure under the simulation condition. 
 The simulation was performed using the NAMD2 program 83 with the integration time 
of 2 fs with periodic boundary condition. It was at 310 K maintained by Langevin dynamics 
with a damping coefficient of 1 ps-1 and 1 atm maintained by the Nose-Hoover Langevin 
piston method 84,85 with a piston period of 200 fs. All bonds involving hydrogen atoms 
were kept rigid using the SHAKE algorithm 86. The particle mesh Ewald method 87 was 
used to evaluate long-range electrostatic interactions, and the cutoff for van der Waals 
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interactions was set at 12Å. The simulated atoms were described by the CHARMM36 
force field parameter sets 88-90. 
 Phosphatidylcholine (PC) was used as the molecule for identifying potential binding 
sites of sphingomyelin, which contains a phosphorylcholine head group. To expedite the 
probing, 50 PC molecules were added to the 20-ns equilibrated VacA complex. The PC-
VacA complex was simulated for 250 ns. The simulated trajectory, comprising 25,000 
frames, was analyzed by the VMD’s VolMap plugin to determine the binding sites of PC 
molecules. The PC molecules were considered to bind the protein if they were within 5Å 
of the protein.  
2.2.13 Computational model of VacA and plasma membrane interactions. 
 Membrane preparation is previously described (REF). Briefly, the highly mobile 
membrane-mimetic (HMMM) model was constructed by placing two leaflets of divaleryl-
phosphatidylecholine (DVPC), each composed of 1188 lipids and solvated by water at an 
~43:1 water/lipid ratio were simulated. The DVPC molecules were generated by 
shortening the lipid tails of a palmitoyl-oleoyl-phosphatidylcholine (POPC) molecules to 
only 5 carbons (REF). The HMMM membrane was assembled with Packmol, employing 
a DCLE box with dimensions of 65 Å x 65 Å X 72 Å. The resulting structure was then 
solvated using the SOLVATE plugin of VMD, resulting in a system with ~23000 atoms. 
The solvated membrane system was energy minimized and simulated for 2 ns, using an 
NPnAT ensembles at 1.0 atm and 310 K and with a time step of 2 fs. Constant pressure 
was maintained by using the Nosé-Hoover Langevin piston method and constant 
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temperature was maintained by Langevin dynamics with a damping coefficient g of 0.5 
ps-1 applied to all atoms. The resulting membrane was then employed in the subsequent 
VacA-membrane binding simulations. 
 The p55 domain of VacA was solvated with 32,674 TIP3P water molecules, neutralized 
and ionized with 200 mM NaCl. The VacA structure was obtained from PDB entry 2QV3 
resolved by X-ray crystallography at 2.4 Å resolution 58. The solvated and ionized VacA 
complex was equilibrated for 20 ns to allow for the relaxation of the crystal structure under 
the simulation condition.  
 VacA (residues 355 - 811; PDB: 2QV3), after solvation and ionization, was added to a 
highly mobile membrane-mimetic (HMMM) model, which was constructed by placing two 
leaflets of divaleryl-phosphatidylcholine (DVPC). VacA is initially placed where its center 
of mass (COM) is positioned 20 - 28 Å above the phosphorus plane of  
the leaflet that faces VacA, without contacting the model membrane. The VacA - 
membrane systems consisted of a rectangular cube with dimensions of 65 Å x 65 Å X 72 
Å. The systems were energy-minimized for initial 50 ps and simulated for 375 ns using 
NAMD2, utilizing the CHARMM27 force field with CMAP corrections for proteins 
 and CHARMM36 parameters for lipids. Three independent simulations were performed 
(n =3). All the HMMM simulations were performed in NPnAT ensembles at 1.0 atm and 
310 K and with a time step of 2 fs. Constant pressure was maintained by using the Nosé-
Hoover Langevin piston method and constant temperature was maintained by Langevin 
dynamics with a damping coefficient g of 0.5 ps-1 applied to all atoms. The one successful 
simulation was analyzed and visualized using VMD.  
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2.2.14 Protease sensitivity assay 
 To assess gross structural perturbations of the mutant VacA toxins relative to wildtype 
VacA, the protein’s sensitivity to proteolytic digestion with trypsin 91 was evaluated. Briefly, 
purified toxins were incubated at room temperature with or without trypsin (PBS, pH 7.4; 
Sigma-Aldrich, MO). After 1 h, trypsin digestion was stopped by addition of SDS-
polyacrylamide sample buffer (Bio-Rad, Hercules, CA) containing ß-ME (Thermo Fisher, 
IL) and heating at 100 ̊ C for 10 min. The samples were analyzed by Western blot analysis, 
using rabbit anti-VacA antibodies prepared as described above under “Western blot 
analysis of VacA.” The resulting dose-dependent banding patterns were visually 
evaluated for gross differences, which would be interpreted to suggested in overall VacA 
structure resulting in altered sensitivity to the protease.   
2.2.15 Glycerol gradient sedimentation assay  
 To distinguish between the monomeric and oligomeric forms of VacA, glycerol gradient 
sedimentation was employed as described previously 20. 3.5-ml 0- 40% glycerol gradients 
were prepared in either a neutral pH buffer (60 mM Tris-HCl, 100 mM NaCl, pH 7.4) or 
an acidic pH buffer (100 mM glycine, 100 mM NaCl, pH 3.0). 1 mL of 40% glycerol was 
overlaid with 2 mL of 20% glycerol, which was topped with 0.5 mL of the pH buffers 
without glycerol. Purified toxins were layered on the top of the gradients and centrifuged 
at 4 ˚C at 35, 000 g for 16 hrs. Six fractions (580 µl each) were collected from the top to 
the bottom of the gradient. Each fraction was resolved using SDS-PAGE, and VacA was 
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detected by immunoblot analysis employing the polyclonal rabbit a-VacA antibody, as 
described above under “Western blot analysis of VacA.”  
2.2.16 Flow cytometry 
 Analytical flow cytometry was carried out using a BD FACSCanto II flow analyzer (BD 
Biosciences, San Jose, CA).  Cell analyses were standardized for scatter and 
fluorescence utilizing fluorescently labeled compensation beads. Events were recorded 
on a log fluorescence scale and the geometric mean fluorescence values were 
determined using FCS Express 6.0 (De Novo Software, Glendale, CA). 
2.2.17 VacA binding to cell surface of epithelial cells 
 
 Flow cytometry analyses of VacA binding was conducted using suspensions (106 cells 
/ mL) of AZ-521, AGS, or HeLa cells. In some experiments, cells were pre-incubated in 
the presence of SMase C (200 mU / mL) or the vehicle control (PBS, pH 7.4, 4 °C) at 
37 °C for 1 h prior to VacA exposure. The total cellular SM for the cells was confirmed 
using the Amplex Red fluorescent-based SM quantification method described above 
under “SM quantification.” Cells were chilled to 4 °C prior to toxin exposure. After 20 min, 
the cells were incubated with VacA at 4 °C. After 30 min, the cells were then washed with 
PBS (pH 7.4, 4 ˚C) and fixed by incubating with formaldehyde (4 %) in PBS (pH 7.4, 4 
˚C). After 20 min, the cells were washed and incubated at 4 ˚C with polyclonal rabbit a-
VacA antibody in a rotary shaker. Cells were washed and incubated with Alexa Flour 488-
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conjugated goat a-rabbit antibody (Thermo Fisher, CA). After 1 h, cells were analyzed by 
flow cytometry.  
2.2.18 Alexa Fluor 488 labeling of VacA 
 Purified toxin was conjugated with Alexa Fluor 488, using the Alexa Fluor labeling kit 
(Invitrogen, CA) according to the manufacturer’s instructions. Briefly, purified VacA (250 
µL, 3 µM, PBS pH 7.4) was incubated with sodium bicarbonate (25 µL, 1M; Sigma-Aldrich, 
MO). After 5 min, VacA was incubated with Alexa Fluor 488 (10 µL, in DMSO) at room 
temperature in the dark. After 1 h, 1000-molar excess of 2 M Tris buffer (in PBS pH 8.0, 
Sigma-Aldrich) towards the concentration of VacA, was added at room temperature in the 
dark to stop the conjugation reaction. To remove free Tris from purified VacA, the Alex 
Fluor 488 conjugation solution was dialyzed in PBS (pH 7.4) using a dialysis cassette 
(Slide-A-LyzerTM, MWCO; 20kDa, Thermo Fisher Scientific, Walthan, MA). The final 
concentration of VacA was determined by measuring the total protein concentration using 
BCA assay with a set of bovine serum albumin (BSA) standards (0.025 – 1.5 mg/mL). 
Alexa Fluor 488 labeling of VacA was experimentally determined to not have detectable 
effects on the capacity of toxin to induce vacuole biogenesis on cells.  
2.2.19 Competitive cell surface VacA binding experiments  
 Flow cytometry analysis of VacA binding was carried out (106 cells / mL in suspension) 
using AZ-521, AGS, or HeLa cells. Cells were pre-chilled to 4°C and incubated at 4°C 
with activated Alexa Fluor 488-labeled toxins in the absence or presence of 100 molar 
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excess of unlabeled VacA. After 30 min, cells were washed with PBS (pH 7.4, 4 ˚C) and 
fixed by incubating with formaldehyde (4%) in PBS (pH 7.4, 4 ̊ C). After 20 min, cells were 
washed were analyzed for VacA binding to the cell surface by flow cytometry.  
2.2.20 Preparation of DRMs 
 Detergent resistant membrane (DRM) fraction preparations and analyses were 
performed as previously described 92,93. DRMs were fractionated using Optiprep (Axis-
shield, Oslo, Norway) density centrifugation. AZ-521, AGS, or HeLa cells (4 X 106 cells / 
mL in suspension), were incubated at 4 °C in the presence or absence of SMase (200 
mU / mL). After 1 h, the cells were chilled on ice. After 30 min, cells were further incubated 
on ice with pre-chilled toxins (500 nM). After 30 min, cells were washed once with PBS 
(pH 7.4, 4 °C) and collected by centrifugation at 300 xg at 4 °C. After 5 min, the cell pellet 
was resuspended in TNE buffer (25 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, pH 7.4, 
4 °C) containing Protease Inhibitor cocktail, Complete Mini (EDTA free; Roche). The 
suspended cells were lysed by 15 passages through a 25-gauge needle. Membranes 
were solubilized by adding Triton X-100 (1% final concentration in TNE, 4 °C) and 
incubated further at 4 °C on a rotary shaker. After 1 h, the lysates were adjusted to 40% 
Optiprep (500 µL) and loaded into the bottom of Beckman thick walled polycarbonate 
tubes, overlaid with 2 mL of 20% Optiprep medium in TNE buffer, which was subsequently 
topped with TNE buffer (500 µL). The gradient was centrifuged at 35,000 xg. After 4 h, 
six fractions (580 µL each) were collected from the top to the bottom of the Optiprep 
gradient. The fractions were analyzed by Western blot analysis, using rabbit anti-VacA 
antibodies prepared as described above under “Western blot analysis of VacA.” 
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2.2.21 Statistical analysis 
 Unless otherwise indicated, each experiment consisted of 3 independent replicates, 
each comprise of three technical replicates. Statistical analyses were performed using 
Prism 6.0e (GraphPad Software Inc., La Jolla, CA). Error bars indicate standard 
deviations. All P values were calculated using either the t test with paired, two-tailed, one-
way ANOVA, or two-way ANOVA (corrected using Sidak’s multiple comparisons test). A 




2.3.1 The tryptophan-modification reagent, N-bromosuccinimide, attenuates VacA 
cellular activity 
 
 Previously, we identified the abundant plasma membrane sphingolipid, sphingomyelin 
(SM), as a VacA receptor that is important for toxin cell surface binding and activity 43,93 
(Figure 2.1). However, our previous investigations did not address the molecular basis 
by which VacA associates with SM. In this study, we evaluated the overall hypothesis that 
the SM-dependent cellular activity of VacA is mediated through a specific SM binding site. 
A prediction of this hypothesis is that if VacA possesses a specific SM-binding site, then 
deliberate disruption of the receptor-binding site would attenuate VacA cellular activity. 
To begin testing this prediction, we took advantage of previous published efforts to 
understand protein-SM interactions.  Although specific, conserved sequence motifs for 
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SM interactions have not been identified, structural 44-46 and biochemical 44,47-49 
approaches revealed a potential role for aromatic residues, and in particular, tryptophan 
residues, in mediating protein-SM interactions. Based on these studies, we first 
addressed the potential importance of VacA tryptophan residues for the toxin’s cellular 
activity.  
 During our initial studies, we examined the effects of exposing purified VacA to the 
chemical modifying agent N – bromosuccinimide (NBS) on toxin-mediated cellular 
activity. NBS, which oxidizes the indole rings of accessible tryptophan residues, has been 
used in a number of studies to interrogate the importance of tryptophan residues for 
protein function 52,75,76,94,95. For these, and all subsequent studies, we used an s1i1m1 
allelic form of VacA, which, in vitro, demonstrates a high level of cellular activity 17,96. More 
specifically, we used VacA from culture filtrates of H. pylori 60190, which possesses 
eleven tryptophan residues within the 88 kDa mature form of the toxin. Monolayers of 
human-derived AZ-521 epithelial-like cells, which have been extensively used as an in 
vitro model to study VacA-cell interactions 23,24,40,97-99, were incubated at 37 °C in the 
absence or presence of VacA (250 nM) that had been pre-incubated in the absence or 
presence of NBS (11 µM) (Figure 2.2). After 16 h, the monolayers were evaluated for 
relative vacuole biogenesis using light microscopy, as well as by measuring the uptake 
of the acidotropic dye, neutral red 16,26,100. These studies revealed visibly fewer 
intracellular vacuoles within monolayers of cells incubated with VacA pretreated with NBS 
relative to cells incubated with mock-pretreated VacA (i.e. PBS pH 7.4 in the place of 
NBS) (Figure 2.3A). These imaging results were validated using the neutral red uptake 
assay, in which the lysates from cells that had been incubated with VacA pretreated with 
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NBS yielded significantly less absorbance at 520 nm than lysates from cells incubated 
with mock-pretreated VacA (Figure 2.3B). These data indicated that significantly less 
neutral red had been taken up into monolayers of cells that had been incubated with VacA 
pretreated with NBS than mock-pretreated VacA, denoting less vacuole biogenesis in 
cells that had been exposed to NBS-pretreated VacA. These results are consistent with 
the idea that NBS-pretreatment had inactivated VacA, suggesting that one or more 
tryptophan residues of VacA are important for toxin function. However, these studies did 
not address which tryptophan residue or residues might be required for VacA-mediated 
cellular activity. 
 
2.3.2 Alanine scanning mutagenesis reveals VacA tryptophan residues important 
for toxin-mediated cellular activity     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 The studies described above are consistent with the idea that one or more tryptophan 
residues are important for VacA cellular function. However, these studies did not reveal 
the VacA residue or residues modified during NBS treatment that had resulted in loss of 
toxin cellular activity. To evaluate if one or more of the eleven VacA tryptophan residues 
(Figure 2.4A) are important for VacA function, eleven mutant forms of VacA were 
generated by site directed mutagenesis, each with a single tryptophan residue changed 
to alanine. Each purified mutant form of VacA was examined for the capacity to induce 
cellular vacuolation relative to wildtype toxin. Monolayers of AZ-521 cells pre-chilled at 4 
°C, so as to prevent membrane uptake from the cell surface, were incubated in the 
absence or presence of a range of concentrations (1, 3.5, 10, 35, 100, 250 nM) of wildtype 
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VacA or one of the eleven mutant forms of VacA with a single tryptophan changed to 
alanine. After 30 min, the monolayers were washed to remove unbound VacA, and then 
further incubated with cell culture medium at 37 °C. After 16 h, the monolayers were 
evaluated for cellular vacuolation, both qualitatively, using phase contrast microscopy 
imaging, and quantitatively, by measuring the increase cellular uptake of the acidotrophic 
dye neutral red. Phase contrast microscopy revealed visible intracellular vacuoles within 
nearly all the cells of monolayers that had been incubated with wildtype VacA or with nine 
of the eleven mutant forms of VacA at 35 nM (not shown). In contrast, very few or no cells 
were visible with intracellular vacuoles in cells that had been incubated with two of the 
eleven mutant proteins, VacA (W30A) and VacA (W603A) (not shown).  
 These phase contrast microscopy data were validated using the neutral red uptake 
assay, in which the lysates from cells that had been incubated with VacA (W30A) and 
VacA (W603A) yielded significantly less absorbance at 520 nm than lysates from cells 
incubated with wild-type VacA and the other nine mutant forms of VacA (not shown). We 
quantified the concentrations of each mutant form of VacA required to achieve 50% of the 
maximal uptake of neutral red, which we define as the Vac50 value, and typically compare 
as 1/Vac50 values, which are unique to specific cell lines. These studies revealed that 
nine of the eleven mutant forms of VacA yielded 1 / Vac50 values similar to those obtained 
for wild type VacA (Figure 2.4B). In contrast, two mutant forms of VacA, VacA (W30A) 
and VacA (W603A), yielded approximately 6-fold and 8-fold decreased in 1/Vac50 value, 
respectively, relative to wildtype VacA. These data indicated that alanine substitutions for 
either W30 or W603 attenuate toxin-mediated vacuolation, suggesting that both W30 and 
W603 are important for VacA-mediated cellular activity. However, these studies did not 
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provide clues as to whether either W30 or W603 might be important for VacA interactions 
with SM. 
2.3.3 W603, but not W30, is important for VacA interactions with SM 
 The studies described immediately above suggested that two of the eleven tryptophan 
residues of VacA, W30 and W603, are important for toxin-dependent vacuole biogenesis. 
However, these studies did not address the exact role of either W30 or W603 for VacA 
interaction with SM. To evaluate the potential importance of W30 or W603 for VacA-SM 
interactions, we employed an ELISA-based assay to compare the relative binding of 
wildtype VacA, VacA (W30A), and VacA (W603A) to SM-coated wells. This assay has 
previously been used to demonstrate the preferential binding of VacA (and other SM-
binding proteins) to SM over a number of alternate common plasma membrane lipids 43,55. 
Individual wells within 96-well Immulon 1B microtiter plates, that had been previously 
coated with SM (500 pmol), were incubated at 4 ̊ C in the absence or presence of wildtype 
VacA, VacA (W30A), or VacA (W603A) (1, 3.5, 10, 35, 100, 250 nM; 50 µL each). As 
previously reported 43, preliminary studies confirmed that the binding of wildtype VacA 
was dose-dependent and plateaued at approximately 100 nM VacA (Figure 2.4.1). After 
16 h, unbound toxins were washed out of the wells, and VacA retained within the wells 
was quantified by ELISA, using α-VacA antibodies. These experiments revealed that the 
ELISA signals corresponding to VacA retained in the wells was significantly greater for 
wildtype VacA than VacA (W603A) (Figure 2.4C). In contrast, there were not significant 
differences in the ELISA signal corresponding to VacA between wildtype VacA and VacA 
(W30A). These data indicated that VacA (W603A) binding to SM-coated wells was 
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reduced relative to either wildtype VacA or VacA (W30A). These results suggested that 
W603, but not W30, is important for toxin interactions with SM. While the exact reason 
underlying the attenuated cellular activity of VacA (W30A) is not clear, it is worth noting 
that W30 is located in a hydrophobic amino-terminal region of VacA that had been 
previously suggested to interact with lipid bilayers 101,102. 
2.3.4 Molecular dynamics simulations identify a potential SM-binding site on VacA, 
which includes residues R552, W603, R647, that is computationally predicted to 
be favorable for binding the phosphorylcholine headgroup of SM 
 Results from the studies described above suggested the importance of W603 for both 
VacA cellular activity, and toxin interactions with SM. However, these studies did not 
address the possibility that additional residues in close three-dimensional proximity to 
W603 may also contribute to VacA cellular activity through promoting VacA-SM 
interactions. To evaluate whether additional VacA residues in proximity to W603 may also 
be important for toxin-SM interactions, we took advantage of the existing structural data 
for the carboxyl-terminal fragment of VacA comprising residues 355-811 58. Specifically, 
using Molecular Dynamic (MD) simulations, we identified pockets on the surface of VacA 
predicted to provide favorable sites for binding the phosphorylcholine headgroup of SM 
83,103. Notably, previous studies in our laboratory 43 revealed that VacA binds to both SM 
and phosphatidylcholine (PC), which share the same phosphorylcholine headgroup, but 
not to other common membrane lipids. These studies also revealed that VacA does not 
bind ceramide, which shares the same sphingosine-based side chain with SM and, in fact, 
is the product of sphingomyelinase C, which cleaves of the phosphorylcholine head group 
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of SM, resulting in a depletion of cellular SM and reduction of cellular sensitivity to VacA 
43. These observations support the importance of the phosphorylcholine headgroup of SM, 
rather than the hydrophobic acyl chain, for VacA interactions. MD simulations were 
performed using the structure of a carboxyl terminal fragment of VacA comprising 
residues 355 – 811 (PDB: 2QV3) that had been solvated with water molecules and 
neutralized and ionized with NaCl. Within this defined environment, the carboxyl-terminal 
fragment of VacA was exposed to 50 phosphatidylcholine (PC) molecules, each 
containing the identical phosphorylcholine headgroup as SM. 250 nsec MD simulations 
were conducted in order to identify surface regions possessing both the geometry and 
electrostatic characteristics that could best accommodate the phosphorylcholine head 
group.  
 These MD simulations revealed multiple sites on the surface of VacA that were 
predicted to accommodate the association of phosphorylcholine within 5 Å of the VacA 
surface (Figure 2.5). Interestingly, two of the highest probability sites included W603, 
which we had already identified to be important for VacA cellular activity. Examination of 
the crystal structure of VacA (355-811) revealed that W603 is located within a loop 
comprising residues 597-605 that joined two beta-strands within the beta solenoid that 
makes up a large part of the VacA carboxyl-terminus (Figure 2.6). In close spatial 
proximity to the indole side chain of W603 are the guanidinium side chains of two arginine 
residues, R552, and, R647, both of which are located on separate and adjacent loops to 
the loop containing W603. Because the positive charges associated with the guanidinium 
side chains of both arginine residues could conceivably contribute to stabilizing the 
negatively charged phosphate moiety of the phosphorylcholine headgroup, we next 
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focused on assessing the importance of R552 and R647, in conjunction with W603, for 
VacA cellular activity.  
2.3.5 Characterization of VacA (R552A/W603A/R647A) 
 The molecular dynamics simulation described immediately above revealed a location 
on the surface of VacA structure, which includes W603, as well as the side chains of R552 
and R647, that is computationally predicted to be suitable for accommodating the 
phosphorylcholine head group of SM. To experimentally evaluate this computational 
prediction, a triple mutant of VacA comprising alanine substitutions for R552, W603, and 
R647, VacA (R552A/W603A/R647A), was generated, expressed as a recombinant 
protein in H. pylori, and purified from culture supernatants (Figure 2.7A).  
 To evaluate the potential effects of alanine substitutions for R552, W603, and R647 on 
VacA structure and stability, we examined VacA (R552A/W603A/R647A) for gross 
structural perturbations, by comparing the protease sensitivity profiles of wildtype VacA 
and VacA (R552A/W603A/R647A). Purified wildtype VacA and VacA 
(R552A/W603A/R647A), were incubated separately at 25 °C in the absence or presence 
of trypsin (0.1, 1, 10 nM). After 1 h, each sample was analyzed by immunoblot analysis, 
for the profile of VacA peptides generated during trypsin digestion, using anti-VacA 
antibodies. These studies revealed that, both wildtype VacA and VacA 
(R552A/W603A/R647A), incubation with trypsin resulted in similar dose-dependent 
patterns of immune-specific bands identified by α-VacA antibodies (Figure 2.7B). These 
data indicated that both wildtype VacA and VacA (R552A/W603A/R647A) were digested 
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in a similar manner by trypsin. These results suggest that alanine substitutions for 
residues R552, W603, and R647 do not cause gross structural perturbations in toxin 
structure. 
 VacA assembles into higher-ordered oligomeric rings, and previous work indicating 
that mutant forms of VacA that cannot assemble into oligomeric structures lack cellular 
activity 104-106, strongly support a model that oligomer assembly is critical for toxin activity. 
Several imaging techniques have revealed that VacA monomers assemble into oligomers 
with the amino-terminal p33 domains forming the inner ring believed to ultimately form 
membrane spanning ion-conducting channels 20,107-110. Two small regions, one located in 
the amino-terminal p33 domain (residues 49-57) 106, and the other, two residues in the 
p55 domain (residues 346-347) 105 have been demonstrated to be required for VacA 
oligomer assembly, and believed to represent the contact sites between p33 and p55 in 
adjacent monomers. Although the exact location of VacA residues R552, W603, and 
R647 have not been mapped within the context of toxin oligomers, it is noteworthy that 
the 3-dimensional EM images predict that most of the p55 domain for each monomer, 
including the region containing residues R552, W603, and R647, extend away from the 
p33-comprised center ring 20,58, akin to petals on a flower, and does not appear to be 
involved in the context of monomer-monomer contacts. Although we predicted that VacA 
residues R552, W603, and R647 would not have a direct role in toxin monomer assembly, 
we validated this prediction experimentally. To evaluate the potential effects of alanine 
substitutions for R552, W603, and R647 on the capacity to form higher-ordered 
structures, we examined VacA (R552A/ W603A/R647A) for gross changes in quaternary 
structures by comparing the glycerol density gradient profiles of both wildtype VacA and 
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VacA (R552A/W603A/R647A). Purified wildtype VacA or VacA (W603A/R552A/R647A) 
(1 µM), at either pH 7.4, conditions under which wildtype VacA forms soluble oligomeric 
rings of 6 or seven monomers 20,111, or pH 3.0, conditions under which VacA exists as 
soluble monomers, were fractionated at 4 ˚C by glycerol gradient density centrifugation 
(0 - 40%; 35,000 xg). After 16 h, six fractions of equal volumes were collected from the 
top (0%) to the bottom (40%) of the gradient. The collected fractions were analyzed by 
immunoblot analysis, using α-VacA antibodies, to determine the relative levels of VacA 
in each fraction. These studies revealed that the profile of immuno-specific bands 
corresponding to VacA were very similar for both VacA (R552A/W603A/R647A) and 
wildtype VacA (Figure 2.7C).  These data indicate that alanine substitutions for VacA 
residues R552, W603, and R647 has no visible effect on the glycerol density gradient 
profiles of VacA, suggesting that R552, W603, and R647 do not have detectable roles for 
pH dependent oligomer assembly or disassembly. Although we recognize that a plethora 
of different experimental approaches could be used to evaluate changes in protein 
stability and quaternary structure, results from our preliminary studies are consistent with 
a conclusion that alanine substitutions for residues R552, W603, and R647 do results in 
gross structural changes. 
2.3.6 VacA (R552A/W603A/R647A) is attenuated in cellular vacuolation activity 
relative to wildtype VacA 
 The results described immediately above indicated that alanine substitutions for VacA 
residues R552, W603, and R647 do not introduce gross structural alterations or perturb 
the quaternary structure of VacA (R552A/W603A/R647A). However, these studies did not 
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address the potential effects of these mutations on VacA cellular activity. As explained 
above, our alanine scanning studies revealed that an alanine substitution for W603 
resulted in an approximate eight-fold increase in the Vac50 value for VacA (W603A) 
relative to wildtype toxin (Figure 2.4B). If our model that R552 and R647 are important 
components of the putative SM binding site is correct, we predicted that alanine 
substitutions for these residues would result in a mutant form of VacA that is more 
attenuated in toxin cellular activity than VacA (W603A). To evaluate the importance of 
R552, W603, and R647 for VacA cellular activity, we compared the capacity of VacA 
(R552A/ W603A/R647A) and wildtype VacA to induce vacuole biogenesis. Monolayers of 
AZ-521 cells, that had been pre-chilled to 4 °C to promote toxin binding in the absence of 
cellular uptake, were incubated at 4 °C in the absence or presence of wildtype VacA or 
VacA (R552A/W603A/R647A) (10 to 2,000 nM). After 30 min, the monolayers were 
washed with ice-cold PBS (pH 7.4) to remove unbound toxin, and then further incubated 
at 37 °C. After 16 h, the monolayers were evaluated for the presence of intracellular 
vacuoles, using light microscopy. These studies revealed very few cells (<1% of total 
cells) with visible intracellular vacuoles in monolayers that had been incubated with VacA 
(R552A/ W603A/R647A) at 250 nM, a concentration at which nearly all of the cells (>95% 
of total cells) contained visible vacuoles within monolayers that had been incubated with 
wildtype VacA (Figure 2.8A). 
 These results from microscopic visualization of the monolayers were validated using 
the neutral red uptake assay, in which lysates of cells that had been incubated with VacA 
(R552A/W603A/R647A) yielded significantly less absorbance at 530 nm than lysates of 
cell incubated with wildtype VacA (Figure 2.8B). These data indicated that significantly 
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less neutral red had been taken up into cells incubated with VacA (R552A/ 
W603A/R647A) than wildtype VacA. These results are consistent with the conclusion that 
cells exposed to VacA (R552A/W603A/R647A) underwent significantly less vacuole 
biogenesis than those cells exposed to wildtype toxin. Only at the highest concentration 
of VacA (R552A/W603A/R647A) tested (2000 nM), which is at the practical limit of what 
we can evaluate in the laboratory (because of the difficulty in readily concentrating stock 
VacA to greater than approximately 10 µM without extensive losses), was a modest 
increase in cellular vacuolation detected (Figure 2.8B). Based on these data, we 
estimated that the VacA50 value of VacA (R552A/ W603A/R647A) is approximately 50-
100 fold great than the VacA50 value of wildtype VacA. Together, these studies suggested 
that alanine substitutions at residues R552A, W603A, and R647A results in a mutant form 
of VacA whose cellular activity is highly attenuated relative to wildtype toxin, although not 
entirely absent at higher toxin concentrations.  
2.3.7 The reduction in cellular vacuolation activity induced by VacA 
(R552A/W603A/R647A) is recapitulated across multiple cell lines 
 The studies described immediately above were performed in AZ-521 cells, which 
although originally sold as a human stomach cancer cell line, has recently been 
characterized to be of human duodenal cancer origin. Nonetheless, AZ-521 cells have 
proven to be a valuable in vitro model for studying the cell biology of VacA intoxication of 
epithelial cells 23,40,93,97,112-115 To address the extent that the attenuated cellular 
vacuolation activity of VacA (R552A/ W603A/R647A) is recapitulated across multiple cell 
lines and not idiosyncratic only to AZ-521 cells, we compared the cellular vacuolation 
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activity of VacA (R552A/W603A/R647A) to wildtype VacA in AGS cells, which are human-
derived gastric adenocarcinoma cells 116, and HeLa cells, which are human-derived, 
cervical cancer cells 117. Along with AZ-521 cells, both AGS cells 37,40,118 and HeLa cells 
31,43,64 have been extensively used as in vitro models to study VacA cellular activity 22,43. 
Monolayers of AGS or HeLa cells were pre-incubated separately at 4 °C, to prevent 
endocytic uptake from the cell surface, in the absence or presence of VacA (R552A/ 
W603A/R647A) or wildtype VacA (1 to 250 nM). After 30 min, the cells were washed with 
PBS (pH 7.4) to remove unbound toxin, and then further incubated at 37 °C. After 16 h, 
the cell monolayers were assayed for the presence of intracellular vacuoles, as a 
surrogate for VacA cellular activity. Inspection of the monolayers using phase contrast 
microscopy revealed fewer intracellular vacuoles in monolayers of either AGS or HeLa 
cells that had been incubated with VacA (R552A/ W603A/R647A) than wildtype VacA 
(Figure 2.9). These results were validated using the neutral red uptake assay, in which 
lysates of cells that had been incubated with VacA (R552A/ W603A/R647A) yielded 
significantly less absorbance at (530 nm) than lysates of cell incubated with wildtype VacA 
(Figure 2.9). These data indicated that significantly less neutral red has been taken up 
into cells that had been incubated with VacA (R552A/ W603A/R647A) than wildtype 
VacA. These results confirmed that the attenuated capacity of VacA (R552A/ 
W603A/R647A) to induce intracellular vacuole biogenesis is not idiosyncratic to AZ-521 
cells, but recapitulated across several cell lines, including the AGS gastric-derived cell 
line. 
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2.3.8 The reduction in cellular vacuolation activity induced by VacA 
(R552A/W603A/R647A) is recapitulated in primary murine gastric epithelial cells 
 The studies described immediately above revealed that the cellular activity of VacA 
(R552A/ W603A/R647A) is substantially less than wildtype VacA in several immortalized 
cell lines that have been broadly used to study interactions of VacA with mammalian cells. 
To further validate the use of immortalized cell lines for comparing the properties and 
cellular functions of VacA (W603A/R552A/R647A) and wildtype VacA, we evaluated the 
capacity of VacA (R552A/ W603A/R647A) to induce cellular vacuolation in primary murine 
gastric epithelial cells isolated ex vivo from the stomachs of C57BL/6 mice, using 
previously published methods 33,80. Isolated cells were confirmed using 
immunofluorescence microscopy to be positive for the epithelial markers ZO-1, E-
cadherin, and cytokeratin 18, and negative for both the mesenchymal marker vimentin, 
and the endothelial/fibroblast cellular marker smooth muscle actin. 
 To evaluate whether primary gastric cells from our preparations are sensitive to VacA, 
monolayers, that had been pre-chilled at 4 ° C to prevent activation of plasma membrane 
uptake pathways, were incubated in the absence or presence of wildtype VacA (1-2000 
nM). After 30 min, the monolayers were washed with PBS (pH 7.4, 4 °C) to remove 
unbound toxin, and then further incubated at 37 °C. After 16 h, the monolayers were 
evaluated for the presence of intracellular vacuoles, using phase contrast microscopy 
imaging. These studies revealed visible vacuolar compartments in cells incubated with 
wildtype VacA (Figure 2.10). Under the “pulse intoxication” conditions under which these 
experiments were performed, where only pre-bound toxin is allowed to enter cells, we 
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estimated that the VacA50 value for primary gastric epithelial cells is approximately 250-
500 nM. As a point of comparison, under the same “pulse intoxication” conditions, the 
VacA50 value for AZ-521 cells was calculated to be approximately 50 nM. Although the 
reasons underlying these differences in sensitivity to VacA are not currently understood, 
these studies confirmed that these ex vivo isolated primary gastric cells are sensitive to 
VacA. 
 Previous studies from our laboratory demonstrated that the sensitivity of mammalian 
cells to VacA could be attributed, in part, to the relative abundance of plasma membrane 
SM, which was demonstrated to be important for cell surface binding of the toxin 43,93. 
Experimentally, the association between plasma membrane SM and VacA cellular 
binding and activity was demonstrated by depleting cell surface SM with the hydrolytic 
enzyme sphingomyelinase C, which converts SM into ceramide by cleaving off the 
phosphorylcholine headgroup of SM. To evaluate whether cell surface SM is also a 
determinant of VacA activity in primary gastric epithelial cells, monolayers were pre-
incubated at 37 °C in the presence or absence of sphingomyelinase C. After 1h, the 
monolayers were chilled to 4 °C, and then further incubated in the absence or presence 
of VacA (500 nM). After 30 min, the monolayers were washed with PBS pH 7.4 to remove 
unbound toxin, and then further incubated at 37 °C. After 16 h, the monolayers were 
evaluated for the presence of intracellular vacuoles, using phase contrast microscopy 
imaging. These studies revealed a visibly diminished number of intracellular vacuoles in 
cells, as well as smaller vacuolar compartments, in cells that had been pre-incubated in 
the presence than absence of sphingomyelinase C (Figure 2.10). These data indicated 
that VacA-dependent cellular vacuole biogenesis was reduced within sphingomyelinase 
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C-pretreated cells, consistent with the idea that the sensitivity of primary gastric epithelial 
cells, much like what was previously reported using several immortalized cell lines 43,93 is 
dependent on cell surface SM within the plasma membrane. These studies using ex vivo 
isolated primary gastric cells further validated the use of AZ-521 cells as an in vitro model 
system to study and compare the cellular intoxication properties of VacA.  
 Based on the evidence described immediately above that the sensitivity of primary 
gastric epithelial cells is dependent, at least in part, on plasma membrane SM, we 
predicted that monolayers of these ex vivo isolated cells would be less sensitive to VacA 
(R552A/ W603A/R647A) than wildtype VacA. To test this prediction, primary gastric 
epithelial cells, that had been pre-chilled to 4 °C to prevent activation of plasma 
membrane uptake pathways, were incubated at 4 °C in the absence or presence of 
purified VacA (R552A/ W603A/R647A) than wildtype VacA (1- 2000 nM). After 30 min, 
the monolayers were washed with PBS (pH 7.4, 4 °C) to remove unbound toxin, and then 
further incubated at 37 °C. After 16 h, inspection of the primary murine gastric epithelial 
cells using phase contrast microscopy revealed that intracellular vacuoles were not visible 
in monolayers that had been incubated with VacA (R552A/ W603A/R647A) (Figure 2.10). 
For these studies, we did not validate our visual observations by measuring neutral red 
uptake because intracellular vacuoles were not visible even at the highest concentration 
of VacA (R552A/ W603A/R647A) tested (2000 nM). Nonetheless, our visual observations 
are consistent with the conclusion that primary gastric cells isolated ex vivo from gastric 
tissue were substantially less sensitive to VacA (R552A/ W603A/R647A) than wildtype 
toxin, similar to the results described above using several immortalized cell lines. These 
studies further validated the use of AZ-521 cells as an appropriate in vitro model system 
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to study and compare the cellular intoxication properties of VacA (R552A/W603A/R647A) 
and wildtype toxin. 
2.3.9 VacA (R552A/W603A/R647A) binding to SM-coated plates is attenuated 
relative to wildtype VacA 
  The results described above indicated that VacA residues R552, W603, and R647, 
which are spatially proximal to one another other in the VacA crystal structure 58, are 
important for toxin cellular activity. However, these studies did not address the potential 
importance of these residues for binding of VacA to SM. To evaluate whether VacA 
residues R552, W603, and R647 are important for VacA-SM interactions, we compared 
the relative binding of wildtype VacA and VacA (R552A/W603A/R647A) to SM-coated 
wells using an ELISA binding assay. Individual wells within 96-well Immulon 1B microtiter 
plates, that had been previously coated with SM (500 pmol), were incubated at 4 ˚C in 
the absence or presence of wildtype VacA or VacA (R552A/W603A/R647A) (1-100 nM; 
50 µL in each well). After 16 h, unbound toxin was washed out of the wells, and VacA 
retained within the wells was quantified by ELISA using α-VacA antibodies. These 
experiments revealed that the ELISA signal at 460 nm, corresponding to bound-VacA, 
was significantly less for VacA (R552A/W603A/R647A) than for wildtype VacA (Figure 
2.11A). These data indicated that significantly less VacA (R552A/W603A/R647A) (10%) 
was bound within SM-coated wells relative to wildtype VacA. These results suggested 
that VacA residues R552, W603, and R647 together are important for toxin interactions 
with SM. However, these studies did not address the importance of VacA residues R552, 
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W603, and R647 for conferring binding specificity of the toxin for the phosphorylcholine 
headgroup of SM. 
2.3.10 VacA (W603A/R552A/R647A) binding is attenuated relative to wildtype VacA 
for SM and phosphatidylcholine (PC), but not for phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), and ceramide 
 Previous evidence for the importance of the phosphorylcholine headgroup for VacA-
SM interactions originated from earlier studies in our laboratory 43,93 demonstrating that 
toxin binds equally well to both SM and PC, both of which possess the phosphorylcholine 
headgroup. Compared to SM and PC, VacA interactions with ceramide were attenuated; 
ceramide shares the same sphingosine-linked fatty acid side chain as SM, but lacks the 
phosphorylcholine headgroup. In addition, VacA binding to PE- or PI-coated wells was 
significantly less than SM-coated wells 43,93. Together, these data were interpreted to 
indicate that VacA-interactions with the phosphorylcholine headgroup, rather than the 
sphingosine-linked fatty acid side chain backbone, underlie VacA-SM binding.  
 The results described in the previous sections revealed that the binding of VacA 
(R552A/W603A/R647A) to SM-coated wells is attenuated relative to wildtype VacA. To 
evaluate the idea that VacA residues R552, W603, and R647 confer specificity of VacA 
for the phosphorylcholine headgroup of SM, we next compared the relative binding of 
VacA (R552A/ W603A/647A) and wildtype VacA to lipids with or without 
phosphorylcholine headgroups. These studies were based on the prediction that, if VacA 
residues R552, W603, and R647 confer binding specificity and/or affinity for 
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phosphorylcholine, then toxin binding to wells coated with lipids not possessing 
phosphorylcholine, such as ceramide, PE, or PI, should be insensitive to alanine 
substitutions for VacA residues R552, W603, and R647. 
 Individual wells within 96-well Immulon 1B microtiter plates, which had been previously 
coated with SM, PC, ceramide, PE, or PI (500 pmol in each well), or, left uncoated, were 
incubated at 4 ˚C in the absence or presence of wildtype VacA or VacA 
(R552A/W603A/647A) (100 nM; 50 µL in each well). After 16 h, unbound toxin was 
washed out of the wells, and VacA retained within the wells was quantified by ELISA 
using α-VacA antibodies. These experiments revealed that, as expected, the ELISA 
signals at 460 nm in SM-or PC-coated wells incubated with VacA (R552A/W603A/647A) 
were significantly less than in wells incubated with wildtype VacA (Figure 2.11B). For 
both wildtype VacA and VacA (R552A/W603A/647A), the absorbance at 460 nM was 
lower (but above background absorbance obtained in non-lipid coated wells incubated 
with either toxin) within ceramide-, PE-, or PI- coated wells than SM- or PC-coated wells, 
reflecting the overall lower binding in wells coated with lipids not possessing the 
phosphorylcholine headgroup, as previously reported only for wildtype VacA in our earlier 
work 43. However, in contrast to those studies conducted with SM- or PC-coated wells, 
statistically significant differences were not measured for the ELISA signals at 460 nm 
corresponding to the binding of VacA (R552A/W603A/R647A) and wildtype VacA within 
ceramide-, PE-, or PI- coated wells (Figure 2.11B). These data indicated that wildtype 
VacA bound to wells coated with lipids possessing phosphorylcholine head groups (SM 
or PC) significantly better than VacA (R552A/W603A/647A). In contrast, wildtype VacA 
and VacA (R552A/W603A/647A) bound equally well to wells coated with lipids lacking 
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phosphorylcholine head groups (ceramide, PE, or PI). From these results, we concluded 
that VacA residues R552, W603, and R647 are important for toxin binding to the 
phosphorylcholine headgroup of SM and PC, but not for binding to ceramide, PE, or PI, 
each of which lack a phosphorylcholine headgroup. The outcome of these studies support 
a model that VacA residues R552, W603, and R647 may, at least in part, comprise a 
phosphorylcholine-specific binding site for VacA. 
2.3.11 Enzymatic removal of the phosphorylcholine headgroups of SM or PC 
reduces binding of wildtype VacA, but not VacA (W603A/R552A/R647A) 
The results described above suggest a role for VacA residues R552, W603, and R647 
in conferring VacA-binding specificity and/or affinity for the phosphorylcholine headgroup. 
To further explore this idea, we examined the relative binding of wildtype VacA and VacA 
(R552A/W603A/R647A) to SM- or PC-coated wells that had been pre-treated with either 
sphingomyelinase C (SMase C) or PC-specific phospholipase C (PC-PLC), which 
enzymatically cleaves off the headgroups of SM or PC, respectively. These studies were 
based on the prediction that, if VacA residues R552, W603, and R647 confer binding 
specificity and/or affinity for phosphorylcholine, then toxin binding to SM- or PC-coated 
wells that had been pretreated with SMase C or PC-PLC, resulting in the depletion of SM- 
or PC-associated phosphorylcholine headgroups, should be insensitive to alanine 
substitutions for VacA residues R552, W603, and R647. 
Individual wells within 96-well Immulon 1B microtiter plates, which had been previously 
coated with SM or PC (500 pmol in each well), were pre-incubated with the absence or 
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presence of the phosphorylcholine specific cleavage enzymes sphingomyelinase C 
(SMase C; 100 mU / mL), or, PC-specific Phospholipase C (PC-PLC; 200 mU / mL). 
SMase C is a hydrolase that specifically cleaves SM into phosphorylcholine and ceramide 
while PC-PLC is a hydrolase that specifically cleaves PC into phosphorylcholine and 
diacylglycerol. Removal of the phosphorylcholine headgroups of SM by SMase C, and 
PC by PC-PLC, was confirmed using the Amplex Red assay kit for quantifying the relative 
PC headgroup release in each well (not shown:). We also found that phosphorylcholine 
was not released when SM-coated wells were preincubated with PC-PLC, or, PC-coated 
wells were preincubated with SMase C (Figure 2.12). confirming the specificity of these 
pretreatments. After 3 h, the wells were washed, and further incubated at 4 ˚C in the 
absence or presence of wildtype VacA or VacA (R552A/W603A/647A) (100 nM; 50 µL in 
each well). After 16 h, unbound toxin was washed out of the wells, and VacA retained 
within the wells was quantified by ELISA using α-VacA antibodies.  
These experiments revealed that, the ELISA signals at 460 nm in SM- or PC-coated 
wells incubated with wildtype VacA were significantly less when the wells were pre-
incubated with SMase C or PC-PLC, respectively (Figure 2.13A). The ELISA signals at 
460 nm from SM- or PC-coated wells incubated with VacA (R552A/W603A/647A) were 
lower than when incubated with wildtype VacA. However, for VacA   
(R552A/W603A/647A), the ELISA signals at 460 nm, corresponding to bound toxin, were 
the same from those SM- or PC-coated wells, regardless of whether or not the wells had 
been pretreated with SMase C or PC-PLC (Figure 2.13B). These data indicated that 
although wildtype VacA binding to SM- or PC-coated wells was attenuated when the wells 
were pretreated to remove the phosphorycholine headgroups of the bound lipids, the 
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binding of VacA (R552A/W603A/647A) to SM- or PC-coated wells was unaffected by 
pretreatment with either SMase C or PC-PLC. These results were again consistent with 
the conclusion that VacA residues R552, W603, and R647 are important for toxin binding 
to SM- and PC-coated plates in a manner dependent upon the presence of the 
phosphorylcholine headgroup, and, provide additional support for the model that that 
VacA residues R552, W603, and R647 comprise, at least in part, the phosphorylcholine-
specific binding site of VacA 
2.3.12 VacA residues R552, W603, and R647 function in a synergistic manner to 
promote VacA cellular activity 
 The results from studies described above support a model that VacA residues R552, 
W603, and R647 together are important for VacA cellular activity by conferring specificity 
and affinity for the phosphorylcholine headgroup of SM. Although our alanine scan of 
VacA tryptophan residues identified W603 alone as an important residue for toxin activity 
and interactions with SM, the relative importance of R552 or R647, either alone, or in 
binary combinations with W603 or each other, was unclear. To evaluate in more detail 
the individual contributions of R552, W603, and R647 for VacA interactions with SM and 
toxin cellular activity, additional mutant forms of VacA were generated with, either single 
alanine substitutions, VacA (R552A) and VacA (R647A), or double alanine substitutions, 
VacA (R552A/W603A), VacA (R552A/R647A), or VacA (W603A/R647A).  
 Monolayers of AZ-521 cells, that had been pre-chilled to 4 °C to prevent activation of 
plasma membrane uptake pathways, were incubated in the absence or presence of VacA 
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(R552A), VacA (W603A), VacA, (W647A), VacA (R552A/W603A), VacA (R552A/R647A), 
VacA (W603A/R647A), VacA (R552A/W603A/R647A) or wildtype VacA (for each toxin, 
cells were exposed to a 1 - 250 nM concentration range). After 30 min, the monolayers 
were washed with PBS (pH 7.4, 4 °C) to remove unbound toxin, and then further 
incubated at 37 °C. After 16 h, the monolayers were evaluated for the presence of 
intracellular vacuoles as a surrogate for VacA cellular activity, using phase contrast 
microscopy imaging. Consistent with the results obtained from our alanine-scanning 
mutagenesis experiments, these studies revealed fewer cells with visible intracellular 
vacuoles in monolayers that had been incubated with VacA (W603A) (not shown) at 250 
nM, a concentration at which >90% of the cells incubated with wildtype VacA contained 
visible intracellular vacuoles. Likewise, we noted visible intracellular vacuoles in fewer 
cells within monolayers incubated with VacA (R552A/W603A), VacA (W603A/R647A), or 
VacA (R552A/W603A/R647A) (not shown). In contrast, monolayers incubated with VacA 
(R552A), VacA (R647A), or VacA (R552A/R647A) all possessed approximately the same 
number of cells with visible intracellular vacuoles as cells incubated with wildtype VacA 
(not shown).  
 The microscopy-based observations described above were confirmed using the 
neutral red uptake assay, which indicated that lysates from monolayers of cells that had 
been incubated with VacA (R552A), VacA (R647A), or VacA (R552A/R647A) yielded 
similar absorbance values at 530 nm as lysates of cell incubated with wildtype VacA (not 
shown). These data indicated that cells incubated with VacA (R552A), VacA (R647A), 
VacA (R552A/R647A), or wildtype VacA all took up similar amounts of neutral red, 
suggesting that VacA residues R552 and R647, either alone or in combination with each 
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other, were not essential for VacA-mediated vacuole biogenesis. In contrast, lysates from 
monolayers of cells that had been incubated with VacA (W603A), VacA (R552A/W603A), 
VacA (W603A/R647A), or VacA (R552A/W603A/R647A) yielded significantly lower 
absorbance values at (530 nm) than lysates of cell incubated with wildtype VacA (not 
shown). These data indicated that each of these mutant forms of VacA took up 
significantly less neutral red, suggesting that each was attenuated in vacuole biogenesis. 
From the dose response data, the calculated VacA50 value corresponding to VacA 
(R552A/W603A) (550 nM, Figure 2.14A, Table S6) or VacA (W603A/R647A) (310 nM, 
Figure 2.14A, Table S6) was similar to that calculated for VacA (W603A) (360 nM, Figure 
2.14A, Table S6), suggesting that R552 and R647A individually did not contribute 
substantially to the attenuated capacity of VacA (R552A/W603A) or VacA 
(W603A/R647A) to induce cellular vacuolation. However, although combining alanine 
substitutions at either R552 or R647 individually had little effect on further attenuating the 
effects of an alanine substitution for W603, as the calculated VacA50 value corresponding 
to VacA (R552A/W603A/R647A) (5500 nM, Figure 2.14A, Table S6) was substantially 
higher than either VacA (R552A/W603A) or VacA (W603A/R647A) (550 and 310 nM, 
respectively, Figure 2.14A, Table S6). Taken together, these results support a model 
that the effects on VacA cellular activity, of combining alanine substitutions for all three 
residues (R552, W603, R647) are more than simply additive of the effects of the single 
substitutions 119. 
2.3.13 VacA residues R552, W603, and R647 function in a synergistic manner to 
promote SM interaction 
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 Previous data indicate that VacA (R552A/W603A/R647A) was significantly more 
impaired in the capacity to induce vacuole biogenesis than VacA (W603A). Based on our 
findings that single alanine substitutions for R552 or R647 had little impact on VacA 
cellular activity relative to wildtype toxin, our findings suggest that, when combined with 
the alanine substitution at W603, that the effects of combining alanine substitutions for all 
three residues (R552, R603, R647) is more than additive.   
 To obtain additional insights into the contributions of residues R552, W603, and R647 
for VacA-SM interactions, we again employed our ELISA-based assay to compare the 
relative binding of three additional mutant forms of VacA, each with two of the three 
residues altered by site directed mutagenesis to alanine. These experiments revealed 
that the ELISA signals corresponding to VacA retained in the wells was significantly 
greater for wildtype VacA than for either VacA (R552A/W603A) or VacA (W603A/R647A), 
for which the ELISA signals corresponding to VacA retained in the wells, were reduced 
50% and 56% respectively (Figure 2.14B). Moreover, the ELISA signals corresponding 
to VacA retained in the wells were not significantly different for wildtype VacA and VacA 
(R552A/R647A) (Figure 2.14B). 
2.3.14 Enrichment of plasma membrane SM partially restores cell sensitivity to 
VacA (R552A/W603A/R647A) 
 The studies described above demonstrated that W603, with a synergistic facilitation of 
R552 and R647, plays an important role on both cytotoxicity and SM interaction. However, 
these studies did not address the reasons underlying the relatively diminished sensitivity 
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of cell lines to VacA (R552A/ W603A/R647A) as compared to wildtype VacA. Our earlier 
studies establishing SM as a VacA receptor demonstrated that the sensitivity of cultured 
cells to VacA was strongly associated with the relative amounts of plasma membrane SM 
43. Moreover, cell line sensitivity to VacA could be manipulated by altering cell surface 
levels of SM. Depletion of cell surface SM through treatment of cultured cells, including 
AZ-521 cells, with sphingomyelinase C decreased cell line sensitivity to VacA, thereby 
requiring higher concentrations of toxin to generate intracellular vacuoles. Moreover, 
enrichment of plasma membrane SM by incubating monolayers of cultured cells, including 
AZ-521 cells, with exogenous SM 43 increased cell line sensitivity to VacA. 
 If the lower cellular activity of VacA (R552A/ W603A/R647A) is due to the alteration of 
the VacA SM-binding site, we speculated that sensitivity to this mutant form of toxin could 
be restored, at least in part, by enrichment of the plasma membrane outer leaflet with SM. 
Monolayers of AZ-521 cells were pre-incubated at 4 °C in the absence or presence of 
SMase. After 1h, the cells were washed out with PBS (pH 7.4, 4°C) , then pretreated with 
exogenous SM (0.0035, 0.035, 0.35, 3.5, 35, 100 µM). After 1 h, the monolayers were 
further incubated in the absence or presence of either wildtype VacA (50 nM) or VacA 
(R552A/ W603A/R647A) (500 nM), concentrations of either form of toxin that yield 50% 
of the cells induce cellular vacuolation in AZ-521 cells (Figure 2.15 A and B). After 16 h, 
cellular vacuolation was quantified by measuring relative neutral red uptake assay. While 
SM enriched AZ-521 cells restores cell sensitivity towards wildtype VacA at 3.5 µM, the 
cell sensitivity towards VacA (R552A/W603A/R647A) restores above 30-fold more SM 
enrichment on cells. This data indicates that the vacuolation activity of VacA (R552A/ 
W603A/R647A) is restored only in higher concentration by SM enrichment exogenously. 
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This data suggests that the alanine substitutions on the three residues may have low 
affinity towards SM on the cell surface. However, this experiment does not provide 
information whether VacA (R552A/W603A/R647A) can interact with cell surface.  
2.3.15 Cell surface binding of VacA (W603A/R552A/R647A) is decreased, but not 
eliminated relative to wildtype VacA 
 The results described immediately above indicated that VacA (R552A/W603A/R647A) 
has less cell sensitivity than wildtype VacA. However, these studies did not address the 
binding of (R552A/W603A/R647A) to the surface of cells. Pre-chilled AZ-521 cells were 
incubated with wildtype VacA or VacA (R552A/ W603A/R647A) at 4 ˚C. After 30 min, the 
cells were then washed with PBS pH 7.4, and then fixed with paraformaldehyde. The 
membrane bound wildtype VacA or VacA (R552A/ W603A/R647A) was detected with 
Alexa Fluor 488-conjugated secondary antibody against ɑ-VacA antibody using flow 
cytometry. Flow cytometry measurement revealed that cell surface binding of VacA 
(R552A/ W603A/R647A) is significantly decreased relative wildtype VacA (Figure 2.16A) 
by more than 30% (Figure 2.16B) In addition, we demonstrated that the AGS and HeLa 
cells showed significantly reduced cell surface binding of VacA (R552A/ W603A/R647A) 
relative to wildtype VacA by 30% and 10% on AGS and HeLa, respectively (Figure 2.17). 
The data indicate that VacA with alanine substitution on three VacA residues bind less to 
cell surface of epithelial cells. This data suggest that the three SM-interacting residues 
are crucial for VacA-membrane interaction.  
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2.3.16 VacA binding to cell surface is not saturable within the range of 
concentrations that shows the spectrum of vacuolation activity 
 The results described immediately above revealed that, although the binding of VacA 
(R552A/W603A/R647A) to the surface of cultures is significantly reduced relative to 
wildtype toxin, the decrease is somewhat modest. This finding suggests that a detailed 
examination of cell-membrane interaction is required to further understand how three SM-
interacting residues contribute to cell surface binding of VacA. Being one of the most 
crucial steps in VacA trafficking, cell surface binding of VacA has been studied extensively 
to suggest that VacA binding on cell surface is highly non-specific with utilizing an 
abundant low binding affinity receptor on cell surface 30,92,120,121. To understand how VacA 
interacts with the cell surface of epithelial cells, flow cytometry measurement of Alexa 
Flour 488-labeled VacA on the cell surface of AZ-521, AGS, or HeLa cells, was performed 
(Figure 2.18). The data showed that VacA-membrane interaction shows the dissociation 
constant values at equilibrium of 2.7 µM (AZ-521), 1.3 µM (AGS), and 1.2 µM (HeLa). For 
these cell lines, VacA was shown to reach its 50% vacuolation activity (Vac50) within nM 
range at 3.5 nM (AZ-521), 5 nM (AGS), and 35 nM (HeLa). The µM range of the 
dissociation constant of VacA on three different epithelial cell lines indicate that cell 
surface binding of VacA is not saturable within the range of toxin concentrations that 
reaches its best vacuolation activity. The data suggests cell surface binding of VacA is 
complex.  
2.3.17 VacA binding to cell surface has two binding modalities: receptor-dependent 
and receptor-independent interaction 
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 The studies described immediately above revealed that binding of VacA to the plasma 
membrane of cells is not saturable, even when using toxin concentrations that induce 
vacuolation within all the cells in a monolayer, consistent with previous reports from 
several different groups 30,92,120,121. Non-saturable protein binding to the surface of cells 
is consistent with the idea of a receptor that is highly abundant, so that the number of cell 
surface receptors exceeds the number plasma membrane bound protein molecules over 
the range of protein concentrations tested. Alternatively, non-saturable binding could also 
suggest that protein binding to the surface of cells does not require a specific receptor. 
 Previous experiments suggest that VacA binding to cell surface is complex. We 
hypothesized that the complexity of VacA binding to cell surface is mediated in two ways: 
receptor-dependent and receptor-independent membrane interaction. To test this 
hypothesis, we examined how fluorescent labeled wildtype VacA (50 nM) binds in the 
absence or presence of 100 molar excess of unlabeled wildtype VacA by flow cytometry 
analysis, where the presence of 100 molar excess unlabeled wildtype VacA can compete 
against fluorescent labeled wildtype VacA for receptor occupancy (Figure 2.19). The data 
revealed that cell surface binding of labeled VacA was reduced by 50% in the presence 
of 100 molar excess of unlabeled VacA using AZ-521 cells. The data indicate a partial 
blockage of VacA binding to cell surface was shown upon competition. Similar partial 
blockage patterns were observed when the competition assays were performed in two 
additional mammalian cell-derived epithelial cell lines, AGS and HeLa cells, where 40% 
and 35% reductions were observed respectively (Figure 2.20). The data suggest that a 
significant portion of VacA binding to cell surface of epithelial cells is mediated by receptor 
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dependent interaction. However, the results do not show how the other portion of VacA-
membrane interaction is mediated. 
 Previous experiments suggest that a significant portion of VacA binding to cell surface 
is mediated by the presence of receptor, suggesting our hypothesis of two binding 
modalities is still valid. To further validate the hypothesis, we examined the cell surface 
binding of VacA after receptor depletion. Mammalian cells were pre-incubated for 1 h with 
SMase C, a phosphodiesterase that hydrolyzes plasma membrane SM to ceramide and 
free phosphorylcholine, which previously was demonstrated to show reduction on both 
SM content on cells as well as VacA-mediated cellular vacuolation 43, Table 7). After 
SMase treatment, pre-chilled AZ-521 cells were incubated with fluorescent labeled 
wildtype VacA (50 nM) in the absence or presence of 100 molar excess of unlabeled 
wildtype VacA to examine VacA binding to the cell surface epithelial cells by flow 
cytometry analysis (Figure 2.19). The data revealed that cell surface binding of labeled 
VacA was still comparable between in the absence or in the presence of 100 molar excess 
of unlabeled VacA using AZ-521 cells. Similarly, comparable VacA binding patterns were 
observed without or with receptor depletion in two additional mammalian cell-derived 
epithelial cell lines, AGS and HeLa cells (Figure 2.20). These experiments indicate that 
non-competitive VacA-membrane interaction exists as a significant component of VacA-
cell surface interaction of epithelial cells. These experiments suggest that a portion of 
VacA-cell surface interaction is receptor-independent interaction. These experiments 
support our hypothesis of two binding modalities of VacA-membrane interaction: receptor-
dependent interaction and receptor-independent interaction. While the exact mechanism 
on how receptor-independent interactions happens is not clear, it is worth noting that 
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many membrane-interacting proteins are interacting with membrane nonspecifically via 
merely electrostatic and ionic interaction. 
2.3.18 VacA (R552A/W603A/R647A) exhibits less binding to specific components 
on the plasma membrane of cultured cells than wildtype toxin 
 Results from the studies described immediately above are consistent with previous 
work 30,92,120,121 suggesting that VacA interacts with both specific and non-specific 
components on the surface of cultured cells. Because VacA (R552A/W603A/R647A) 
binding to SM-coated plates is significantly attenuated relative to wildtype VacA, we 
speculated that residues R552, W603, and R647 contribute specifically to SM-dependent 
binding. To test this idea, AZ-521 cells were incubated with fluorescent labeled VacA 
(R552A/W603A/R647A) (35 nM) in the absence or presence of 100 molar excess of 
unlabeled wildtype VacA by flow cytometry analysis (Figure 2.21). The data revealed that 
cell surface binding of labeled VacA (R552A/W603A/R647A) was not much changed 
without or with 100 molar excess of unlabeled wildtype VacA. Similar VacA binding 
patterns were shown upon competition assay in two additional mammalian cell-derived 
epithelial cell lines, AGS and HeLa cells (Figure 2.22). The data indicate VacA 
(R552A/W603A/R647A) does not compete with wildtype VacA. The data suggests that 
cell surface binding of VacA (R552A/W603A/R647A) is mainly receptor-independent 
interaction. The data support the idea that R552, W603, and R647 are crucial for receptor-
dependent VacA-membrane interaction. 
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2.3.19 Wildtype VacA partitions to a greater extent than VacA 
(R552A/W603A/R647A) into detergent resistant membranes (DRMs) on the 
plasma membrane of cultured cells 
 The competitive binding studies described immediately above revealed that the binding 
of VacA and VacA (R552A/W603A/R647A) to the plasma membrane was only partially 
inhibited in the presence of a molar excess of toxin, suggesting that VacA and VacA 
(R552A/W603A/R647A) bind to both specific and non-specific components on the surface 
of cells. However, the ratio of specific to non-specific binding was determined to be 
greater for wildtype VacA than VacA (R552A/W603A/R647A), supporting the idea that 
the mutant toxin binds to the surface of cells in a different manner than wildtype toxin. 
Because previous studies indicated that cell surface bound VacA partially partitions into 
SM-enriched microdomains important for cellular uptake of VacA and toxin activity, we 
speculated that toxin residues R552, W603, and R647 might be important for toxin 
partitioning into SM-enriched microdomains. Pre-chilled AZ-521 cells were incubated with 
wildtype VacA (500 nM) or VacA (R552A/W603A/R647A) (500 nM). After 30 mins, the 
cells were washed and lysed and solubilized in TNE buffer containing Triton X-100 (1%) 
and protease inhibitor cocktail by rotating at 4 ˚C. After 1 h, the lysates were loaded and 
fractionated at 4 ˚C by Optiprep gradient density centrifugation. After 4 h, six fractions 
were collected from the top to the bottom of the gradient. Immunoblot analysis of the 
collected fractions using α VacA antibody revealed the presence of VacA in each fraction. 
The immunoblot analysis revealed that VacA (R552A/W603A/R647A) showed visibly 
reduction on VacA association with DRM fraction compared to wildtype VacA (Figure 8A, 
ref#76). Quantification of DRM associated with VacA (R552A/W603A/R647A) showed 
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about 35 % reduction compared to DRM association of wildtype VacA (Figure 2.23). Such 
phenomena were observed in HeLa and AGS cells. (Figure 2.24). These data indicate 
that alanine substitution on R552, W603 and R647 leads to reduction on VacA association 
with DRMs. These data suggest that R552, W603 and R647 are crucial residues for VacA 
partitioning to SM-enriched microdomains. 
2.4 Discussion 
This manuscript shows our effort to understand the molecular basis of VacA and its 
cell surface membrane sphingolipid receptor, sphingomyelin (SM). We identified three 
VacA residues as the molecular prerequisites for VacA - SM interaction. We 
demonstrated that one tryptophan and two adjacent arginine residues that are important 
for vacuolation activity as well as the interaction with SM-coated plates. Studies on many 
unrelated SM-interacting proteins suggested the importance of aromatic residues, in 
particular tryptophan residues on SM interactions 49,68, evidenced by biochemical 44,48 and 
structural 47,51 observation. While the importance of tryptophan residues for SM interaction 
has been a recurring theme throughout the literature in the SM-interacting proteins 
48,50,68,122-124, additional molecular determinants for sphingomyelin specificity are unique 
to the individual SM-interacting proteins 44-46,67,123-125. Our data suggest that VacA 
incorporates one tryptophan residue, in alignment with previously identified SM-
interacting proteins, along with two adjacent positive-charged arginine residues, for SM 
interaction. Such receptor incorporation of VacA via tryptophan and arginine residues 
may allow π-cation interaction and hydrophobic interaction for stabilizing VacA-SM 
interaction, which are the mechanisms utilized by few SM-interacting proteins 46,123.  
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Our data not only agrees with previous work of membrane interaction of VacA, but also 
further explains the membrane interaction in an atomic level. Many previous data 
indicated the importance of C-terminal region of VacA for cell surface binding on human 
epithelial cells 59,61,63-65. Biochemical evidence demonstrated that the C-terminal region of 
VacA is both sufficient 59 and necessary 65 for membrane binding activity of VacA. In 
agreement with the previous work, the location of the newly identified SM-interacting 
residues on VacA, R552, W603 and R647, are within the C-terminal region of VacA. To 
our knowledge, this report firstly provides an atomic level explanation on VacA-receptor 
interaction. In addition to the importance of membrane interaction molecularly, the C-
terminal region of VacA has been indicated to be the key component to understand the 
cellular mechanism of the allelic dependent cytotoxicity of VacA 17. Within the C-terminal 
region of VacA contains, the highest genetic variation region, named “m region” which is 
highly associated with the risk of development of human gastric diseases 17,63,64. 
Biochemical evidence demonstrated the genetic variation on “m region” among different 
H. pylori strains is important for the differences on VacA-mediated cytotoxicity 61 and the 
cell surface binding ability 63. We identified that the location of the three VacA residues 
are located within the “m region”. In addition, based on protein alignment of VacA among 
different alleles of H. pylori, we identified the three VacA residues, R552, W603 and R647, 
are only conserved in toxic strains of VacA. Further examination on the three VacA 
residues will provide a better clue in understanding the molecular mechanism of the allelic 
dependent cytotoxicity of VacA, which would show the importance of the receptor binding 
residues in clinical isolates of H. pylori. 
	 82	
 To understand how the three residues may facilitate the VacA-membrane interaction, 
molecular dynamic (MD) simulations between the crystal structure of the three SM 
interacting-containing C-terminus VacA and a computerized highly mobile 
phosphatidylcholine-composed membrane model were performed (Figure 2.25). Out of 
three 350 ns-running time attempts, one attempt showed a successful anchorage of the 
VacA crystal structure onto the membrane mimicking model. The simulation suggests that 
the subdomain with the three SM-interacting residues allows the initial anchoring event 
of VacA on membrane mimicked lipid bilayers to nucleate specific VacA-membrane 
interaction, which is seen around 200 ns. In addition to the anchoring role of the SM-
interacting subdomain, the MD simulation suggested a complicated and long 
configuration of the optimized VacA-membrane interaction. In a later time point of 300ns, 
the MD simulation identified the final stage of optimized VacA-membrane interaction. The 
orientation of VacA towards the membrane was stabilized through yet an additional 
arginine residue, R460, located distant from the SM interacting subdomain. Such 
observation suggests the amino acid level of examination on the VacA-membrane 
interaction is further necessary to fully understand the VacA-membrane interaction.   
 By binding to cell surface via specific receptor interaction, many bacterial toxins begin 
the entering and travelling inside of toxin-sensitive cells 36. Our current studies of VacA 
suggest that SM interaction of VacA plays an important role to differentiate the functional 
VacA-membrane interaction from the non-functional one. Our results indicated that the 
three SM-interacting residues of VacA are important to shift the membrane-bound VacA 
population towards more sphingolipid-enriched microdomain, while the three residues did 
not affect the overall VacA binding to the plasma membrane. The overall VacA binding 
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on the plasma membrane has been shown to be not saturating, with the suggestion that 
VacA membrane interaction is mediated by abundant cell surface molecules 30,92,120,121. 
Agreeing with the previous suggestions, our data also showed that the three SM-
interacting residues can now differentiate mere VacA-membrane interaction from the 
specific VacA interaction towards sphingolipid-enriched microdomain. On sphingolipid-
enriched microdomain, VacA encounters GEEC/CLIC mediated, cdc42-dependent, and 
clathrin-independent internalization pathway 37,126, which conveys VacA to the endo-
lysosomal trafficking system 127 for traveling to its target organelle, mitochondria 22,113,128.  
Our data suggests the importance of SM-interacting residues on VacA for its membrane 
interaction specificity for its functional consequences. 
 What factors may mediate VacA-nonsphingolipid enriched microdomain interaction? 
One possible explanation of this interaction may be due to via multiple component-
mediated plasma membrane interaction. Due to a rather large size of VacA protein, the 
multiple component mediated plasma membrane interaction may be mediated by mere 
electrostatic and hydrophobic interaction between VacA and plasma membrane, which 
does not let VacA go into the cells.  
 Another possible explanation for the VacA-nonsphingolipid enriched microdomain 
interaction may be due to some host molecule interaction located in nonsphingolipid 
enriched microdomain. Recently, a novel transmembrane protein, called LRP-1, was 
reported to be as a specific VacA receptor for one distinct VacA activity, autophagy 24. 
Suggested model based on this report was that VacA interaction of plasma membrane, 
depend on which receptor VacA interacts, can lead VacA into different biological activity. 
Interestingly, it has been shown that LRP-1 is not associated with lipid rafts in resting 
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stage in many mammalian cells 129. LRP-1 can be, however, transiently associated with 
lipid rafts upon its ligand interaction 129. We hypothesized that VacA-LRP-1 association 
may be beneficial to relocate the VacA on non-sphingolipid enriched microdomain to 
sphingolipid enriched microdomain by allowing VacA to encounter SM in the sphingolipid 
enriched microdomain. Such a model has been suggested for another host membrane 
protein, RPTP-𝛼98, for its role in clustering VacA into sphingolipid enriched microdomain. 
 Many host cell surface molecules were suggested to be VacA receptor ranging from 
plasma membrane proteins 11,24,130,131 to lipid or lipid based molecules 41-43,109,132,133. While 
most of the VacA interacting host components showed their potentials by the direct 
interaction with VacA in in vitro systems, sphingomyelin is the sole host lipid molecules 
that showed the presence of absence is important for the VacA cellular activity as well as 
the VacA-plasma membrane interaction on gastric epithelial cells. Our data further 
support this idea with biochemical and molecular evidence on identification of a novel 
receptor interacting motif on VacA.   
 Even though we addressed the importance of SM-interacting residues for VacA-
membrane interaction, we still do not know the stoichiometry of VacA-SM interaction. One 
approach to this problem is to obtain a co-crystal structure with VacA and sphingomyelin 
mimic lipids. A recent report on the co-crystal structure of lysenin with sphingomyelin 
mimic lipid revealed the confined molar ratio between the two molecules interaction, 
which helped to understand the evolution of this SM-interacting protein and its family 
members 53. Co-crystal structure of VacA and SM can help to understand how many lipid 
molecules are incorporated into the receptor-binding site. Another approach to 
understand the stoichiometry of VacA-SM interaction is to examine VacA interaction using 
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a complete controlled nanoscale lipid bilayer systems called Nanodiscs. Shaw et al 134,135 
demonstrated the number of phospholipid molecules required to have an active blood 
clotting protease, called tissue factor VIIa (TF VIIa), upon lipid bilayer interaction, as well 
as the importance of localized phosphatidylserine, via thorough characterization of the 
Nanodisc bound with TF VIIa. Characterizing VacA-SM interaction using a complete 
controlled nanoscale lipid bilayer system can contribute to understand the stoichiometry 
of VacA-SM interaction on the plasma membrane and how the localized concentration of 
SM is important for VacA-membrane interaction. 
 Another important question that was not addressed here is how the lipid incorporation 
contributes for VacA to form a higher ordered structure for its channel activity. 
Biochemical evidences suggested that VacA is secreted and interact with the plasma 
membrane as monomers 106,133. However, whether the higher ordered structure by 
oligomerization of VacA is important for membrane interaction and whether the 
oligomerized VacA complex on the plasma membrane is active is not clear. We 
hypothesize that VacA-receptor interaction on the plasma membrane orients VacA to 
favor the high ordered structure to form an inactive pre-pore complex, which consequently 
helps VacA to recruit the right cellular uptake machinery. We are currently investigating 
the effects of oligomerization status on VacA-membrane interaction, based on this 
hypothesis. 
 While the chemically complex environment of the membrane surface offers many 
possibilities for proteins to interact with the plasma membrane via hydrophobic and 
electrostatic interaction, many membrane interacting proteins utilizes aromatic residues, 
such as tryptophan, tyrosine and phenylalanine, for their target lipid interaction on the 
	 86	
plasma membrane 136,137. VacA is a rather large protein of 88kDa that goes to a higher 
order structure by oligomerization for its channel activity 18,21, shown to have a high 
tendency towards the mere chemical interaction with plasma membrane. Among the mere 
VacA-membrane interaction, a VacA subdomain consists of a tryptophan residue and its 
two adjacent arginine residues contributes for VacA to find its target lipid, which leads 
VacA to be localized on a specific microdomain, where VacA can travel to an active 
pathway. We hope that our study can pave a way to further understand the cell tropism 
of VacA. In addition, given that VacA and plasma membrane interaction is the most 
targetable step, our data can be beneficial for inhibitor design in the future, which can be 











2.5 Figures and Tables 
 
TABLE 2.1. Helicobacter pylori strains used in this study 
Strains Description Reference 
60190 Wildtype H.pylori containing s1/m1 vacA 
gene 
TL Cover 
et al 1992 
JBC 
VM022 vacA gene deletion mutant of 60190 AD Vinion-
Dubiel et al 
1999 JBC  
VM022 (∆vacA) VM022 transformed with pHEL2 plasmid This study 
VM022 (∆vacA::vacA) VM022 transformed with pHEL2-vacA 
plasmid 
This study 
VM022(∆vacA::vacA (W30A)) VM022 transformed with pHEL2-vacA-
W30A plasmid 
This study 
VM022(∆vacA::vacA (W49A)) VM022 transformed with pHEL2-vacA-
W49A plasmid 
This study 
VM022(∆vacA::vacA (W80A)) VM022 transformed with pHEL2-vacA-
W80A plasmid 
This study 
VM022(∆vacA::vacA (W82A)) VM022 transformed with pHEL2-vacA-
W82A plasmid 
This study 
VM022(∆vacA::vacA (W90A)) VM022 transformed with pHEL2-vacA-
W90A plasmid 
This study 
VM022(∆vacA::vacA (W96A)) VM022 transformed with pHEL2-vacA-
W96A plasmid 
This study 
VM022(∆vacA::vacA (W225A)) VM022 transformed with pHEL2-vacA-
W225A plasmid 
This study 
VM022(∆vacA::vacA (W283A)) VM022 transformed with pHEL2-vacA-
W283A plasmid 
This study 
VM022(∆vacA::vacA (W577A)) VM022 transformed with pHEL2-vacA-
W577A plasmid 
This study 
VM022(∆vacA::vacA (W603A)) VM022 transformed with pHEL2-vacA-
W603A plasmid 
This study 
VM022(∆vacA::vacA (W773A)) VM022 transformed with pHEL2-vacA-
W773A plasmid 
This study 
VM022(∆vacA::vacA (R552A)) VM022 transformed with pHEL2-vacA- 
R552A plasmid 
This study 
VM022(∆vacA::vacA (R647A)) VM022 transformed with pHEL2-vacA- 
R647A plasmid 
This study 
VM022(∆vacA::vacA (W603A/R552A)) VM022 transformed with pHEL2-vacA- 
W603A/R552A plasmid 
This study 
VM022(∆vacA::vacA (W603A/R647A)) VM022 transformed with pHEL2-vacA- 
W603A/R647A plasmid 
This study 









TABLE 2.2. Primers used in this study 
























































1Primers were ordered from Integrated DNT technologies Inc. (www.idtdna.com, 
Coralville, IA) 
2Underlined and bold DNA sequences, GCG or GCA on forward primers, or, CGC or 
TGC on reverse primers, were the mutagenized sequences to obtain alanine 




TABLE 2.3. plasmids used in this study 
 
Plasmid Description reference 
pHEL2 E.coli and H.pylori shuttle vector D 
Heuermann 
and R Haas 
1998 Mol 
Gen Genet. 
pHEL2-vacA pHEL2 containing full-length of vacA gene 
and autotransporter gene 
This study 
pHEL2-vacA-W30A Point mutation on pHEL2-vacA to generate 
VacA (W30A) 
This study 
pHEL2-vacA-W49A Point mutation on pHEL2-vacA to generate 
VacA (W49A) 
This study 
pHEL2-vacA-W80A Point mutation on pHEL2-vacA to generate 
VacA (W80A) 
This study 
pHEL2-vacA-W82A Point mutation on pHEL2-vacA to generate 
VacA (W82A) 
This study 
pHEL2-vacA-W90A Point mutation on pHEL2-vacA to generate 
VacA (W90A) 
This study 
pHEL2-vacA-W96A Point mutation on pHEL2-vacA to generate 
VacA (W96A) 
This study 
pHEL2-vacA-W225A Point mutation on pHEL2-vacA to generate 
VacA (W225A) 
This study 
pHEL2-vacA-W283A Point mutation on pHEL2-vacA to generate 
VacA (W283A) 
This study 
pHEL2-vacA-W577A Point mutation on pHEL2-vacA to generate 
VacA (W577A) 
This study 
pHEL2-vacA-W603A Point mutation on pHEL2-vacA to generate 
VacA (W603A) 
This study 
pHEL2-vacA-W773A Point mutation on pHEL2-vacA to generate 
VacA (W773A) 
This study 
pHEL2-vacA- R552A Point mutation on pHEL2-vacA to generate 
VacA (R552A) 
This study 


























TABLE 2.4. Effects of supplementation or depletion of cellular SM content on several cell 
lines 
 
cell lines1 treatment2 temperature3 time4 
[SM]  
(nmol SM/mg of total 
protein)5,6 
P value7 
 AZ- 521 -     37 ºC   1 h     1.60 (±0.03)  
 SM (35 µM) 37 ºC 1 h 1.95 (±0.09) < 0.0001 
 sphingomyelinase  (200mU / mL) 37 ºC 1 h 1.17 (±0.09) < 0.0001 
  HeLa - 37 ºC 1 h 0.73 (±0.04)  
 SM (35 µM) 37 ºC 1 h 1.25 (±0.26) < 0.0001 
 sphingomyelinase  (200mU / mL) 37 ºC 1 h 0.56 (±0.67) 0.048 
   AGS - 37 ºC 1 h 0.42 (±0.02)  
 SM (35 µM) 37 ºC 1 h 0.53 (±0.05) < 0.0001 





- 37 ºC 1 h 0.60 (±0.02)  
SM (35 µM) 37 ºC 1 h 0.73 (±0.03) < 0.0001 
sphingomyelinase  
(200mU / mL) 37 ºC 1 h         0.51 (±0.02) 0.0024 
1The cell lines used for quantifying cellular sphingomyelin (SM) contents, as indicated. 
2Cells were incubated in the presence or absence of SM, or sphingomyelinase, at the 
indicated concentrations.  
3Cells were incubated in the presence or absence of SM, or sphingomyelinase, at the 
indicated temperature 
4Cells were incubated in the presence or absence of SM, or sphingomyelinase, at the 
indicated time 
5SM contents were expressed as nmol of SM per mg of total protein 
6The data were combined from three independent experiments (n = 3), each performed with 
three technical replicates.  
7P-values less than 0.05 indicate statistical significance. Statistical significance (α = 0.05) was 
calculated for the differences in SM contents of cells incubated with SM, or sphingomyelinase, 
compared to that of untreated cells using one-way ANOVA (and corrected using Sidak’s 










TABLE 2.5. Comparison of Vac50 of wildtype VacA and eleven tryptophan to alanine 
substituted form of VacA 
 
variant1 [Vac50] (nM)2,3 relative vacuolation activity4 
Wildtype VacA 42 (±4.5)     100 
VacA (W30A) 200 (±0.25) 21 
VacA (W49A) 44 (±1.6) 96 
VacA (W80A) 33 (±3.2) 130 
VacA (W82A) 44 (±1.2) 96 
VacA (W90A) 42 (±2.9) 100 
VacA (W96A) 32 (±2.2) 130 
VacA (W225A) 47 (±2.0) 89 
VacA (W283A) 50 (±1.20) 85 
VacA (W577A) 48 (±2.1) 88 
VacA (W603A) 350 (±0.17) 12 
VacA (W773A) 50 (±1.9) 83 
1Variants are mutant forms of VacA where the alanine is substituted for the 
indicated tryptophan residue 
2Vac50 refers to the concentration of VacA which yields 50% of the maximum 
neutral uptake assay within a monolayer and was calculated using the IC50 
calculation function within Prism 6.0e. Errors indicate standard deviations 
3The data were combined from three independent experiments (n = 3), each 
performed with three technical replicates 
4Relative vacuolation activity was calculated by dividing the Vac50 of the variants 























TABLE 2.6. Comparison of Vac50 of wildtype VacA and single, double, or triple alanine 
substituted form of VacA on R552, W603 and R647 
 
variant1 [Vac50] (nM)2,3 fold attenuation in vacuolation activity4 
P values5 
wildtype VacA 35 (±2.2)     1.0  
VacA (W603A) 360 (±0.17) 10 < 0.001 
VacA (R552A) 48 (±1.7) 1.3 0.6 
VacA (R647A) 41 (±2.0) 1.1 0.8 
VacA (R552A/W603A) 550 (±0.053) 15 < 0.001 
VacA (W603A/R647A) 310 (±0.24) 9.0 < 0.001 
VacA (R552A/R647A) 53 (±0.43) 1.5 0.7 
VacA 
(R552A/W603A/R647A) 5500 (±1000) Greater than 150 
< 0.001 
1Variants are mutant forms of VacA where the alanine is substituted for the indicated tryptophan 
residue or arginine residue 
2Vac50 refers to the concentration of VacA which yields 50% of the maximum neutral uptake 
assay within a monolayer and was calculated using the IC50 calculation function within Prism 
6.0e. Errors indicate standard deviations 
3The data were combined from three independent experiments (n = 3), each performed with 
three technical replicates 
4Fold attenuation in vacuolation activity was measured by dividing the Vac50 of the VacA variants 
by the Vac50 of wildtype VacA 
5P values less than 0.05 indicate statistical significance. Statistical significance (α = 0.05) was 
calculated for the differences in the Vac50 of the VacA variants against that of wildtype VacA 



















TABLE 2.7. Comparison of relative binding to SM-coated plates of wildtype VacA and 









No VacA 1.0 (±1.6)    -    - 
wildtype VacA 25 (±8.1)     1.0    - 
VacA (W603A) 13 (±3.4) 1.9 < 0.0001 
VacA (R552A) 28 (±6.0) 0.87 0.95 
VacA (R647A) 29 (±3.4) 0.84 0.78 
VacA (R552A/W603A) 13 (±3.1) 1.9 < 0.0001 
VacA (W603A/R647A) 14 (±5.1) 1.8 < 0.0001 
VacA (R552A/R647A) 29 (±8.2) 0.85 0.90 
VacA (R552A/W603A/R647A) 2.4 (±2.2) 10. < 0.0001 
1Variants are mutant forms of VacA where the alanine is substituted for the indicated 
tryptophan residue or arginine residue 
2Relative VacA binding to SM-coated wells was calculated by subtracting O.D. values at 
460 nm obtained from wells incubated with VacA (50 nM, each protein) in the absence of 
lipids subtracted from O.D. values at 460 nm obtained from SM-coated wells incubated with 
VacA. Each of the values were expressed relative to values obtained in the absence of 
wildtype VacA on lipid-coated wells, which was assigned an arbitrary value of 1.0. 
3The data were combined from three independent experiments (n = 3), each performed with 
three technical replicates 
4Fold attenuation was measured by dividing the relative VacA binding of the VacA variants 
by the relative VacA binding of wildtype VacA 
5P values less than 0.05 indicate statistical significance. Statistical significance (α = 0.05) 
was calculated for the differences in relative VacA binding to SM-coated plates of each 
mutant forms of VacA against that of wildtype VacA using one-way ANOVA (and corrected 








 Figure 2.1. Oh, Blanke et al. 2017
Figure 2.1. Supplementation or depletion of cellular SM is important for VacA-induced vaculation. Monolayers of 
AZ-521 cells were incubated at 37 ˚C, in the absence or presence of VacA (5 nM for (A) and (B), or, 250 nM for (C) and 
(D)), that had been pre-treated at 37 ˚C without or with sphingomyelin (SM, 35 μM) for (A) and (B), or, without or with 
sphingomyelinase C (SMase, 100 mU mL-1) for (C) and (D). For (A) or (C), after 16 h, phase contrast images of cells 
were collected (scale bar, 10 μm). The images are representative of those collected during three independent 
experiments, each performed with three technical replicates (n = 3). For (B) or (C), after 16 h, the relative vacuolation 
activity was measured using the neutral red uptake assay, and the data were normalized according to total protein per 
well. The data were combined from three independent experiments, each performed with three technical replicates 
(n = 3). The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical 
significance (α = 0.05)  was calculated for the differences in relative VacA-induced vacuolation activity on 
SM-supplemented, or not supplemented, cells for (B), or the VacA activity on SMase treated, or not treated, cells for (D), 






























































































































































Figure 2.2. The effect of N-bromosuccinimide (NBS) concentration on VacA-mediated vacuolation. Monolayers 
of AZ-521 cells were incubated at 37 ˚C in the absence or presence of VacA (250 nM), that had been pre-treated at 
room temperature without or with NBS at different molar ratios to VacA. After 16 h, the relative vacuolation activity was 
measured using the neutral red uptake assay, and the data were normalized according to total protein per well. 
Immunoblot analysis against α-VacA antibody revealed the relative amounts of VacA used for each of the experimental 
samples employed for the neutral red uptake assay. The data were combined from three independent experiments, 
each performed with three technical replicates (n = 3). The data were rendered as a bar graph using Prism 6.0e. Error 
bars indicate standard deviations. Statistical significance (α = 0.05) was calculated for the differences in relative 
vacuolation activity of the NBS-treated VacA or untreated cells against that of untreated VacA using one-way ANOVA 
(and corrected using Sidak’s mulitple comparisons test). P-values less than 0.05 indicate statistical significance.
Figure 2.2. Oh, Blanke et al. 2017






















































































Figure 2.3. N-bromosuccinimide (NBS) treatment attenuates VacA-induced vacuolation. 
Monolayers of AZ-521 cells were incubated at 37 ˚C, in the absence or presence of VacA (250 nM), that had been 
pre-treated at room temperature without or with NBS (11 μM). (A) After 16 h, phase contrast images of cells were 
collected (scale bar, 10 μm). The images are representative of those collected during three independent experiments, 
each performed with three technical replicates (n = 3). (B) After 16 h, the relative vacuolation activity was measured 
using the neutral red uptake assay, and the data were normalized according to total protein per well. The data were 
combined from three independent experiments (n = 3), each performed with three technical replicates. The data were 
rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05)  
was calculated for the differences in relative vacuolation activity of the NBS-treated VacA or no VacA against that of 
untreated VacA using one-way ANOVA (and corrected using Sidak’s multiple comparisons test). P-values less than 
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Figure 2.4a. Alanine scanning of eleven VacA tryptophan residues identifies one tryptophan residue important
 for both toxin cellular activity and binding to SM-coated plates. 
(A) The location of the eleven VacA tryptophan residues in the primary sequence of processed mature toxin 
(821 residues). (B) Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA 
(0 - 250 nM) or, separately, with each of the eleven VacA mutant forms with a tryptophan-to-alanine substitution
 (0 - 250 nM). After 16 h, the relative vacuolation activity was measured using the neutral red uptake assay, and 
the data were normalized according to total protein per well. The data were combined from three independent 
experiments, each performed with three technical replicates (n = 3). The data were rendered as a bar graph 
using Prism 6.0e. Vac50 refers to the concentration of VacA which yields 50% of the maximum neutral uptake 
within a monolayer and was calculated using IC50 calculation function within Prism 6.0e. Error bars indicate standard 
deviations. Statistical significance (α = 0.05) was calculated for the differences in 1 / Vac50 of VacA W30A and 
VacA W603A against that of wildtype VacA using one-way ANOVA (and corrected using Sidak’s multiple comparisons
 test). P-values less than 0.05 indicate statistical significance. (C) 96-well Immulon 1B microtiter plates, with 
individual wells coated with SM (500 pmol) were incubated at 4 ˚C in the absence or presence of wildtype 
VacA (50 nM; 50 μL each), or VacA (W603A/R552A/R647A) (50 nM; 50 μL each). After 16 h, unbound toxins were 
washed out of the wells with PBS (pH 7.4, 4 ˚C), and the extent of VacA binding was measured using ELISA while 
employing α-VacA antibody. The O.D. value at 460 nm in each well was measured using a microplate reader. Relative 
VacA binding to SM-coated wells was calculated by subtracting the O.D. values at 460 nm obtained from wells incubated
with VacA in the absence of lipids from the O.D. values at 460 nm obtained from SM-coated wells incubated with VacA. 
Each of the values were expressed relative to values obtained in the absence of wildtype VacA, which was assigned an 
arbitrary value of 1. The data were combined from three independent experiments, each performed with three technical 
replicates (n = 3). The data were then rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. 
Statistical significance (α = 0.05) was calculated for the differences in relative SM binding of VacA W30A and VacA 
W603A against that of wildtype VacA using one-way ANOVA (and corrected using Sidak’s multiple comparisons test). 




residue 1 residue 821VacA
W30


















































































































































Oh, Blanke et al. 2017Figure 2.4a
	 98	
 
Figure 2.4b. VacA binding to SM-coated plates is dependent on VacA concentration and is saturating.
96-well Immulon 1B microtiter plates, with individual wells coated with SM (500 pmol) were incubated at 4 ˚C 
in the absence or presence of wildtype VacA (0.05, 0.5, 1.75, 5, 12.5 pmol). The presence of SM on the 
surface in individual wells was confirmed by quantifying the total surface bound SM in individual wells using 
the Amplex Red fluorescent-based SM quantification method (as described under experimental procedures). 
After 16 h of toxin binding, the wells were washed with PBS (pH 7.4, 4 ˚C) to remove unbound toxin molecules, 
and the extent of VacA binding was measured using an ELISA employing α-VacA antibody. The O.D. value at 
460 nm in each well was measured using a microplate reader. Relative VacA binding to SM-coated wells was 
calculated by subtracting the O.D. values at 460 nm obtained from uncoated wells incubated with VacA from 
the O.D. values at 460 nm obtained from SM-coated wells incubated with VacA. Each of the values were 
expressed relative to values obtained in the absence of wildtype VacA, which was assigned an arbitrary 
value of 1. The data were combined from five independent experiments (n = 5), each performed with three 
technical replicates. The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard 
deviations. Statistical significance (α = 0.05)  was calculated for the differences in relative VacA binding to 
SM-coated plates of VacA (100 nM) against that of no VacA using a two-tailed paired t-test. P-values less than 
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Figure 2.5. Computational modeling predicts that the phosphorylcholine headgroup of SM could potentially 
occupy space in proximity to tryptophan 603 (W603), arginine 552 (R552), and arginine 647 (R647). MD simulation 
of VacA (residues 355 - 811; PDB: 2QV3) was performed in a 90 Å x 90 Å x 130 Å rectangular cube after solvation and 
ionization. Phosphatidylcholine (PC), which contains the same phosphorylcholine head group as sphingomyelin, was added 
into the simulation as a surrogate for identifying potential interactions of SM with VacA. The PC - VacA complex was 
simulated for 250 ns using the NAMD2 program. The simulation was analyzed by the VMD’s VolMap plugin to determine 
high probability on interaction sites of PC molecules, which are within 5 Å of the protein. The brown bubbles highlight the 
most probable regions with PC molecules, which includes the side chains of W603, R552, and R647, as indicated with 
red arrows.






Figure 2.6. The location of tryptophan 603 within the three-dimentional structure of the VacA C-terminal domain. 
The structure of the C-terminal domain of VacA (residues 355 - 811; PDB : 2QV3) was rendered using 
PyMol ver.1.8. (open source; www.pymol.org) . The site of tryptophan 603 on the structure is indicated with a white arrow. 
The indole ring of tryptophan is highlighted in yellow.
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Figure 2.7. Quality control analyses of purified wildtype VacA and VacA (W603A/R552A/R647A). 
(A) Left, Coomassie Brilliant blue-stained SDS-PAGE gel (12.5 %) of purified toxin, either wildtype VacA (0.7 μg) or 
VacA (W603A/R552A/R647A) (0.7 μg). The data are representative of several dozen purifications (n > 3). Right, 
immunoblot analysis of purified toxin, either wildtype VacA (250 nM) or VacA (W603A/R552A/R647A) (250 nM), using 
α−VacA antibody. The data are representative of at least three independent experiments (n > 3). (B) Evaluation of 
VacA (W603A/R552A/R647A) for structural perturbations by comparing trypsin sensitivity relative to wildtype VacA. 
Purified toxin, either wildtype VacA (0.88 μM) or VacA (W603A/R552A/R647A) (0.88 μM), was incubated at room 
temperature without or with trypsin (final concentrations : 0, 0.1, 1, 10 nM). After 1 h, the trypsin digestion was stopped 
by addition of SDS-PAGE sample buffer containing β-ME and heating at 95 ˚C for 5 min. Immunoblot analysis using 
α−VacA antibody revealed the trypsin sensitivity profiles of the toxins. The data are representative of three independent 
experiments (n = 3). (C) Evaluation of VacA (W603A/R552A/R647A) for higher-ordered structure formation by glycerol 
gradient sedimentation relative to wildtype VacA. Purified toxin, either wildtype VacA (1 μM) or VacA 
(W603A/R552A/R647A) (1 μM), in two buffers, either at pH 7.4 or at pH 3, was loaded and fractionated at 4 ˚C by 
glycerol gradient density centrifugation (0 - 40%). After 16 h, six fractions were collected from the top (0%) to the 
bottom (40%) of the gradient. Immunoblot analysis of the collected fractions using α−VacA antibody revealed the 
presence of VacA in each fraction. High-molecular mass forms of VacA were detected in higher density fractions,
 while low-molecular mass forms of VacA were detected in lower density fractions. The data are representative of three 






















































































Figure 2.8. VacA (R552A/W603A/R647A) shows attenuation in cellular vacuolation activity relative 
to wildtype VacA. 
Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA (100, 250, 
500, 1000, 2000 nM), or VacA (R552A/W603A/R647A) (100, 250, 500, 1000, 2000 nM). (A) After 16 h, the 
monolayers were imaged using phase contrast microscopy (scale bar, 10 μm). The images are representative 
of those collected during three independent experiments (n = 3), each performed with three technical replicates. 
(B) After 16 h, the relative vacuolation activity was measured using the neutral red uptake assay, and the 
data were normalized according to total protein per well. The data were combined from three independent 
experiments (n = 3), each performed with three technical replicates. The data were rendered as a bar graph 
using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05) was calculated for 
the differences in relative vacuolation activity of VacA (R552A/W603A/R647A) against that of wildtype VacA 
at different concentrations using two-way ANOVA (and correctedusing Sidak’s multiple comparisons test). 
P-values less than 0.05 indicate statistical significance.
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Figure 2.9. Multiple cell lines demonstrate decreased sensitivity to VacA (W603A/R552A/R647A) relative 
to wildtype VacA. Monolayers of mammalian epitheial-derived cells, AGS or HeLa cells, were incubated at 37 ˚C 
in the absence or presence of VacA (1, 10, 35, 100, 250 nM), or VacA (W603A/R552A/R647A) (1, 10, 35, 100, 250 nM). 
For (A) or (C), after 16 h, phase contrast images of either AGS (A) or HeLa cells (C), incubated in the absence or 
presence of wildtype VacA (250 nM) or VacA (W603A/R552A/R647A) (250 nM) were collected (scale bar, 10 μm). The 
images are representative of those collected during three independent experiments, each performed with three technical 
replicates (n = 3). For (B) or (D), after 16 h, the relative vacuolation activities of AGS (B) or HeLa cells (D) was measured 
using the neutral red uptake assay, and the data were normalized according to total protein per well. The data were 
combined from three independent experiments, each performed with three technical replicates (n = 3). The data were 
rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05) was 
calculated for the differences in relative vacuolation activity of VacA (W603A/R552A/R647A) against that of wildtype 
VacA using two-way ANOVA (and corrected using Sidak’s multiple comparisons test). P-values less than 0.05 indicate 
statistical significance.
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Figure 2.10. Primary gastric epithelial cells isolated ex vivo from the stomachs of C57BL/6 mice are sensitive
to wildtype VacA, but not VacA (R552A/W603A/R647A), in a SM-dependent manner.
Ex vivo cultured primary gastric epithelial cells isolated from the stomachs of 12 - 17 week-old C57BL/6 mice 
were incubated at 37 ˚C in the absence or presence of wildtype VacA (500 nM), that had been pre-treated 
at 37 ˚C without or with sphingomyelinase C (SMase C, 200 mU mL-1) (A), or, solely in the absence or presence 
of wildtpe VacA (500nM) or VacA (R552A/W603A/R647A) (B). For (A) and (B), after 8 h, the monolayers were 
evaluated for VacA-mediated vacuole biogenesis using phase contrast microscopy imaging (scale bar, 10 µm). 
The images are representative of those collected during three independent experiments (n = 3), each involving 
preparations of gastric primary cells from three independent blocks of mice, with each block comprising three mice. 
Each independent experiement was performed with three technical replicates.









200 mU mL-1 500 nM
A. B.
	 105	
Figure 2.11. VacA (R552A/W603A/R647A) binding to plates coated with SM or PC, but not ceramide (Cer), 
PE, or PI, is attenuated relative to wildtype VacA. 96-well Immulon 1B microtiter plates, with individual
 wells coated with SM (500 pmol) (A), or with the indicated lipid (500 pmol, SM; sphingomyelin, PC; 
phosphatidylcholine, Cer.; ceramide, PE; phosphatidylethanolamine, PI; phosphatidylinositol) (B), were 
incubated at 4 ˚C in the absence or presence of wildtype VacA, or VacA (R552A/W603A/R647A) 
(1, 3.5, 10, 35, 100 nM in 50 µL for each well (A), or, 100 nM for (B)). After 16 h, unbound toxins were washed 
out of the wells with PBS (pH 7.4, 4 ˚C), and the extent of VacA binding was quantified using ELISA while 
employing α-VacA antibody. The O.D. values at 460 nm were measured in each well using a microplate reader. 
Relative VacA binding to SM-coated wells (A) or the indicated lipid-coated wells (B) was calculated by 
subtracting the O.D. values at 460 nm obtained from wells incubated with VacA in the absence of lipids, from 
the O.D. values at 460 nm obtained from SM-coated wells (A) or the indicated lipid-coated wells (B) incubated 
with VacA. Each of the values wasexpressed relative to values obtained in the absence of VacA (A) or the values 
obtained in the presence of wildtype VacA on the indicated lipid coated plates (B), which was assigned an arbitrary 
value of 1. The data were combined from three independent experiments (n = 3), each performed with three 
technical replicates. The data were then rendered as a bar graph using Prism 6.0e. Error bars indicate standard 
deviations. Statistical significance (α = 0.05)  was calculated for the differences in binding of VacA 
(R552A/W603A/R647A) compared to that of wildtype VacA in SM-coated plates (A), or the indicated lipid-coated 
plates (B), using two-way ANOVA (and corrected using Sidak’s multiple comparisons test). P values less 
than 0.05 indicate statistical significance.          
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Figure 2.12. Enzymatic removal of phosphorylcholine headgroup from SM- or PC-coated plates is specific to 
the corresponding enzymes; sphingomyelinase C for SM, or PC-specific phospholipiase C for PC.
96-well Immulon 1B microtiter plates, with individual wells coated with the indicated lipid (sphingomyelin (SM), 
or, phosphatidylcholine (PC); 500 pmol), were incubated at 37 ˚C with Amplex Red reagent (50 μl / well), 
a fluorescent-based reagent to detect phosphorylcholine headgroup release, in the absence or presence
of the indicated phosphorylcholine specific cleavage enzymes, sphingomyelinase C (SMase C; 100 mU / mL) 
or PC-specific phospholipase C (PC-PLC; 200 mU / mL). After 3 h, the fluorescence of the Amplex Red reagent 
in each well was measured (excitation: 540 nm / emission: 590 nm), using a black-colored 96-well plate, for the 
phosphorylcholine headgroup release. Relative fluorescence intensity for phosphorylcholine headgroup release 
from lipid-coated plates was calculated by subtracting the fluorescence intensity obtained from the wells on non 
lipid-coated plates, from the fluoresence intensity obtained from the wells on SM- or PC-coated plates. Each of the 
values was expressed relative to the fluorescence intensity obtained in SM- or PC-coated wells without enzyamtic 
treatment, which was assigned an arbitrary value of 1.0, respectively. The data were combined from three 
independent experiments (n = 3), each performed with six technical replicates. The data were then rendered as 
a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05)  was 
calculated for the differences in relative fluoresence intensity on the indicated SM- or PC-coated plates in the 
absence or presence of the the phosphorylcholine specific cleavage enzymes, using a one-way ANOVA 
(corrected using Sidak’s multiple comparision). P values less than 0.05 indicate statistical significance. 
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Figure 2.13. Preincubation of SM- or PC-coated wells with sphingomyelinase C or 
PC-specific phospholipase C, respectively, reduced wildtype VacA, but not VacA (R552A/W603A/R647A), 
binding to SM or PC-coated plates.
96-well Immulon 1B microtiter plates, with individual wells coated with the indicated lipid (sphingomyelin (SM), 
or, phosphatidylcholine (PC); 500 pmol), were incubated at 37 ˚C with Amplex Red reagent (50 μl/well), 
a fluorescent-based reagent, to detect phosphorylcholine headgroup release, in the absence or presence
of the indicated phosphorylcholine specific cleavage enzymes, sphingomyelinase C (SMase C; 100 mU/mL) 
or PC-specific phospholipase C (PC-PLC; 200 mU/mL). After 3 h, the fluorescence of the Amplex Red reagent 
in each well was measured (excitation: 540 nm / emission: 590 nm), using a black-colored 96-well plate, for the 
phosphorylcholine headgroup release. The Immulon 1B microtiter plate was further incubated at 4 ˚C in the 
absence or presence of wildtype VacA (A), or VacA (R552A/W603A/R647A) (B) (35 nM in 50 µL for each well). 
After 16 h, unbound toxins were washed out of the wells with PBS (pH 7.4, 4 ˚C), and the extent of VacA binding 
was quantified using ELISA while employing α-VacA antibody. The O.D. values at 460 nm were measured in each 
well using a microplate reader. Relative VacA binding to the indicated lipid-coated wells was calculated by 
subtracting the O.D. values at 460 nm obtained from the wells incubated with wildtype VacA (A), or VacA 
(R552A/W603A/R647A) (B), on non lipid-coated plates, from the O.D. values at 460 nm obtained from the wells on 
SM- or PC-coated plates. Each of the values was expressed relative to the O.D. values at 460 nm obtained in 
SM- or PC-coated plates without enzymatic incubation, which respectively was assigned an arbitrary value of 1.0. 
The data were combined from three independent experiments (n = 3), each performed with three technical replicates. 
The data were then rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical 
significance (α = 0.05)  was calculated for the differences in relative VacA in the presence of the indicated enzyme 
compared to that in the absence of the enzyme on the indicated SM- or PC-coated plates, respectively, using a 
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Figure 2.14. Single, double, or triple mutant forms of VacA, W603A, R552A/W603A, W603A/R647A, 
R552A/W603A/R647A, revealed the synergy of the three residue for toxin cellular activity and binding to 
SM-coated plates. (A) Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype 
VacA, VacA W603A, VacA R552A, VacA R647A, VacA (R552A/W603A), VacA (W603A/R647A), VacA (R552A/R647A), 
or VacA (R552A/W603A/R647A) (0 nM - 250 nM). After 16 h, the relative vacuolation activity was measured using the 
neutral red uptake assay, and the data were normalized according to total protein per well. The data were combined 
from three independent experiments, each performed with three technical replicates (n = 3). The data were rendered as
 a bar graph using Prism 6.0e. Vac50 refers to the concentration of VacA which yields 50% of the maximum neutral 
uptake assay within a monolayer and was calculated using IC50 calculation function within Prism 6.0e. Error bars 
indicate standard deviations. Statistical significance (α = 0.05) was calculated for the differences in 1 / Vac50 of 
VacA W603A, VacA (R552A/W603A), VacA (W603A/R647A), and VacA (R552A/W603A/R647A) against that of wildtype 
VacA using one-way ANOVA (and corrected using Sidak’s multiple comparisons test). P-values less than 0.05 indicate 
statistical significance. (B) 96-well Immulon 1B microtiter plates, with individual wells coated with SM (500 pmol) were 
incubated at 4 ˚C in the absence or presence of 50 μL of wildtype VacA, VacA W603A, VacA R552A, VacA R647A, 
VacA (R552A/W603A), VacA (W603A/R647A), or VacA (R552A/W603A/R647A) (50 nM, each protein). After 16 h, 
unbound toxins were washed out of the wells, and the extent of VacA binding was measured using ELISA while 
employing α -VacA antibody. The O.D. at 460 nm was measured in each well using a microplate reader. Relative 
VacA binding to SM-coated wells was calculated by subtracting O.D. values at 460 nm obtained from wells incubated 
with VacA in the absence of lipids subtracted from O.D. values at 460 nm obtained from SM-coated incubated wells with 
VacA. Each of the values were expressed relative to values obtained in the absence of wildtype VacA, which was 
assigned an arbitrary value of 1. The data were combined from three independent experiments, each performed with 
three technical replicates (n = 3). The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard 
deviations. Statistical significance (α = 0.05)  was calculated for the differences in relative VacA binding to SM-coated 
plates of VacA W603A, VacA (R552A/W603A), VacA (W603A/R647A), and VacA (R552A/W603A/R647A) against that 
of wildtype VacA using one-way ANOVA (and corrected using Sidak’s multiple comparisons test). P-values less than 
0.05 indicate statistical significance. 



























































































































































































Figure 2.15. Exogenous SM restores both toxin sensitivity and cell surface binding of wildtype VacA as well 
as VacA (R552A/W603AR647A)
Monolayers of AZ-521 cells (A) and (B) were pre-incubated at 37 ˚C without or with sphingomyelinase 
(SMase, 200 mU/mL). After 1h, the cells were washed with PBS (pH 7.4,  4 ˚C) and brought down to 4 ˚C. 
After 20min, the cells were incubated at 4 ˚C in the absence or presence of sphingomyelin 
(SM, concentration : 0, 0.0035, 0.035, 0.35, 3.5, 35, 100, 200 μM). After 1h, cells were washed with PBS 
(pH 7.4, 4 ˚C) and incubated with wildtype VacA (50 nM) (A) or VacA (R552A/W603A/R647A) (500 nM) (B).The 
increased total cellular SM for the monolayers incubated with exogenous SM was confirmed using the Amplex 
Red flourescent-based SM quantification method (as described under experimental procedures). 
(A) and (B) SM-dependent recovery of vacuolation activity is calculated by normalizing the relative vacuolation 
activity of cells with different treatments by the relative vaculation activity of VacA treated cells, measured after 
16 h incubation, using wildtype VacA (A), or, VacA (R552A/W603A/R647A) (B), respectively. The relative vacuolation 
activity was measured using the neutral red uptake assay, and the data were normalized according to total protein 
per well. The data were combined from three independent experiments  (n = 3), each performed with three technical 
replicates. The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. 
Statistical significance (α = 0.05)  was calculated for the differences in relative vacuolation activity of treated cells to 
the relative vacuolation activity of VacA treated cells, either wildtype VacA or VacA (R552A/W603A/R647A) using a 
one-way ANOVA (corrected using Sidak’s multiple comparision). P values less than 0.05 indicate statistical significance.
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Figure 2.16. VacA (R552A/W603A/R647A) binding to the cell surface of epithelial cells is smaller than 
wildtype VacA. 
AZ-521 cells (1 X 106 cells mL-1 in suspension) were incubated at 4 ˚C in the absence or presence of wildtype 
VacA (100 nM), or VacA (R552A/W603A/R647A) (100 nM). After 30 min, the cells were washed with PBS 
(pH 7.4, 4 ˚C) and fixed  by incubating with paraformaldehyde (4%) in PBS (pH 7.4, 4 ˚C). After 20 min, 
the cells were washed and incubated at 4 ˚C with ɑ-VacA antibody in a rotary shaker. After 16 h, the cells 
were washed and incubated with Alexa Flour 488-conjugated secondary antibody against ɑ-VacA antibody 
at room temperature. After 1 h, the cells were analyzed by flow cytometry. (A) Flow cytometry histogram of 
cells incubated in the absence or presence of wildtype VacA (100 nM), or VacA (R552A/W603A/R647A) 
(100 nM), as indicated by black arrows. MF is the geometric mean fluorescence. The histogram is 
representative of those collected during three independent experiments, each performed with three technical 
replicates (n = 3). (B) VacA binding to the cell surface was calculated by subtracting the background 
geometric mean fluorescence of cells without toxin from the geometric mean fluorescence of the cells in 
the presence of wildtype VacA (100 nM), or VacA (R552A/W603A/R647A) (100 nM), and normalized by 
the value of wildtype VacA, which was assigned an arbitrary value of 1.0. The data were combined from 
three independent experiments (n = 3), each performed with three technical replicates. The data were rendered 
as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05)  was 
calculated for the differences in relative VacA binding to the cell surface of VacA (R552A/W603A/R647A) 
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Figure 2.17. Binding of VacA (R552A/W603A/R647A) to the plasma membrane of several different 
cell lines is reduced relative to wildtype VacA. 
Human epithelial-derived AGS or HeLa cells (1 X 106 cells mL-1 in suspension) were incubated at 4 ˚C 
in the absence or presence of wildtype VacA (100 nM), or VacA (R552A/W603A/R647A) (100 nM). After 
30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed by incubating with paraformaldehyde 
(4%) in PBS (pH 7.4, 4 ˚C). After 20 min, the cells were washed and incubated at 4 ˚C with ɑ-VacA 
antibody in a rotary shaker. After 16 h, the cells were washed and incubated with Alexa Flour 
488-conjugated secondary antibody against ɑ-VacA antibody. After 1 h, the cells were analyzed by 
flow cytometry. For (A) or (C), flow cytometry histograms of AGS cells (A), or HeLa cells (C) are shown, 
in the absence or presence of wildtype VacA (100 nM), or VacA (R552A/W603A/R647A) (100 nM), 
as indicated by black arrows. MF is the geometric mean fluorescence. The histogram is representative 
of those collected during three independent experiments (n = 3), each performed with three technical 
replicates. For (B) or (D), VacA binding to the cell surface of AGS (B) or HeLa cells (D) was calculated 
by subtracting the background geometric mean fluorescence of cells without toxin from the geometric 
mean fluorescence of the cells in the presence of wildtype VacA (100 nM), or VacA 
(R552A/W603A/R647A) (100 nM), and normalized by the value of wildtype VacA, which was assigned 
an arbitrary value of 1.0. The data were combined from three independent experiments (n = 3), each 
performed with three technical replicates. The data were then rendered as a bar graph using Prism 6.0e. 
Error bars indicate standard deviations. Statistical significance (α = 0.05) was calculated for the differences 
in the relative VacA binding to cell surface of VacA (R552A/W603A/R647A) versus that of wildtype VacA 
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Figure 2.18. Cell surface binding of wildtype VacA is not saturating within the concentration where toxin is active 
using multiple cell lines. (A) Mammalian epithelial-derived cells (1 X 106 cells mL-1 in suspension), either AZ-521, AGS
or HeLa cells, were incubated at 4 ˚C in the absence or presence of Alexa Fluor 488-labeled wildtype VacA (0 - 500 nM). 
After 30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed with paraformaldehyde (4%) in PBS. After 
20 min, the cells were washed and analyzed by flow cytometry. The relative VacA binding to cell surface was 
measured by the geometric mean fluorescence of the cells with the labeled wildtype VacA (0 - 500 nM), normalized by 
the geometric mean fluorescence of cells without toxin. The data were combined from two independent experiment, 
each performed with three technical replicates (n = 2). The data were then rendered as a bar graph using Prism 6.0e. 
Error bars indicate standard deviations. KD values were measured using one-site specific binding equation calculation 
within Prism 6.0e. 
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Figure 2.19. Depletion of cell surface SM results in a smaller fraction of total membrane bound VacA 
asscociated with a specific component or components on the surface of cultured cells.
AZ-521 cells (1 X 106 cells mL-1 in suspension) were incubated at 37 ˚C without or with sphingomyelinase C 
(SMase, 200 mU mL-1; in PBS pH 7.4). The decreased total cellular SM for the cells was confirmed using 
the Amplex Red flourescent-based SM quantification method (as described under experimental procedures). 
After 60 min, the cells were prechilled on ice. After 20 min, the cells were washed with PBS (pH 7.4, 4˚C) and 
incubated with Alexa-Fluor 488 labeled wildtype VacA (35 nM) in the absence or presence of 100-fold molar 
excess unlabeled VacA. After 30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed by incubating 
with formaldehyde (4%) in PBS (pH 7.4, 4 ˚C). After 20 min, the cells were washed with PBS (pH 7.4, 4 ˚C) 
and analyzed for VacA binding on the cell surface by flow cytometry. The geometric mean fluorescence 
obtained from the flow cytometry analysis of Alexa-Flour 488 labeled forms of VacA represented the total 
binding of the toxins to the surface of cultured cells, which was assigned an arbitary value of 1.0. Fractions 
of total membrane bound VacA associated in a nonspecific manner with the cell surface was obtained by 
measuring the geometric mean fluorescence of Alexa-Fluor 488 labeled VacA in the presence of 100-fold 
molar excess of unlabeled forms of the toxin. In order to calculate the fraction of total membrane 
bound VacA associated with a specific cell surface component or components, the fraction of total membrane 
bound VacA associated in a nonspecific manner with the cell surface was subtracted from total membrane 
bound VacA.The data were combined from three independent experiments, each performed with three 
technical replicates (n = 3). The data were rendered as a bar graph using Prism 6.0e. Error bars indicate 
standard deviations. Statistical significance (α = 0.05)  was calculated for the difference bewteen the fraction 
of total membrane bound VacA associated with a specific component or components on the cell surface 
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Figure 2.20. Depletion of cell surface SM results in a smaller fraction of total membrane bound VacA 
asscociated with a specific component or components on the surface of AGS or HeLa cells.
AGS or HeLa cells (1 X 106 cells mL-1 in suspension) were incubated at 37 ˚C without or with sphingomyelinase C 
(SMase, 200 mU mL-1; in PBS pH 7.4). The decreased total cellular SM for the cells was confirmed using 
the Amplex Red flourescent-based SM quantification method (as described under experimental procedures). 
After 60 min, the cells were prechilled on ice. After 20 min, the cells were washed with PBS (pH 7.4, 4˚C) and 
incubated with Alexa-Fluor 488 labeled wildtype VacA (35 nM) in the absence or presence of 100-fold molar 
excess unlabeled VacA. After 30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed by incubating 
with formaldehyde (4%) in PBS (pH 7.4, 4 ˚C). After 20 min, the cells were washed with PBS (pH 7.4, 4 ˚C) 
and analyzed for VacA binding on the cell surface by flow cytometry. The geometric mean fluorescence 
obtained from the flow cytometry analysis of Alexa-Flour 488 labeled forms of VacA represented the total 
binding of the toxins to the surface of cultured cells, which was assigned an arbitary value of 1.0. Fractions 
of total membrane bound VacA associated in a nonspecific manner with the cell surface was obtained by 
measuring the geometric mean fluorescence of Alexa-Fluor 488 labeled VacA in the presence of 100-fold 
molar excess of unlabeled forms of the toxin. For (A) or (B), In order to calculate the fraction of total membrane 
bound VacA associated with a specific cell surface component or components on the cell surface of AGS (A)
or HeLa cells (B), the fraction of total membrane bound VacA associated in a nonspecific manner with the 
cell surface was subtracted from total membrane bound VacA.The data were combined from three 
independent experiments, each performed with three technical replicates (n = 3). The data were rendered as
 a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05)  was 
calculated for the difference bewteen the fraction of total membrane bound VacA associated with a specific 
component or components on the cell surface without and with SMase incubation, using a two-tailed 
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Figure 2.21. A larger fraction of total membrane associated wildtype VacA than VacA (R552A/W603A/R647A) 
binds to a specific component or components on the surface of cultured cells.
AZ-521 cells (1 X 106 cells mL-1 in suspension) were incubated at 4 ˚C with Alexa-Fluor 488 labeled wildtype 
VacA (35 nM), or VacA (R552A/W603A/R647A) (35 nM), in the absence or presence of 100-fold molar excess 
unlabeled VacA. After 30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed by incubating with 
formaldehyde (4%) in PBS (pH 7.4, 4 ˚C). After 20 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and 
analyzed for VacA binding on the cell surface by flow cytometry. The geometric mean fluorescence obtained 
from the flow cytometry analysis of Alexa-Flour 488 labeled forms of VacA represented the total binding of 
the toxins to the surface of cultured cells which was independently assigned an arbitary value of 1.0, for both 
wildtype VacA and VacA (R552A/W603A/R647A). Fractions of total membrane bound VacA associated in a 
nonspecific manner with the cell surface was obtained by measuring the geometric mean fluorescence of 
Alexa-Fluor 488 labeled wildtype and mutant forms of VacA in the presence of 100-fold molar excess of 
unlabeled cognate forms of the toxins. In order to calculate the fraction of total membrane bound VacA 
associated with a specific cell surface component or components, the fraction of total membrane bound VacA 
associated in a nonspecific manner with the cell surface was subtracted from total membrane bound VacA.
The data were combined from three independent experiments, each performed with three technical replicates 
(n = 3). The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. 
Statistical significance (α = 0.05)  was calculated for the difference bewteen the fraction of total membrane 
bound VacA associated with a specific component or components of wildtype VacA and VacA 
(R552A/W603A/R647A), using a two-tailed paired t-test. P-values less than 0.05 indicate statistical significance.
wt : wildtype VacA
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Figure 2.22. Oh, Blanke et al. 2017
Figure 2.22. A larger fraction of total membrane associated wildtype VacA than VacA (R552A/W603A/R647A) 
binds to a specific component or components on the plasma membrane of AGS or HeLa cells.
AGS (A) or HeLa cells (B) (1 X 106 cells mL-1 in suspension) were incubated at 4 ˚C with Alexa-Fluor 488 labeled 
wildtype VacA (35 nM), or VacA (R552A/W603A/R647A) (35 nM), in the absence or presence of 100-fold molar 
excess unlabeled VacA. After 30 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and fixed by incubating with 
formaldehyde (4%) in PBS (pH 7.4, 4 ˚C). After 20 min, the cells were washed with PBS (pH 7.4, 4 ˚C) and 
analyzed for VacA binding on the cell surface by flow cytometry. The geometric mean fluorescence obtained from 
the flow cytometry analysis of Alexa-Flour 488 labeled forms of VacA represented the total binding of the toxins 
to the surface of cultured cells which was independently assigned an arbitary value of 1.0, for both wildtype 
VacA and VacA (R552A/W603A/R647A). Fractions of total membrane bound VacA associated in a nonspecific 
manner with the cell surface was obtained by measuring the geometric mean fluorescence of Alexa-Fluor 488 
labeled wildtype and mutant forms of VacA in the presence of 100-fold molar excess of unlabeled cognate 
forms of the toxins. In order to calculate the fraction of total membrane bound VacA associated with a specific 
cell surface component or components, the fraction of total membrane bound VacA associated in a nonspecific 
manner with the cell surface was subtracted from total membrane bound VacA.The data were combined from three 
independent experiments, each performed with three technical replicates (n = 3). The data were rendered as 
a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical significance (α = 0.05)  was 
calculated for the difference bewteen the fraction of total membrane bound VacA associated with a specific 
component or components of wildtype VacA and VacA (R552A/W603A/R647A), using a two-tailed paired t-test. 
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Figure 2.23. Oh, Blanke et al. 2017
Figure 2.23. Alanine substitutions at residues R552, W603, and R647 reduce VacA association with 
cell surface detergent resistant membranes (DRMs), but not with non-DRMs.
AZ-521 cells (4 X 106 cells / mL in suspension) were incubated at 4 ˚C in the absence or presence of wildtype 
VacA (500 nM), or VacA (R552A/W603A/R647A) (500 nM). After 30 min, the cells were washed with PBS 
(pH 7.4, 4 ˚C) and lysed by 15 passages through 25-gauge needle in TNE buffer containing a protease inhibitor 
cocktail. Membranes were solubilized by adding ice-cold Triton X-100 (1%) and incubated further on a rotary 
shaker (4 ˚C). After 1 h, the lysates were fractionated at 4 ˚C using OptiPrep gradient density (0 - 40%) 
centrifugation (35,000 xg). After 4 h, six fractions were collected from the top (0%) to the bottom (40%) of the 
gradient. Immunoblot analysis of the collected fractions using α−VacA antibody revealed the presence of VacA 
in each fraction. (A) A representive immunoblot of fractionated wildtype VacA, or VacA (R552A/W603A/R647A), 
acquired during three independent experiments (n =3) is shown. Previous experiments and preliminary studies 
confirmed that the fractions 1-3 corresponded to DRMs, as indicated by partitioning of flotillin-1 
(Gupta et al, 2007). In addition, fractions 4-6 were previously demonstrated to correspond to non-DRMs, 
as indicated by partitioning of the transferrin receptor (Gupta et al, 2007). (B) The density of signals 
corresponding to VacA within each fraction was quantified using the Quantity Tool in Image Lab 5.2.1 (Bio-Rad). 
Relative association of wildtype VacA, or VacA (R552A/W603A/R647A), with DRMs, or non-DRMs, was 
represented relative to values for wildtype VacA associated with DRMs, or with non-DRMs, which were assigned an 
arbitrary value of 1.0, respectively. The data were combined from three independent experiments (n = 3). 
The data were rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical 
significance (α = 0.05)  was calculated for the differences of VacA (R552A/W603A/R647A) association with DRMs, 
or with non-DRMs, compared to wildtype VacA association with DRMs, or with non-DRMs, respectively, using a 
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Figure 2.24. Oh, Blanke et al. 2017
Figure 2.24. A smaller fraction of total membrane bound VacA (R552A/W603A/R647A) than wildtype VacA
partitions to detergent resistant membranes (DRMs) in AGS or HeLa cells.
AGS or HeLa cells(4 X 106 cells / mL in suspension) were incubated at 4 ˚C in the absence or presence of wildtype 
VacA (500 nM), or VacA (R552A/W603A/R647A) (500 nM). After 30 min, the cells were washed with PBS 
(pH 7.4, 4 ˚C) and lysed by 15 passages through 25-gauge needle in TNE buffer containing protease inhibitor 
cocktail. Membranes were solubilized by adding ice-cold Triton X-100 (1%) and incubated further on a rotary 
shaker (4 ˚C). After 1 h, the lysates were fractionated at 4 ˚C by OptiPrep gradient density (0 - 40%) centrifugation
(35,000 xg). After 4 h, six fractions were collected from the top (0%) to the bottom (40%) of the gradient. 
Immunoblot analysis of the collected fractions using α−VacA antibody revealed the presence of VacA in each fraction. 
(A) and (C) A representive immunoblot of wildtype VacA, or VacA (R552A/W603A/R647A), acquired during three 
independent experiments (n =3) using AGS (A) or HeLa cells (D). Previous experiments and preliminary studies 
confirmed that the fractions 1-3 were corresponded to DRMs, as indicated by partitioning of flotillin-1 
(Gupta et al, 2007). In addition, fractions 4-6 were corresponded to non-DRMs, as indicated by partitioning of 
transferrin receptor (Gupta et al, 2007). (B) The density of signals corresponding 
to VacA within each fraction was quantified using Quantity Tool in Image Lab 5.2.1 (Bio-Rad). The fraction of 
total membrane bound wildtype VacA, or VacA (R552A/W603A/R647A), partitioned to DRMs, was obtained by 
analyzing the total density of signals corresponding to VacA within the fractions 1-3, while toxin partitioning to 
non-DRMs was analyzed by the total density of signals corresponding to VacA within the fractions 4-6. 
Each of the values for DRMs, or non-DRMs, were expressed relative to values of wildtype VacA partitioned to 
DRMs, or non-DRMs, which was assigned an arbitrary value of 1.0, respectively. The data were combined from 
three independent experiments (n = 3). The data were rendered as a bar graph using Prism 6.0e. Error bars 
indicate standard deviations. Statistical significance (α = 0.05)  was calculated for the differences in the 
fraction of total membrane bound VacA (R552A/W603A/R647A) partitioned to DRMs, or non-DRMs,
compared to wildtype VacA partitioned to DRMs, or non-DRMs, using a two tailed paired t-test. P-values less 
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Figure 2.25. Computational simulation of VacA-plasma membrane interaction using a highly mobile 
membrane-mimetic (HMMM) model suggests one time-dependent scenario, which VacA interacts 
and becomes anchored onto the membrane by a mechanism involving arginine 552 (Arg-552),
tryptophan 603 (Trp-603), and arginine (Arg-647). 
VacA (residues 355 - 811; PDB: 2QV3), after solvation and ionization, was added to a highly mobile membrane-
mimetic (HMMM) model, which was constructed by placing two leaflets of divaleryl-phosphatidylcholine (DVPC). 
VacA is initially placed where its center of mass (COM) is positioned 20 - 28 Å above the phosphorus plane of 
the leaftlet that faces VacA, without contacting the model membrane. The VacA-membrane systems consisted 
of a rectangular cube with dimensions of 65 Å x 65 Å X 72 Å. The systems were energy-minimized for initial 50 ps 
and simulated for 375 ns using NAMD2, utilzing the CHARMM27 force field with CMAP corrections for proteins
 and CHARMM36 parameters for lipids. Three independent simulations were performed (n =3), and one 
successful membrane-binding simulation is represented here. The other two simulation were not further pursued
after 375 ns simulation due to the computationally expensive simulation time. All the HMMM simulations were 
performed in NPnAT ensembles at 1.0 atm and 310 K and with a time step of 2 fs. Constant pressure was
 maintained by using the Nosé-Hoover Langevin piston method and constant temperature was maintained 
by Langevin dynamics with a damping coefficient γ of 0.5 ps-1 applied to all atoms. The one successful simulation 
was analyzed and visualized using VMD. (A) Snapshots were taken at five different times (t = 0, 100, 200, 250, 
and 310 ns) from the 375 ns HMMM simulation of VacA, representing membrane anchoring and insertion observed 
in the simulation. Side chains of Arg-552 is represented in blue color, Trp-603 in red, Arg-647 in black, Trp-577 
in green, and Arg-460 in pink. The phospholipids in stick representation indicate the phospholipids within the 
distance of 2 Å towards the five color-indicated VacA residues. (B) To monitor the membrane insertion of VacA 
during the 375 ns HMMM simulation of VacA, the position of the five individual VacA residues (Arg-552 represented 
in blue color, Trp-603 in red, Arg-647 in black, Trp-577 in green, and Arg-460 in pink) with respect to the model 
membrane was characterized by the height (depth of interaction) along the membrane normal (z - axis) of the 
center of mass (COM) of the side chains of the five VacA residues. Membrane insertion was assumed when 
the COM of the side chains of the five VacA residues was located around or below the the average position of 
the phosphorus atoms of the lipid head groups, drawn as a brown line. The avarage position of the nitrogen
 atoms is drawn as a gray line.
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Chapter 3 : INVESTIGATION OF THE MOLECULAR BASIS OF vacA GENETIC 





Since the first discovery of Helicobacter pylori in human stomach in 1984 1, the 
thirty years of research demonstrated that H. pylori colonize over half of the world’s 
population 2-5. Among the H. pylori infected individuals, approximately 20% of them have 
shown a strong association with clinical disease such as peptic ulcers, gastric 
adenocarcinoma, or mucosa-associated lymphoid tissue (MALT) lymphoma 6-9. Indeed, 
the discovery on strong correlation of H. pylori infection with both gastric adenocarcinoma 
and MALT lymphoma, which are early stages of development of gastric cancer, led H. 
pylori classified as class I carcinogen by the World Health Organization. On the other 
hand, the remaining 80% of infected individuals, the chronic inflammation caused by H. 
pylori infection results in no overt clinical symptoms. In addition, H. pylori association with 
humans is hypothesized to have originated in Africa, preceding the human migration 
approximately 58,000 years ago, supporting an idea of co-evolution between H. pylori 
and human species 138-140. These recent observations, majority of H. pylori-infected 
individuals do not develop disease and the co-evolution of H. pylori with human migration, 
are leading a paradigm shift to classify H. pylori as normal human microflora 2. 
Supporting the idea that H. pylori is a part of normal human flora, which are 
beneficial for human health, recent findings suggest that H. pylori infection has a 
protective role in various aspects of human health 141-150. Several reports suggested an 
inverse correlation between H. pylori infection with asthma and allergy in early childhood 
based on meta-analysis 142,143,145,146. In addition, H. pylori shows a protective role against 
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tuberculosis and diabetes141,148. Both human subjects and non-human primates show H. 
pylori-infected individuals are less likely develop active tuberculosis148 In terms of H. pylori 
infection with diabetes, a recent work indicates that eradication of H. pylori may has a role 
in development of metabolic disorders, such as diabetes, in individuals with higher BMI141. 
When H pylori was eradicated in individuals with higher BMI, increasing of human gastric 
hormones that control energy homeostasis, leptin and ghrelin, was observed147 Increased 
leptin and ghrelin is a major risk for higher BMI patients to develop diabetes.  Lastly, H. 
pylori infection may have protective role for esophageal reflux disease and esophageal 
adenocarcinoma 144,149. As the prevalence of H. pylori has decreased over the last century, 
there is a rise in esophageal diseases based on both meta-analysis studies and 
prospective studies. Given the fact that H. pylori infection can be either harmful or 
beneficial to human health, it is important to identify the factors that lead H. pylori more 
virulent2. In this chapter, I am exploring one possible bacterial factor that cause H. pylori 
infection more harmful: allelic dependent cytotoxicity of vacA gene. 
H. pylori is demonstrated to be one of the most variable species of bacteria 2. This 
heterogeneity has been used as a classification system to discriminate among strains 
13,14. vacA gene, a virulent H. pylori gene responsible for secreting pore-forming protein 
Vacuolating cytotoxin A, has been utilized for developing such a classification system. 
vacA gene is virtually found in all H. pylori strains. Moreover, vacA contains allelic diversity 
that varies across H. pylori strains. The middle region, called ‘m region,’ is one of the best 
characterized regions 17. Allelic difference, which only share 55% amino acid identity on 
m region, categorize H. pylori strains into m1 or m2 strains. The heterogeneity on m region 
shows higher correlation with the developing of gastric diseases. While m2 vacA 
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sequence variants are less associated with the gastric diseases, m1 vacA sequence 
variants are more associated with the gastric diseases 14,17.  
The heterogeneous m region is located within the C-terminus domain of VacA, 
called p55, which was demonstrated to be important for its membrane interaction activity 
15,16,59,60. The non-toxic C-terminus domain of VacA p55 purified from the engineered H. 
pylori strain to contain the partial vacA gene responsible for the C-terminus domain of 
VacA, showed similar cell binding pattern as the holotoxin suggesting the importance of 
C-terminus for membrane interaction 59. When individual subunits of VacA, N-terminus 
and C-terminus forms of VacA, were examined for VacA internalization into the cells using 
fluorescent labeled recombinant VacA subunits purified from E. coli, the internalization 
only happens in when C-terminus subunit of VacA was present, further suggesting the 
importance of p55 domain for membrane interaction 60.  
m region has been demonstrated to be important for cell specificity possibly via 
receptor interaction, even though the molecular evidence was still not well understood. 61-
64. When culture filtrates of several H. pylori strains, both m1 and m2 strains, were 
examined for vacuolation activity on HeLa cells, the most well-studied immortalized 
laboratory epithelial cell lines for VacA activity, the culture filtrates of m1 strains, but not 
that of m2 strains, showed cytotoxicity 64. When RK-13 cells, a distinct epithelial cell line 
derived from rabbit kidney epithelial cells, were examined for cytotoxicity, however, the 
culture filtrates of m2 H. pylori strains, but not that of m1 strains, showed extensive 
cytotoxicity, suggesting the difference on m region may utilize different host cell surface 
molecules as cell receptor for cell specificity. In addition, the difference on m region 
showed two distinctive cell binding pattern depending on the heterogeneity of m region 
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65. Examination of VacA binding affinity using a soluble GST-VacA fusion system with m1 
showed very high binding affinity, while m2 VacA showed distinctive binding pattern with 
lower binding affinity. This examination further supports the importance of m region for 
cell specificity: difference on m region confers different binding pattern.  
In addition, an independent investigation on examination of the difference within m 
region identified a 150-amino acid region is responsible for allelic dependent cytotoxicity 
61. By comparing differences of VacA protein sequences on m region using several H. 
pylori strains, clinically isolated m1, m2, and hybrid m1/m2 strains, the 150-amino acid 
region showed the most dramatic difference between m1 and m2 which is correlated to 
the difference of cytotoxicity between m1 and m2 strains. To examine whether this region 
was responsible for allelic dependent cytotoxicity, chimeric VacA was generated to 
contain the 150-amino acid region of m2 strain on m1 background. The chimeric VacA 
showed reduced vacuolation activity, suggesting that this 150-amino acid region is 
important for the difference on cytotoxicity. However, the detailed mechanism on how this 
region plays a role in the cytotoxicity is still a gap in knowledge. On the other hand, the 
investigation to identify the responsible host molecule had not been very fruitful 62. 
Examination of the importance of the cell surface transmembrane tyrosine phosphatase 
RPTPb, a cell surface receptor for VacA, demonstrated that m region-dependent 
cytotoxicity is independent of this cell surface molecule. When HL-60 cell, a cell line that 
induces overexpression of RPTPb upon phenol 12-myristate 13-acetae (PMA) treatment, 
was examined for cell binding of m1 or m2 VacA, the cell binding showed no difference 
between the two without or with PMA treatment. This examination suggests that 
responsible mechanism for m region dependent cell specificity is still a gap in knowledge. 
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These previous studies provided evidence that m region is important for the allelic 
difference, yet the molecular basis of the difference is still not well understood. In this 
chapter, I provide some molecular evidence that the difference on the m region is 




3.2 Materials and methods 
 
 
3.2.1 Bacterial strains and growth conditions 
  H. pylori 60190 (49503; ATCC, Manassas, VA) and all other H pylori strains, listed 
in Table 1, were cultured under biphasic conditions at 37 ºC under 5% CO2 and 10% O2 
within a humidified environment, using bisulfite- and sulfite-free Brucella broth (BSFB) 
broth (dextrose; 0.1%, β -cyclodextrin; 0.2%, NaCl; 0.5%, Sigma-Aldrich, St. Louis, MO, 
and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2%, BD Biosciences, Sparks, MD) 
containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, MO) on Ham F-12 plates 
supplemented with fetal bovine serum (FBS, 10%; Atlanta Biologicals Inc., Flowery 
Branch, GA) 70. For genetic manipulation, H. pylori VM022 (∆vacA) was utilized 30. H. 
pylori VM022 was cultured at 37 ºC under 5% CO2 and 10% O2 within a humidified 
environment on Columbia blood agar (CBA) plates supplemented with vancomycin (10 
µg / mL; Oxoid, Hampshire, UK), trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; 
Oxoid), and amphotericin B (5 µg / mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, 
MO) with 10% defibrinated sheep blood (Hemostat Laboratories, Dixon, CA). For 
selection of H. pylori transformants, the CBA plates supplemented with sucrose (100 mg 
/ mL; Sigma-Aldrich) were used in place of kanamycin.   
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3.2.2 DNA manipulation and plasmid construction 
Genomic DNA was extracted from H. pylori 60190 or H. pylori Tx30a using Wizard 
genomic DNA purification kit (Promega Corp., Madison, WI). A 4513-bp fragment of the 
vacA gene from 60190, or 4661-bp from Tx30a, was amplified from the genomic DNA by 
polymerase chain reaction (PCR) using the oligonucleotides, BamHI-vacA-F (5´-
CGCGCGGATCCAACTGCTTGGCATCGGG-3´) and vacA-BamHI-R (5´- 
GCGCGCGGATCCATTTCAAACCCATGCTTTGAGC-3´) (ordered from IDTDNA, 
Coralville, IA). The 4513-bp fragment, or 4661-bp fragment, of the amplified vacA gene 
was digested with BamHI and ligated with BglII digested pHel2 71, a chloramphenicol 
resistant plasmid (kindly gifted by Dr. Ritesh Kumar, the University of Illinois at Urbana-
Champaign, IL), to generate vacA gene containing plasmid, named pHel2-vacA. 
Alteration of vacA gene on pHel2-vacA was performed with the QuikChange site-directed 
mutagenesis kit (Strategene, San Diego, CA) using the oligonucleotides listed in Table 4. 
Chimeric form of vacA gene on pHel2-vacA was performed by sequencing overlap 
extension polymerase chain reaction using the oligonucleotides listed in Table 2. The 
resulting constructs were fully sequenced at the Roy J. Carver Biotechnology Center at 
the University of Illinois at Urbana-Champaign and were compared with wildtype 
sequence using nucleotide BLAST of NIH (https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
3.2.3 Alteration on vacA gene of H. pylori by allelic-exchange strategy  
pHel2-vacA and its derived plasmids, listed in Table 3, were introduced into 
naturally-competent H. pylori VM022 30, by using natural transformation 72. The H. pylori 
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transformants were obtained by sacB-based counter selection 73. Briefly, fresh growing 
cultures of H. pylori VM022 were prepared by incubating the H. pylori culture at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment on Columbia blood agar 
(CBA) plates supplemented with vancomycin (10 µg / mL; Oxoid, Hampshire, UK), 
trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; Oxoid), and amphotericin B (5 µg 
/ mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, MO) with 10% defibrinated sheep 
blood (Hemostat Laboratories, Dixon, CA). After 3 days, the culture of H. pylori was 
transferred to a fresh cold CBA plate with kanamycin. After 6 h, pHel2-vacA and its 
derivatives (concentration: 3–10 µg) were dropped on the top of H. pylori culture and 
mixed using a spreader. After 6 h, H. pylori was scraped from the plate and transferred 
to a cold CBA plate supplemented with sucrose (100 mg / mL; Sigma-Aldrich), allowing 
homologous recombination to occur between the endogenous vacA and the vacA gene 
on the plasmid. After 8 -10 days, H. pylori transformants were picked on both a new CBA 
plates supplemented with sucrose (100 mg / mL; Sigma-Aldrich) and a new CBA plates 
supplemented with kanamycin (30 µg / mL; Sigma-Aldrich, MO). Colonies formed on the 
sucrose CBA plates, but not on the kanamycin CBA plates, were assumed to be 
successful H. pylori transformants. vacA gene from the possibly successful H. pylori 
transformants were fully sequenced at Roy J. Carver Biotechnology Center at the 
University of Illinois at Urbana-Champaign and were compared with the wildtype 
sequence using nucleotide BLAST of NIH (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Yield 
of obtaining successful H. pylori transformants by this method was about 30%. 
Replication of pHEL2 or its derivatives in H. pylori was not observed, based on multiple 
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trials to extract the plasmids from log-phase growth of H. pylori culture (8-10 h incubation) 
using Miniprep plasmid extraction kit (Qiagen Inc., Valencia, CA). 
 
3.2.4 Purification of VacA  
VacA and its derived version of toxins were purified, as previously described 20. 
Briefly, H. pylori 60190 and all of its derived strains were cultured on biphasic conditions 
using BSFB broth (dextrose; 0.1%, β-cyclodextrin; 0.2%, sodium chloride; 0.5%, Sigma-
Aldrich, St. Louis, MO, and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2 %, BD 
Biosciences, Sparks, MD) containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, 
MO) on Ham F-12 plates supplemented with FBS (10%, Atlanta Biologicals Inc.) at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment. After 48 h, the liquid phase 
containing H. pylori growth was transferred to a fresh BSFB liquid culture and further 
incubated at 37 ºC under 5% CO2 and 10% O2 within a humidified environment.  After 48 
h, the supernatant of the H. pylori culture was collected by centrifugation at 8000 xg for 
15 min at 4 ºC. The supernatant was then precipitated 4 ºC with ammonium sulfate (Fisher 
Scientific, Fair Lawn, NJ) to 90% saturation (662 g / L). After 16 h, the precipitates were 
dissolved in the wash buffer (10 mM sodium phosphate dibasic, pH 7.0; Sigma-Aldrich) 
and dialyzed in the same buffer using a dialysis membrane (Spectra/PorTM RC/MWCO; 
50kDa, Spectrum Labs, Rancho Dominquez, CA). After removing the insoluble fractions 
by centrifugation at 8000xg for 15 min at 4 ºC followed by filtration using a filtered funnel 
(Stericup©, MWCO; 0.22 μm; EMD Millipore, Billerica, MA), the VacA containing soluble 
fraction was loaded into a column embedded with an anion exchange resin (DEAE 
Sephacel™, GE healthcare, Little Chalfont, UK). After washing the column with 3 bed 
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volumes of the wash buffer, VacA was eluted with the wash buffer supplemented with 0.2 
M sodium chloride, and collected into small fractions (1.5 mL each). The fractions 
collected were checked for purity by SDS-PAGE gel separation and Coomassie Brilliant 
Blue staining. Fractions with visibly pure VacA were dialyzed in PBS (pH7.4, 4 ºC) using 
a dialysis cassette (Slide-A-LyzerTM, MWCO; 20kDa, Thermo Fisher Scientific, Walthan, 
MA). The final concentration of VacA was determined by measuring the total protein 
concentration using the BCA assay, using bovine serum albumin (BSA) to generate a 
standard curve (0.025 – 1.5 mg / mL). 
3.2.5 Western blot analysis of VacA 
  Protein lysates for western blot analysis were prepared by mixing protein samples, 
or cell lysates, with the equivalent volume of 2X Laemmli sample buffer (Bio-Rad 
Laboratories Inc, CA) and then incubated at 100 ºC  for 10 min for protein denaturation. 
After the standard SDS-PAGE gel separation and transfer to PVDF membrane 
(Immobilon®-P, Pore size; 0.45 μm, Merck Millipore, Tullagreen, Ireland), the blots were 
incubated overnight at 4 °C with primary antibodies diluted in Tris-buffered (pH 7.4) saline 
with 0.1% Tween 20 (TBS-T), supplemented with 5% skim milk (blocking buffer), and then 
for 1 h at room temperature with HRP-conjugated secondary antibodies (1:10000 dilution; 
Cell Signaling, Danvers, MA) diluted in the blocking buffer. After washing 4 times with 
TBS-T for 5 min each, the blots were incubated with HRP substrates (SuperSignal® West, 
Pico and Femto mixed at 4:1 ratio; Thermo Scientific, Rockford, IL). The luminescent 
signals from the blots were imaged using ChemiDoc™ XRS+ imaging system (Bio-Rad, 
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Hercules, CA), and, analyzed using Image Lab™ software (Version 4.1; Bio-Rad, 
Hercules, CA) for quantification of the relative band intensities. 
3.2.6 Mammalian cell culture 
All cultured mammalian cell lines were maintained at 37 °C and under 5% CO2 
within a humidified environment. AZ-521 cells (3940; RIKEN, Japan) was maintained in 
Minimum Essential Medium (MEM; Corning Life Sciences, Tewksbury, MA) with 10% 
FBS (Atlanta Biologicals Inc., GA). Unless otherwise indicated, cells were seeded in 96 
well plates at a confluency not exceeding 90% (2.5 x 104 cells / well).  
3.2.7 Qualitative and quantitative analysis of vacuole biogenesis on cells.  
  Monolayers of AZ-521 were cultured in 96 well plates and allowed to adhere at 37 
ºC, 5% CO2, in humidified atmosphere. After 16 h, the cells were incubated at 4 °C to 
prevent toxin uptake from the cell surface to occur. The cells then received experimental 
treatment in cell culture medium containing ammonium chloride (5 mM; Sigma-Aldrich, 
MO) with a duplicate experimental set on the same plate, one for vacuolation 
measurement and the other for total protein measurement. Following experimentation, 
cells were imaged for qualitative vacuole biogenesis by light microscopy. Cells with more 
than 4-5 visible vacuoles observed throughout the cytosol of the cells were qualified as 
VacA-mediated vacuolated cells. 
  After cell imaging, the monolayers were washed twice with PBS (pH 7.4) for 
quantitative analysis. To measure vacuole biogenesis on cells, one experimental set was 
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incubated at 37 ºC with Neutral Red solution (Sigma-Aldrich) (100 µL / well, diluted 1:5 
with PBS, pH 7.4). After 4 min, cells were washed three times with PBS (pH 7.4, 4 ºC) to 
remove residual neutral red. The cells within the wells were lysed by adding acid alcohol 
(100 µL / well, 3.7% hydrochloride, 70% ethanol, in diH2O) and the colorimetry of the 
neutral red on the plates was measured at 530 nm and 410 nm using a microplate reader 
(BioTek, Winooski, VT). To measure total protein concentration, another experimental set 
was lysed in RIPA buffer (30 µL / well, Thermo Fisher), followed by incubation at 37 ºC 
with BCA reagent (200 µL / well, Thermo Fisher). After 30 min, total protein was measured 
at 562 nm using a microplate reader (BioTek, Winooski, VT). The total protein 
concentration was determined by BCA assay, using bovine serum albumin (BSA) to 
generate a standard curve (0.025 – 1.5 mg / mL). The neutral red uptake data were 
normalized to the respective total protein measurement under the same experimental 
treatment and relativized to the respective untreated control. 
3.2.8 Lipid binding assay 
  A solid state ELISA assay was used to quantify VacA binding to lipids as previously 
described 43,55,82. 96 well Immulon 1B microtiter plates (Thermo Scientific, Rockford, IL) 
were incubated with the indicated concentrations of SM (860062p; Avanti, AL) or mock 
control at room temperature. After 2h or the lipids were visibly dried, the wells were 
washed with PBS (pH 7.4) and blocked using 3% BSA diluted in PBS (pH 7.4) at room 
temperature. After 1.5 h, each well was incubated with VacA in 3% BSA diluted in PBS 
(pH 7.4) at 4 °C. After 16 h, the wells were washed out with PBS (pH 7.4) to remove 
unbound toxins from the wells. The wells were then incubated at room temperature with 
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polyclonal rabbit α-VacA antibody for 2 h, followed by HRP-conjugated α-rabbit antibody 
(Cell Signaling Technology, Danvers, MA). After 40 min, the wells were washed with PBS 
(pH 7.4) six times. Degree of VacA binding on the lipid-coated plates was determined by 
colorimetric method using Ultra TMB-ELISA substrate (50 µl / well; Thermo Fisher, IL). 
After 10 min, the color development was stopped by adding sulfuric acid (2M, 50 µl / well; 
Thermo Fisher) and the colorimetry was measured by using a microplate reader (BioTek, 
Winooski, VT).  
3.2.9 Protease sensitivity assay 
  To assess gross structural perturbations of the mutant VacA toxins relative to 
wildtype VacA, the protein’s sensitivity to proteolytic digestion with trypsin 91 was 
evaluated. Briefly, purified toxins were incubated at room temperature with or without 
trypsin (PBS, pH 7.4; Sigma-Aldrich, MO). After 1 h, trypsin digestion was stopped by 
addition of SDS-polyacrylamide sample buffer (Bio-Rad, Hercules, CA) containing ß-ME 
(Thermo Fisher, IL) and heating at 100 ˚C for 10 min. The samples were analyzed by 
Western blot analysis, using rabbit anti-VacA antibodies prepared as described above 
under “Western blot analysis of VacA.” The resulting dose-dependent banding patterns 
were visually evaluated for gross differences, which would be interpreted to suggested in 
overall VacA structure resulting in altered sensitivity to the protease.   
3.2.10 Statistical analysis 
	 140	
  Unless otherwise indicated, each experiment consisted of 3 independent 
replicates, each comprise of three technical replicates. Statistical analyses were 
performed using Prism 6.0e (GraphPad Software Inc., La Jolla, CA). Error bars indicate 
standard deviations. All P values were calculated using either the t test with paired, two-
tailed, one-way ANOVA, or two-way ANOVA (corrected using Sidak’s multiple 
comparisons test). A P value of less than 0.05 indicate the statistically significant 






3.3.1 H. pylori encodes vacA gene with allelic variations that segregate VacA toxin 
possessing higher or lower cytotoxicity 
Previous observation showed that sequence divergence in vacA genes is 
associated with the level of in vitro cytotoxin activity as well as clinical consequences 
13,14,17. While vacA sequence variants with less in vitro cellular cytotoxicity are less 
associated with the gastric diseases, vacA sequence variants with more in vitro cellular 
cytotoxicity are more associated with the gastric diseases. However, previous 
investigations did not address the molecular basis of such observations. In this study, I 
evaluated the overall hypothesis that VacA, the pore forming protein generated from vacA 
gene, of less toxic allele H. pylori strain has a dysfunctional receptor binding site, which 
induces less cellular cytotoxicity. A prediction of this hypothesis is that if the dysfunctional 
receptor binding site on VacA of less toxic alleles were reconstituted with active receptor 
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binding site, it will restore cellular activity. To begin testing this prediction, I obtained a 
phylogenic tree that was generated based on the alignment of 295 VacA sequences from 
NCBI data bank. (Provided by Dr. Michael L. Reno in Blanke Lab, Figure 3.1) The 
phylogenic tree showed that the 295 VacA sequences can segregate H. pylori strains into 
two clusters. To examine whether the segregation is associated with in vitro cytotoxic 
activity, I located several clinically isolated toxic H. pylori strains, namely 26695, P12, J99, 
60190, G27, and 98-10, and several clinically isolated less toxic H. pylori strains, namely 
3250809, 95-94, Tx30a, B128, 6716134, and 597825843, within the phylogenic tree. The 
cytotoxic activity of these strains was demonstrated previously 151. This observation 
revealed that toxic H. pylori strains are located within one cluster, which is designated as 
‘toxic cluster’, and less toxic H. pylori strains are located within another cluster, which is 
designated as ‘less toxic cluster’. This result validates the previous observation that there 
is a genetic variation on vacA gene that segregates H. pylori depends on its toxicity as 
well as clinical consequences. Based on this observation, I first addressed whether there 
is any difference on the locations of the three VacA residues predicted to be important for 
SM interaction, namely R552, W603, and R647, between toxic and nontoxic alleles (Refer 
to Chapter 2). 
Initially, I examined whether the three VacA residues for SM interaction, namely 
R552, W603, and R647, were identified among VacA sequences of toxic and less toxic 
H. pylori alleles. In chapter 2, I identified and demonstrated that the three VacA residues, 
R552, W603, and R674, are important for SM interaction using VacA from a toxic allele 
H. pylori strain 60190. To evaluate the sequence conservation of three VacA residues 
among H. pylori strains, the region of 172 amino acids (residue 476-648) that contains 
	 142	
the three VacA residues, R552, W603, and R647, were aligned among multiple VacA 
sequences from toxic H. pylori strains and several clinically isolated less toxic H. pylori 
strains using Crystal W, a multiple alignment software to identify conservation of the 
amino acids among the sequences (Figure 3.2). The alignment revealed that most 
sequences within the regions are conservative sequence, conservative mutations, or 
semi-conservative mutations, between toxic and less alleles of H. pylori strains. In 
contrast, R552, W603 and R647 were conservative sequences in toxic H. pylori alleles; 
less toxic H. pylori alleles rather had S552, A603, Q647 as the most conservative residues. 
The result indicates that, the three conservative VacA residues are only conserved in 
toxic alleles. This result suggests that SM interactions of VacA may be fully functional in 
VacA sequences that contains R552, W603, and R647 as the three conservative VacA 
residues. 
 
3.3.2. Chimeric form of VacA by replacing the most heterogeneous region, called 
‘m’ region, of toxic allele with that of less toxic allele attenuated VacA-mediated 
cellular cytotoxicity 
  The studies described above are consistent with the idea that the VacA of less 
toxic allele H. pylori strain has a dysfunctional receptor binding site, which induces less 
cellular cytotoxicity. However, these studies did not reveal whether the region containing 
receptor binding site are important for cellular activity. Previously the middle region of the 
vacA gene, called “m region”, was identified as the most heterogeneous region 17. The 
heterogeneity on m region separates vacA genes into two variants, m1 and m2. While m1 
H. pylori strains are associated with more cellular toxicity and more association with 
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developing the gastric disease, m2 H. pylori strains showed less association with both 
cellular cytotoxicity and the development of the gastric disease 13. I observed that the 
region of 175 amino acid residues containing residue 552, 603, 647 are located within the 
m region (residue 455 – 736). Prior to examine the importance of the region of the 175 
amino acid residues, I validate whether the genetic variants on m region is important for 
cellular cytotoxicity. To validate the importance of genetic variation of m region for cellular 
cytotoxicity, a chimeric form of VacA was generated by substituting the m region of toxic 
allele H. pylori strains 61090, a m1 domain, with the m region of less toxic allele H. pylori 
strain Tx30a, a m2 domain. Prior to examined the cytotoxicity, purified chimeric form of 
VacA containing m2 domain was examined for the capacity to induce cellular vacuolation 
relative to wildtype toxin. Protein stability of the chimeric VacA was compared with 
wildtype VacA by proteinase K sensitivity assay. (Figure 3.3A). Based on the similar 
protein degradation pattern between wildtype VacA and the chimeric VacA, it suggests 
that the chimeric VacA is not disrupting the overall protein structure. In order to examine 
the cytotoxicity, monolayers of AZ-521 cells, that had been pre-chilled to 4 °C to promote 
toxin binding in the absence of cellular uptake, were incubated at 4 °C in the absence or 
presence of wildtype VacA or the chimeric VacA containing m2 domain (100 to 2,000 
nM). After 30 min, the monolayers were washed with ice-cold PBS (pH 7.4) to remove 
unbound toxin, and then further incubated at 37 °C. After 16 h, the monolayers were 
evaluated for the presence of intracellular vacuoles, using light microscopy. These studies 
revealed very few cells (<1% of total cells) with visible intracellular vacuoles in monolayers 
that had been incubated with the chimeric VacA containing m2 domain at 250 nM, a 
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concentration at which nearly all of the cells (>95% of total cells) contained visible 
vacuoles within monolayers that had been incubated with wildtype VacA (Figure 3.4 A).  
  These results from microscopic visualization of the monolayers were validated 
using the neutral red uptake assay, in which lysates of cells that had been incubated with 
the chimeric form of VacA containing m2 domain yielded significantly less absorbance at 
530 nm than lysates of cell incubated with wildtype VacA (Figure 3.4 B). These data 
indicated that significantly less neutral red had been taken up into cells incubated with the 
chimeric VacA containing m2 domain than wildtype VacA. These results are consistent 
with the conclusion that cells exposed to the chimeric VacA containing m2 domain 
underwent significantly less vacuole biogenesis than those cells exposed to wildtype 
toxin. Only at the highest concentration of the chimeric VacA containing m2 domain tested 
(2000 nM), which is at the practical limit of what we can evaluate in the laboratory 
(because of the difficulty in readily concentrating stock VacA to greater than 
approximately 10 µM without extensive losses), was a significant increase in cellular 
vacuolation detected (Figure 3.4B). Taken together, these studies suggested that the 
substitution of the m region of toxic alleles with the m region of less toxic alleles results in 
a chimeric form of VacA containing less toxic alleles whose cellular activity is highly 
attenuated relative to wildtype toxin, although not entirely absent at higher toxin 
concentrations.  
3.3.3. Enrichment of plasma membrane SM partially restores cell sensitivity to the 
chimeric form of VacA containing m region of less toxic allele of H. pylori strain. 
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  The studies described above demonstrated that the immortalized cell line, AZ-521 
cells, are less sensitive to the chimeric form of VacA containing the substituted m region 
of less toxic allele of H. pylori strain Tx30a than wild type VacA. However, these studies 
did not address the reasons underlying the relatively diminished sensitivity of the cell line 
to the chimeric form of VacA of m2 domain as compared to wildtype VacA. Our earlier 
studies establishing SM as a VacA receptor demonstrated that the sensitivity of cultured 
cells to VacA was strongly associated with the relative amounts of plasma membrane SM 
43. Moreover, cell line sensitivity to VacA could be manipulated by altering cell surface 
levels of SM. Depletion of cell surface SM through treatment of cultured cells, including 
AZ-521 cells, with sphingomyelinase C decreased cell line sensitivity to VacA, thereby 
requiring higher concentrations of toxin to generate intracellular vacuoles. Moreover, 
enrichment of plasma membrane SM by incubating monolayers of cultured cells, including 
AZ-521 cells, with exogenous SM increased cell line sensitivity to VacA 43. 
  If the lower cellular activity of the chimeric VacA containing the substituted m 
region of less toxic allele of H. pylori strain Tx30a is due to the alteration of the VacA SM-
binding site, I speculated that sensitivity to this mutant form of toxin could be restored, at 
least in part, by enrichment of the plasma membrane outer leaflet with SM. Monolayers 
of AZ-521 cells were pre-incubated at 4 °C in the absence or presence of exogenous SM 
(50 µM). After 1 h, the monolayers were further incubated in the absence or presence of 
either wildtype VacA (5 nM) or the chimeric VacA containing m2 domain (50 nM), 
concentrations of either form of toxin that do not yield visible cellular vacuolation in AZ-
521 cells. After 16 h, cellular vacuolation was visibly observed (Figure 3.5). While SM-
enriched monolayers of cells become sensitive to wildtype VacA with the low 
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concentration (5 nM) by inducing visible vacuolation, the cells with the same SM treatment 
became sensitive to the chimeric VacA at 50 nM (Figure 3.5). This data indicates that the 
vacuolation activity of the chimeric VacA is restored only in higher concentration by SM 
enrichment exogenously. This data suggests that the substitution of the m region of toxic 
allele on VacA by the m region of less toxic allele may have low affinity towards SM on 
the cell surface. This experiment indicates that the alteration of the m region of VacA has 
effect on receptor interaction. However, this experiment does not provide information 
whether the receptor binding subdomain within the m region is responsible for cellular 
activity induction.  
 
3.3.4. A subdomain containing the SM-binding residues, R552, W603, and R647, 
within m region is necessary for VacA-mediated vacuolation activity.  
 
In order to demonstrate whether the SM-binding domain containing R552, W603, 
and R647 (from now on called it active receptor binding domain) is necessary for 
cytotoxicity, additional chimeric form of VacA was generated by substituting the active 
receptor binding domain of m1 domain with the inactive receptor binding domain of m2 
domain. The purified chimeric form of VacA containing the inactive receptor binding 
domain was examined for the capacity to induce cellular vacuolation relative to wildtype 
toxin. Monolayers of AZ-521 cells pre-chilled at 4 °C, so as to prevent toxin uptake from 
the cell surface, were incubated in the absence or presence of wildtype VacA, the 
chimeric VacA of m2 domain, or the chimeric VacA with inactive receptor binding domain 
(1, 3.5, 10, 35, 100, 250 nM). After 30 min, the monolayers were washed to remove 
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unbound VacA, and then further incubated with cell culture medium at 37 °C. After 16 h, 
the monolayers were evaluated for cellular vacuolation, both qualitatively, using phase 
contrast microscopy imaging, and quantitatively, by measuring the increase cellular 
uptake of the acidotrophic dye neutral red. Visual inspection of these monolayers 
indicated no visible intracellular vacuoles within cells that had been incubated with either 
chimeric VacA of m2 domain or the chimeric VacA with SM-binding domain containing 
S552, A603, and Q647 (35 nM) (Figure 3.6A). In contrast, intracellular vacuoles were 
visible in cells that had been incubated with wild type VacA (Figure 3.6A). 
In addition to visual inspection, we quantified the concentrations of the chimeric 
forms of VacA required to achieve 50% of the maximal uptake of neutral red, which we 
define as the Vac50 value, and typically compare as 1 / Vac50 values, which are unique to 
specific cell lines. These studies revealed that the chimeric VacA with inactive receptor 
binding domain yielded 1 / Vac50 values similar to those obtained for the chimeric VacA 
of m2 domain (Figure3.6B). In contrast, the wildtype VacA yielded approximately 10-fold 
increase in 1 / Vac50 value relative to the chimeric VacA with inactive receptor binding 
domain (Figure 3.6B). These data indicated that the chimeric form of VacA of SM-binding 
domain containing S552, A603, and Q647 attenuated toxin-mediated vacuolation, 
suggesting that the SM-binding domain containing R552, W603, and R647 is necessary 
for VacA-mediated cellular activity. However, these studies did not provide clues as to 
whether the SM-binding domain containing R552, W603, and R647 is sufficient for VacA-
mediated cellular activity.  
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3.3.5. A subdomain containing the SM-binding residues, R552, W603, and R647, 
within m region is sufficient for VacA-mediated vacuolation activity. 
 
Previous studies agree with the premise that the SM-binding domain containing 
R552, W603, and R647 is important for VacA-mediated cellular activity. However, 
whether the VacA containing active receptor interacting domain is sufficient for VacA-
mediated cellular activity is not addressed. In order to test whether the active receptor 
interacting domain is sufficient for cytotoxicity, additional chimeric form of VacA was 
generated by substituting the inactive receptor interacting domain with the active receptor 
interacting domain of toxic allele H. pylori strain 60190, essentially introducing R552, 
W603, and R647. The purified mutant form of VacA was examined for the capacity to 
induce cellular vacuolation relative to wildtype toxin. Monolayers of AZ-521 cells pre-
chilled at 4 °C, so as to prevent toxin uptake from the cell surface, were incubated in the 
absence or presence of wildtype VacA, the chimeric VacA of m2 domain, or the chimeric 
VacA with inactive receptor interacting domain (1, 3.5, 10, 35, 100, 250 nM). After 30 min, 
the monolayers were washed to remove unbound VacA, and then further incubated with 
cell culture medium at 37 °C. After 16 h, the monolayers were evaluated for cellular 
vacuolation, both qualitatively, using phase contrast microscopy imaging, and 
quantitatively, by measuring the increase cellular uptake of the acidotrophic dye neutral 
red. Visual inspection of these monolayers indicated a similar number of intracellular 
vacuoles within cells that had been incubated with either wildtype or the chimeric VacA 
with active receptor interacting domain (35 nM) (Figure 3.7A). In contrast, no intracellular 
vacuoles were visible in cells that had been incubated with the chimeric VacA of m2 
domain (Figure 3.7A).  
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In addition to visual inspection, we quantified the 1 / Vac50 values. These studies 
revealed that the chimeric VacA with active receptor interacting domain yielded 1 / Vac50 
values similar to those obtained for wild type VacA (Figure3.7B). In contrast, the chimeric 
VacA of m2 domain yielded approximately 10-fold decreased in 1 / Vac50 value relative 
to wildtype VacA (Figure 3.7B). These data indicated that the chimeric form of VacA with 
active receptor interacting rescues toxin-mediated vacuolation, suggesting that the SM-
binding domain containing R552, w603, and R647 is sufficient for VacA-mediated cellular 
activity. However, these studies did not provide clues as to whether the SM-binding 
domain containing R552, W603, and R647 might be important for VacA interaction with 
SM. 
 
3.3.6. A subdomain containing the SM-binding residues, R552, W603, and R647, 
within m region is necessary for the interaction of SM-coated plates.  
 
The studies described immediately above suggested that the SM-interacting 
domain containing R552, W603, and R647 is necessary and sufficient for toxin-dependent 
vacuole biogenesis. However, these studies did not address whether the active receptor 
interacting domain on VacA is necessary for SM interaction. To evaluate the potential 
necessity of the active receptor interacting domain for VacA-SM interactions, we 
employed an ELISA-based assay to compare the relative binding of wildtype VacA, the 
chimeric VacA of m2 domain, or the chimeric VacA with inactive receptor interacting 
domain, to SM-coated wells. This assay has previously been used to demonstrate the 
preferential binding of VacA (and other SM-binding proteins) to SM over a number of 
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alternate common plasma membrane lipids 43,55. Individual wells within 96-well Immulon 
1B microtiter plates, that had been previously coated with SM (500 pmol), were incubated 
at 4 ˚C in the absence or presence of wildtype VacA, the chimeric VacA of m2 domain, 
and the chimeric VacA with inactive receptor interacting domain (1, 3.5, 10, 35, 100, 250 
nM; 50 µL each). As previously reported 43, preliminary studies confirmed that the binding 
of wild type VacA was dose-dependent and plateaued at approximately 100 nM VacA 
(Refer to Figure 2.8 in chapter 2). After 16 h, unbound toxins were washed out of the 
wells, and VacA retained within the wells was quantified by ELISA using α-VacA 
antibodies. These experiments revealed that the ELISA signal corresponding to VacA 
retained in the wells was significantly greater for wildtype VacA than the chimeric VacA 
with inactive receptor binding domain (Figure 3.8). In contrast, there were not significant 
differences in the ELISA signal corresponding to VacA between the chimeric VacA of m2 
domain and the chimeric VacA with inactive receptor interacting domain (figure 3.8). 
These data indicated that VacA binding to SM-coated wells was relatively similar between 
the chimeric VacA of m2 domain or the chimeric VacA with inactive receptor binding 
domain. In contrast, VacA binding to SM-coated wells using the chimeric VacA with 
inactive receptor binding domain was reduced compared to wildtype VacA. These results 
suggested that the SM-interacting domain is necessary for toxin interactions with SM. 
However, these studies did not provide clues as to whether the receptor-binding domain 
containing R552, W603, and R647 might be sufficient for VacA interaction with SM. 
3.3.7. A subdomain containing the SM-binding residues, R552, W603, and R647, 
within m region is sufficient for the interaction of SM-coated plates.  
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  The studies described immediately above suggested that the SM-interacting 
domain containing R552, W603, and R647 is necessary for toxin interaction with SM. 
However, these studies did not address whether the SM-interacting domain containing 
R552, W603, and R647 is sufficient for SM interaction. To evaluate whether the active 
receptor interacting domain is sufficient for VacA-SM interactions, an ELISA-based assay 
was used to compare the relative binding of wildtype VacA, the chimeric VacA with active 
receptor interacting domain, or the chimeric VacA of m2 domain from m2 domain, to SM-
coated wells. Individual wells within 96-well Immulon 1B microtiter plates, that had been 
previously coated with SM (500 pmol), were incubated at 4 ̊ C in the absence or presence 
of wildtype VacA, the chimeric VacA with active receptor interacting domain, or the 
chimeric VacA of m2 domain (1, 3.5, 10, 35, 100, 250 nM; 50 µL each). After 16 h, 
unbound toxins were washed out of the wells, and VacA retained within the wells was 
quantified by ELISA using α-VacA antibodies. These experiments revealed that the 
ELISA signal corresponding to VacA retained in the wells was similar for wildtype VacA 
and the chimeric VacA with the active receptor interacting domain (Figure 3.9). In 
contrast, the chimeric VacA with the active receptor interacting domain shows higher 
ELISA signal corresponding to VacA, compared to the chimeric VacA of m2 domain 
(Figure 3.9). These data indicated that VacA binding to SM-coated wells was relatively 
similar between wildtype VacA or the chimeric VacA with the active receptor binding 
domain. In contrast, VacA binding to SM-coated wells using the chimeric VacA of m2 
domain was reduced compared to wildtype VacA. These results suggested that the active 
receptor binding domain is sufficient for toxin interactions with SM. However, these 
studies did not provide clues as to whether the three SM interacting residues, R552, 
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W603, and R647, within the receptor interacting domain, are responsible for VacA-
mediated activity. 
3.3.8 Substitution of S552, A603, and Q647 with R552, W603, and R647 on the 
chimeric VacA of m2 domain partially restores VacA-mediated vacuolation activity. 
  The studies described previously suggested that the SM-interacting domain 
containing R552, W603, and R647 is necessary and sufficient for both toxin-mediated 
cellular activity and toxin interaction with SM. However, these studies did not address 
whether the SM-interacting residues, R552, W603, and R647, within the receptor binding 
domain, are directly responsible for VacA-mediated cellular activity. To evaluate the 
importance of the three residues for VacA-mediated cellular activity, the inactive receptor 
interacting residues, S552, A603, Q647, within m2 domain are reconstituted with active 
receptor interacting residues, R552, W603, and R647 by site-directed mutagenesis on H. 
pylori. Purified reconstituted form of VacA from the mutant form of H. pylori was examined 
for cellular cytotoxicity. Monolayers of AZ-521 cells pre-chilled at 4 °C, so as to prevent 
toxin uptake from the cell surface, were incubated in the absence or presence of wildtype 
VacA, the chimeric VacA with inactive receptor interacting domain, or the chimeric VacA 
with the reconstitution on the receptor interacting residues. (100 nM). After 30 min, the 
monolayers were washed to remove unbound VacA, and then further incubated with cell 
culture medium at 37 °C. After 16 h, the monolayers were evaluated for cellular 
vacuolation, both qualitatively, using phase contrast microscopy imaging, and 
quantitatively, by measuring the increase cellular uptake of the acidotrophic dye neutral 
red. Visual inspection of these monolayers indicated increased number of intracellular 
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vacuoles within cells that had been incubated with the chimeric VacA with the 
reconstitution on the receptor interacting residues than the chimeric VacA with inactive 
receptor interacting domain  (100 nM) (Figure 3.10A).  
In addition to visual inspection, we measured the uptake of neutral red of the 
concentrations of the chimeric forms of VacA on AZ-521 cells using wildtype VacA, the 
chimeric VacA with the inactive receptor interacting domain, or the chimeric VacA with 
the reconstitution on the receptor interacting residues (Figure3.10B). These studies 
revealed that the chimeric VacA with the reconstitution on the receptor interacting 
residues showed increased on the relative vacuolation activity compared to the chimeric 
VacA with the inactive receptor domain. When compared to wildtype, the chimeric VacA 
with the reconstitution on the receptor interacting residues shows a little bit of recovery. 
These data indicated that the reconstitution of the receptor interaction residues partially 
restore the vacuolation activity of the chimeric VacA with inactive receptor interaction 
chimeric form of VacA of SM-binding domain containing R552, W603, and R647 rescues 
toxin-mediated vacuolation of the chimeric form of VacA with i, suggesting that the SM-
binding domain containing R552, w603, and R647 is sufficient for VacA-mediated cellular 
activity. However, these studies did not provide clues as to whether the SM-binding 












During 30 years of research, H. pylori has been studied in the context of a disease-
causing bacteria.152,153 Only in recent years, researchers identified the beneficial role of 
H. pylori2. Moreover, many evidence suggested co-evolution between human and the 
bacteria originated from Africa138,139. The recent observation is leading to a paradigm shift 
to view H. pylori as a normal microflora. Such a movement led many researchers to 
access the factors that contribute H. pylori infection harmful to human diseases.  
In this chapter, I examined how the genetic heterogeneity of H. pylori contributes 
to cytotoxicity. vacA gene, a virulent H. pylori gene responsible for secreting pore-forming 
protein Vacuolating cytotoxin A, has been utilized as a biomarker that segregates H. pylori 
into two major types, toxic alleles and less toxic alleles17. I examined the most 
heterogeneous region of vacA called “m region,” based on the hypothesis that the 
difference in this region is important for the receptor interaction, hence the cytotoxicity. 
Within m region of VacA, a 175-amino acid region containing three SM-interacting 
residues, R552, W603, and R647, are different between toxic and less toxic alleles. I 
examined the importance of this region by generating a chimeric VacA containing less 
toxic m region on toxic background, which showed significant reduction both on 
cytotoxicity and SM interaction. Our data indicates that 175-amino acid region that 
contains active receptor residues are both necessary and sufficient for vacuolation and 
SM interaction. In addition, our data indicate that reconstitution of active SM-interacting 
residues, R552, W603, and R647, on non-active VacA is important for partial restoration 
of the cytotoxicity. 
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Why there is only partial restoration when only three SM-interacting residues are 
substituted? Future investigation will be examining two possibilities. One is that there are 
other contributing amino acids that orient the three residues to make them more active 
configuration for optimized SM interaction. The three residues are located on the flexible 
loops without confined secondary structure. By comparing the difference between toxic 
and less toxic alleles on the residues within these loops, I identified that there are several 
residues that are also different between the two. To examine this possibility, it is important 
to substitute the loops that contain the three SM-interaction residues and examine the 
cytotoxicity. Second possibility is that additional part of VacA, other than the SM-
interacting region, may contribute to the membrane interaction, hence the cytotoxic 
activity. Even though VacA has no homology to any proteins, VacA has very similar 
characteristic of protectin-like proteins 28. Many protectin-like proteins utilize multiple 
loops for its function. Similarly, VacA contains many flexible loops, including the three 
loops that contain R552, W603, and R647. It is possible that additional loops on VacA 
may play a role in membrane interaction. To examine this possibility, it is important to 
examine the differences of the loops other than those loops that contain SM-interacting 
residues. Additional examination on the multiple loops on VacA may help to see the full 
recovery of vacuolation activity.  
After 25 years of initial discovery of allelic differences of VacA and its strong 
association with cytotoxicity, this study allows us to explore a possible molecular 
mechanism behind the allelic dependent cytotoxicity of VacA. My data supports that while 
toxic alleles of VacA, containing active receptor binding residues within multiple loops, 
have a strong binding ability to its receptor, SM, less-toxic alleles of VacA have a weaker 
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binding ability. For future direction, examination of additional multiple loops between the 
toxic and less toxic alleles will be able to help whether there is an additional player that 










































3.5 Figures and Tables 
 
TABLE 3.1. Helicobacter pylori strains used in this study 
Strains Description Reference 
60190 Wildtype H. pylori containing 
s1/m1 vacA gene 
TL Cover et 
al 1992 JBC 
VM022 vacA gene deletion mutant of 
60190 
AD Vinion-
Dubiel et al 
1999 JBC  
Tx30a Wildtype H. pylori containing 
s2/m2 vacA gene 
JC Atherton 
et al 1995 
JBC 
VM022 (∆vacA) VM022 transformed with pHEL2 
plasmid 
This study 
VM022 (∆vacA:: vacA (Am1B m1C m1)) VM022 transformed with pHEL2-
vacA (Am1B m1C m1) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m2C m2)) VM022 transformed with pHEL2-
vacA (Am2B m2C m2) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m1C m1)) VM022 transformed with pHEL2-
vacA (Am2B m1C m1) plasmid 
This study 
VM022 (∆vacA:: vacA (Am1B m2C m1)) VM022 transformed with pHEL2-
vacA (Am1B m2C m1) plasmid 
This study 
VM022 (∆vacA:: vacA (Am1B m1C m2)) VM022 transformed with pHEL2-
vacA (Am1B m1C m2) plasmid 
This study 
VM022 (∆vacA:: vacA (Am1B m2C m2)) VM022 transformed with pHEL2-
vacA (Am1B m2C m2) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m1C m2)) VM022 transformed with pHEL2-
vacA (Am2B m1C m2) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m2C m1)) VM022 transformed with pHEL2-
vacA (Am2B m2C m1) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m2C m2) 
(S552R/A603W/Q647R)) 
VM022 transformed with pHEL2-
vacA (Am2B m2C m2) 
(S552R/A603W/Q647R) plasmid 
This study 
VM022 (∆vacA:: vacA (Am2B m2C m2) 
(Loop2/Loop4/Loop6(m2®m1)) 
VM022 transformed with pHEL2-




VM022 (∆vacA:: vacA (Am1B m2C m1) 
(Loop2/Loop4/Loop6(m2®m1)) 
VM022 transformed with pHEL2-






TABLE 3.2. Primers and templates used for generating amplicon in this study 
Amplicon templates Forward primer (5’-
3’)1 
Reverse primer (5’-3’) 1 
















































































TABLE 3.3. plasmids used in this study 
Plasmid Description reference 
pHEL2 E. coli and H. pylori shuttle vector D 
Heuermann 
and R Haas 
1998 Mol 
Gen Genet. 
pHEL2-vacA (Am1B m1C m1) pHEL2 containing full-length of vacA gene 
and autotransporter gene of 60190 
This study 
pHEL2-vacA (Am2B m2C m2) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m2C m2) 
This study 
pHEL2-vacA (Am2B m1C m1) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m1C m1) 
This study 
pHEL2-vacA (Am1B m2C m1) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am1B m2C m1) 
This study 
pHEL2-vacA (Am1B m1C m2) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am1B m1C m2) 
This study 
pHEL2-vacA (Am1B m2C m2) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am1B m2C m2) 
This study 
pHEL2-vacA (Am2B m1C m2) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m1C m2) 
This study 
pHEL2-vacA (Am2B m2C m1) Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m2C m1) 
This study 
pHEL2-vacA (Am2B m2C m2) 
(S552R/A603W/Q647R) 
Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m2C m2) 
(S552R/A603W/Q647R) 
This study 
pHEL2-vacA (Am2B m2C m2) 
(Loop2/Loop4/Loop6(m2®m1) 
Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 
pHEL2-vacA (Am2B m2C m2) 
(Loop2/Loop4/Loop6(m2®m1) 
This study 
pHEL2-vacA (Am1B m2C m1) 
(Loop2/Loop4/Loop6(m2®m1) 
Substitution of m region in vacA gene of 
60190 with vacA gene of tx30a using 






TABLE 3.4. Primers used in this study 














































































1Primers were ordered from Integrated DNA technologies Inc. (www.idtdna.com, 
Coralville, IA) 
2Underlined and bold DNA sequences both on forward primers and on reverse 






Figure 3.1. Phylogenetic tree segregates Helicobacter pylori strains into toxic and less toxic clusters.
295 VacA full length sequences were obtained from NBCI data bank. The sequences are aligned to generate 
a phylogenetic tree (Provided by Dr. Michael L. Reno in Blanke Lab). The top cluster, names toxic cluster, contains 
Helicobacter pylori strains that are isolated from more severe clinial patients. In addition, the strains are known to induce 
more severe cytotoxicity. The bottom cluster, names less toxic cluster, contains Helicobacter pylori strains that are 
isolated from less severe clinial patients. In addition, the strains are known to induce less, or none, cytotoxicity.
 
Figure 3.1. Oh, Blanke et al. 2017
toxic cluster
less toxic cluster
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Figure 3.2. Protein seqeunce alignment of 155 amino acid region of VacA identifies R552, W603, and R647 
as conserved residues among H. pylori strains in toxic cluster, but not in less toxic cluster.
A 155-amino acid region of VacA sequences (476-648) was examined using several clinically isolated toxic H. pylori 
strains, namely 26695, P12, J99, 60190, G27, and 98-10, and several clinically isolated less toxic H. pylori strains, 
namely 3250809, 95-94, Tx30a, B128, 6716134, and 597825843. (*) indicates conserved sequence. (:) indicates 
conservative mutations. (.) indicates semi-conservative mutations. ( ) indicates non-conservative mutations. Arrow
indicates residue number from intial VacA seqeunce. Residue 552, 603, and 647 are boxed with bold black boxes.
The flexible loops that contains the three residues are boxed with a narrow black boxes. A line is drawn to indicate
the sequence difference between toxic cluster and less toxic cluster.
 










































Figure3.3. Oh, Blanke et al. 2017
Figure 3.3. Quality control analyses of purified VacA and its m swapped domain
(A),(B),(C) Evaluation of m domain swapped Vac for structural perturbations by comparing trypsin sensitivity relative 
to wildtype VacA. Purified toxin, either wildtype VacA (0.88 μM) or VacA (Am2Bm2Cm2) (0.88 μM), was incubated at 
room temperature without or with trypsin (final concentrations : 0, 0.1, 1, 10, 100 nM). After 1 h, the trypsin digestion 
was stopped by addition of SDS-PAGE sample buffer containing β-ME and heating at 95 ˚C for 5 min. Immunoblot 
analysis using α−VacA antibody revealed the trypsin profiles of the toxins. The data are representative of
 three independent experiments. (B) VacA (Am2Bm2Cm2) and  VacA (Am2Bm2Cm2) were compared. 
(C) VacA (Am2Bm2Cm2) and  VacA (Am2Bm2Cm2) were compared.
3B.
3C.





















































































































Figure 3.4. Oh, Blanke et al. 2017
Figure 3.4. Chimeric form of VacA toxin containing ‘m region’ from less toxic allele shows attenuation in 
cellular vacuolation ativity relative to wildtype VacA
Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA (100, 250, 






), containing ‘m region’ from less toxic allele
 (100, 250, 500, 1000, 2000 nM). (A) After 16 h, the monolayers were analyzed by phase contrast microscopy 
imaging (scale bar, 10 µm). The images are representative of those collected during three independent 
experiments (n = 3), each performed with three technical replicates. (B) After 16 h, the relative vacuolation 
activity was measured using the neutral red uptake assay, and the data were normalized according to total 
protein per well. The data were combined from three independent experiments (n = 3), each performed with 
three technical replicates. The data were rendered as a bar graph using Prism 6.0e. Error bars indicate 
standard deviations. Statistical significance (α = 0.05) was calculated for the differences in relative vacuolation 
activity of the chimeric VacA against that of wildtype VacA at different concentrations using two-way ANOVA 













Figure 3.5. Cells incubated with exogenous SM demonstrate visibly increased vacuole 
biogenesis for both wildtype VacA and chimeric VacA toxin containing ‘m region’ from 
less toxic allele.
Monolayers of AZ-521 cells that had been pre-incubated at 37 ˚C without or with sphingomyelin 
(SM, 50 μM) were incubated at 37 ˚C, in the absence or presence of wildtype VacA (5 nM),
or VacA  (Am2Bm2Cm2) (5 and 50 nM). The increased total cellular SM for the monolayers 
incubated with exogenous SM was confirmed using the Amplex Red flourescent-based SM 
quantification method (as described under experimental procedures). After 16 h, the monolayers were 
analyzed for vacuolation using phase contrast microscopy imaging (scale bar, 10 μm). The images are 
representative of those collected during three independent experiments, each performed with three 
technical replicates (n = 3). 












Figure 3.6. The subregion containing the active receptor binding site is necessary for vacuole biogenesis of
VacA.
 Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA (0 - 250 nM), 
VacA  (Am1Bm2Cm1) (0 - 250 nM), or VacA  (Am2Bm2Cm2) (0 - 250 nM). (A) After 16 h, phase contrast images of cells 
were collected (scale bar, 10 μm). The images at concentration 35 nM are representative of those collected during 
three independent experiments (n = 3), each performed with three technical replicates. (B) After 16 h, the relative 
vacuolation activity was measured using the neutral red uptake assay, and the data were normalized according to 
total protein per well. The data were combined from three independent experiments (n = 3), each performed with 
three technical replicates. The data were rendered as a bar graph using Prism 6.0e. Vac50 refers to the concentration 
of VacA which yields 50% of the maximum neutral uptake within a monolayer and was calculated using IC50 


















































Figure 3.7. The subregion containing the active receptor binding site is sufficient for vacuole biogenesis of
VacA.
Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA (0 - 250 nM), 
VacA  (Am2Bm1Cm2) (0 - 250 nM), or VacA  (Am2Bm2Cm2) (0 - 250 nM). (A) After 16 h, phase contrast images of cells were 
collected (scale bar, 10 μm). The images at concentration 35 nM are representative of those collected during three
 independent experiments (n = 3), each performed with three technical replicates. (B) After 16 h, the relative vacuolation 
activity was measured using the neutral red uptake assay, and the data were normalized according to total protein 
per well. The data were combined from three independent experiments (n = 3), each performed with three technical 
replicates. The data were rendered as a bar graph using Prism 6.0e. Vac50 refers to the concentration of VacA which 
yields 50% of the maximum neutral uptake within a monolayer and was calculated using IC50 calculation function 



















































Figure 3.8. The subregion containing the active receptor binding site is necessary for VacA interaction 
with SM-coated plates.
96-well Immulon 1B microtiter plates, with individual wells coated with SM (500 pmol) were incubated at 4 ˚C
 in the absence or presence of wildtype VacA (50 nM), VacA  (Am1Bm2Cm1) (50 nM), or VacA  (Am2Bm1Cm2) (50 nM). 
After 16 h, unbound toxins were washed out of the wells with PBS (pH7.4, 4 ˚C), and the extent of VacA binding 
was quantified using ELISA while employing α-VacA antibody. The O.D. values at 460 nm was measured in each 
well using a microplate reader. Relative VacA binding to SM-coated wells was calculated by subtracting the O.D. 
values at 460 nm obtained from wells incubated with VacA in the absence of lipids subtracted from the O.D. values 
at 460 nm obtained from SM-coated wells incubated with VacA. Each of the values were expressed relative to values 
obtained in the absence of VacA, which was assigned an arbitrary value of 1. The data were combined from three
 independent experiments (n = 3), each performed with three technical replicates. The data were then rendered as 
a bar graph using Prism 6.0e. Error bars indicate standard deviations.    



















































































Figure 3.9. The subregion containing the active receptor binding site is sufficient for VacA interaction 
with SM-coated plates.
96-well Immulon 1B microtiter plates, with individual wells coated with SM (500 pmol) were incubated at 4 ˚C
 in the absence or presence of VacA (Am2Bm2Cm2) (50 nM), VacA  (Am2Bm1Cm2) (50 nM), or wildtype VacA (50 nM). 
After 16 h, unbound toxins were washed out of the wells with PBS (pH7.4, 4 ˚C), and the extent of VacA binding 
was quantified using ELISA while employing α-VacA antibody. The O.D. values at 460 nm was measured in each 
well using a microplate reader. Relative VacA binding to SM-coated wells was calculated by subtracting the O.D. 
values at 460 nm obtained from wells incubated with VacA in the absence of lipids subtracted from the O.D. values 
at 460 nm obtained from SM-coated wells incubated with VacA. Each of the values were expressed relative to values 
obtained in the absence of VacA, which was assigned an arbitrary value of 1. The data were combined from three 
independent experiments (n = 3), each performed with three technical replicates. The data were then rendered as 
a bar graph using Prism 6.0e. Error bars indicate standard deviations.    



















































































Figure 3.10. Reconsitition with active receptor binding site restores vacuole biogenesis on inactive 
VacA.
Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA (100 nM), 
VacA (VacA  (Am1Bm2Cm1)  (100 nM), or VacA (Am1Bm2Cm1) (S552R/A603W/Q647R) (100 nM) (A) After 16 h, 
the monolayers were imaged using phase contrast microscopy (scale bar, 10 μm). The images are 
representative of those collected during three independent experiments (n = 3), each performed with three 
technical replicates. (B) After 16 h, the relative vacuolation activity was measured using the neutral red 
uptake assay, and the data were normalized according to total protein per well. The data were combined 
from three independent experiments (n = 3), each performed with three technical replicates. The data 
were rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. Statistical 
significance (α = 0.05) was calculated for the differences in relative vacuolation activity of VacA  (Am1Bm2Cm1), 
or VacA  (Am1Bm2Cm1) (S552R/A603W/Q647R) against that of wildtype VacA at different concentrations using 
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Chapter 4: Importance of the oligomerization of VacA for VacA activity 
 
 
4.1     Introduction 
 
Individual VacA monomers are known to assemble into large oligomeric 
complexes with a mass of approximately 1,000 kDa20. Early deep-etch electron 
microscopy studies revealed that water-soluble VacA oligomers are flower-shaped 
structures, and each ring is composed of six monomers. These structures are 
approximately 30 nm in diameter and has a central pore that is approximately 15 nm in 
diameter100. Many cellular activity of VacA is mediated by the channel activity of the 
central pore. This central pore was shown to be an anion selective channel21,154. 
Vacuolation activity of VacA is completely blocked when you block the channel activity by 
a chloride channel inhibitor, (5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB)21.  
VacA is comprised of two domains, designated p33 and p55. The p55 domain has 
an important role in binding of VacA to the cell surface60. The p33 domain has an 
important role in pore forming activity as well as in the insertion on lipid bilayers60,101. 
Previously two distinct regions have been identified to be important for oligomerization: 
one small region within the p33 domain and one within the p55 domain. A two-amino acid 
deletion mutation (∆ 346-347) is a small alteration within the p55 amino-terminal 
subdomain that is known to abrogate vacuolation toxic activity30. The investigation on 
understanding the molecular basis for the inactivity of the ∆ 346-347 mutant showed that 
it has impairment in the assembly into functional oligomeric VacA complexes. A nine-
amino acid deletion mutation (∆49-57) within the p33 domain was identified to be 
responsible for the oligomerization of VacA106. Combining this small deletion VacA with 
wildtype has a dominant negative effect on vacuolation activity. These previous studies 
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provided evidence that the oligomerization is crucial for VacA activity. However, these 
studies was not validated in our lab. In addition, the exact molecular basis on how the 
oligomerization is not well understood. In Chapter 4, I provided preliminary data 
suggesting that the oligomerization is mediated by the interaction between the small 
region (∆49-57) in the p33 and another small region in the p55 (∆346-347). Alteration of 
the two domains leads to generate oligomerization defective mutant. In addition, this 
monomeric form of VacA do not directly interact with SM and has no visible activity. 
 
 
4.2 Methods and Materials 
 
 
4.2.1 Bacterial strains and growth conditions 
  H. pylori 60190 (49503; ATCC, Manassas, VA) and all other H pylori strains, listed 
in Table 1, were cultured under biphasic conditions at 37 ºC under 5% CO2 and 10% O2 
within a humidified environment, using bisulfite- and sulfite-free Brucella broth (BSFB) 
broth (dextrose; 0.1%, β -cyclodextrin; 0.2%, NaCl; 0.5%, Sigma-Aldrich, St. Louis, MO, 
and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2%, BD Biosciences, Sparks, MD) 
containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, MO) on Ham F-12 plates 
supplemented with fetal bovine serum (FBS, 10%; Atlanta Biologicals Inc., Flowery 
Branch, GA) 70. For genetic manipulation, H. pylori VM022 (∆vacA) was utilized 30. H. 
pylori VM022 was cultured at 37 ºC under 5% CO2 and 10% O2 within a humidified 
environment on Columbia blood agar (CBA) plates supplemented with vancomycin (10 
µg / mL; Oxoid, Hampshire, UK), trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; 
Oxoid), and amphotericin B (5 µg / mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, 
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MO) with 10% defibrinated sheep blood (Hemostat Laboratories, Dixon, CA). For 
selection of H. pylori transformants, the CBA plates supplemented with sucrose (100 mg 
/ mL; Sigma-Aldrich) were used in place of kanamycin.   
 
4.2.2 DNA manipulation and plasmid construction 
Genomic DNA was extracted from H. pylori 60190 or H. pylori Tx30a using Wizard 
genomic DNA purification kit (Promega Corp., Madison, WI). A 4513-bp fragment of the 
vacA gene from 60190, or 4661-bp from Tx30a, was amplified from the genomic DNA by 
polymerase chain reaction (PCR) using the oligonucleotides, BamHI-vacA-F (5´-
CGCGCGGATCCAACTGCTTGGCATCGGG-3´) and vacA-BamHI-R (5´- 
GCGCGCGGATCCATTTCAAACCCATGCTTTGAGC-3´) (ordered from IDTDNA, 
Coralville, IA). The 4513-bp fragment, or 4661-bp fragment, of the amplified vacA gene 
was digested with BamHI and ligated with BglII digested pHel271, a chloramphenicol 
resistant plasmid (kindly gifted by Dr. Ritesh Kumar, the University of Illinois at Urbana-
Champaign, IL), to generate vacA gene containing plasmid, named pHel2-vacA. 
Alteration of vacA gene on pHel2-vacA was performed with the QuikChange site-directed 
mutagenesis kit (Strategene, San Diego, CA) using the oligonucleotides listed in Table 4. 
Chimeric form of vacA gene on pHel2-vacA was performed by sequencing overlap 
extension polymerase chain reaction using the oligonucleotides listed in Table 2. The 
resulting constructs were fully sequenced at the Roy J. Carver Biotechnology Center at 
the University of Illinois at Urbana-Champaign and were compared with wildtype 




4.2.3 Alteration on vacA gene of H. pylori by allelic-exchange strategy  
pHel2-vacA and its derived plasmids, listed in Table 3, were introduced into 
naturally-competent H. pylori VM022 30, by using natural transformation 72. The H. pylori 
transformants were obtained by sacB-based counter selection 73. Briefly, fresh growing 
cultures of H. pylori VM022 were prepared by incubating the H. pylori culture at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment on Columbia blood agar 
(CBA) plates supplemented with vancomycin (10 µg / mL; Oxoid, Hampshire, UK), 
trimethoprim (5 µg / mL; Oxoid), cefsulodin (5 µg / mL; Oxoid), and amphotericin B (5 µg 
/ mL; Oxoid), kanamycin (30 µg / mL; Sigma-Aldrich, MO) with 10% defibrinated sheep 
blood (Hemostat Laboratories, Dixon, CA). After 3 days, the culture of H. pylori was 
transferred to a fresh cold CBA plate with kanamycin. After 6 h, pHel2-vacA and its 
derivatives (concentration: 3–10 µg) were dropped on the top of H. pylori culture and 
mixed using a spreader. After 6 h, H. pylori was scraped from the plate and transferred 
to a cold CBA plate supplemented with sucrose (100 mg / mL; Sigma-Aldrich), allowing 
homologous recombination to occur between the endogenous vacA and the vacA gene 
on the plasmid. After 8 -10 days, H. pylori transformants were picked on both a new CBA 
plates supplemented with sucrose (100 mg / mL; Sigma-Aldrich) and a new CBA plates 
supplemented with kanamycin (30 µg / mL; Sigma-Aldrich, MO). Colonies formed on the 
sucrose CBA plates, but not on the kanamycin CBA plates, were assumed to be 
successful H. pylori transformants. vacA gene from the possibly successful H. pylori 
transformants were fully sequenced at Roy J. Carver Biotechnology Center at the 
University of Illinois at Urbana-Champaign and were compared with the wildtype 
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sequence using nucleotide BLAST of NIH (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Yield 
of obtaining successful H. pylori transformants by this method was about 30%. 
Replication of pHEL2 or its derivatives in H. pylori was not observed, based on multiple 
trials to extract the plasmids from log-phase growth of H. pylori culture (8-10 h incubation) 
using Miniprep plasmid extraction kit (Qiagen Inc., Valencia, CA). 
 
4.2.4 Purification of VacA  
VacA and its derived version of toxins were purified, as previously described 20. 
Briefly, H. pylori 60190 and all of its derived strains were cultured on biphasic conditions 
using BSFB broth (dextrose; 0.1%, β-cyclodextrin; 0.2%, sodium chloride; 0.5%, Sigma-
Aldrich, St. Louis, MO, and, tryptone; 1%, peptone; 1%, and yeast extract; 0.2 %, BD 
Biosciences, Sparks, MD) containing vancomycin (5 µg / mL; Sigma-Aldrich, St. Louis, 
MO) on Ham F-12 plates supplemented with FBS (10%, Atlanta Biologicals Inc.) at 37 ºC 
under 5% CO2 and 10% O2 within a humidified environment. After 48 h, the liquid phase 
containing H. pylori growth was transferred to a fresh BSFB liquid culture and further 
incubated at 37 ºC under 5% CO2 and 10% O2 within a humidified environment.  After 48 
h, the supernatant of the H. pylori culture was collected by centrifugation at 8000 xg for 
15 min at 4 ºC. The supernatant was then precipitated 4 ºC with ammonium sulfate (Fisher 
Scientific, Fair Lawn, NJ) to 90% saturation (662 g / L). After 16 h, the precipitates were 
dissolved in the wash buffer (10 mM sodium phosphate dibasic, pH 7.0; Sigma-Aldrich) 
and dialyzed in the same buffer using a dialysis membrane (Spectra/PorTM RC/MWCO; 
50kDa, Spectrum Labs, Rancho Dominquez, CA). After removing the insoluble fractions 
by centrifugation at 8000xg for 15 min at 4 ºC followed by filtration using a filtered funnel 
	 179	
(Stericup©, MWCO; 0.22 μm; EMD Millipore, Billerica, MA), the VacA containing soluble 
fraction was loaded into a column embedded with an anion exchange resin (DEAE 
Sephacel™, GE healthcare, Little Chalfont, UK). After washing the column with 3 bed 
volumes of the wash buffer, VacA was eluted with the wash buffer supplemented with 0.2 
M sodium chloride, and collected into small fractions (1.5 mL each). The fractions 
collected were checked for purity by SDS-PAGE gel separation and Coomassie Brilliant 
Blue staining. Fractions with visibly pure VacA were dialyzed in PBS (pH7.4, 4 ºC) using 
a dialysis cassette (Slide-A-LyzerTM, MWCO; 20kDa, Thermo Fisher Scientific, Walthan, 
MA). The final concentration of VacA was determined by measuring the total protein 
concentration using the BCA assay, using bovine serum albumin (BSA) to generate a 
standard curve (0.025 – 1.5 mg / mL). 
4.2.5 Western blot analysis of VacA 
 Protein lysates for western blot analysis were prepared by mixing protein samples, 
or cell lysates, with the equivalent volume of 2X Laemmli sample buffer (Bio-Rad 
Laboratories Inc, CA) and then incubated at 100 ºC  for 10 min for protein denaturation. 
After the standard SDS-PAGE gel separation and transfer to PVDF membrane 
(Immobilon®-P, Pore size; 0.45 μm, Merck Millipore, Tullagreen, Ireland), the blots were 
incubated overnight at 4 °C with primary antibodies diluted in Tris-buffered (pH 7.4) saline 
with 0.1% Tween 20 (TBS-T), supplemented with 5% skim milk (blocking buffer), and then 
for 1 h at room temperature with HRP-conjugated secondary antibodies (1:10000 dilution; 
Cell Signaling, Danvers, MA) diluted in the blocking buffer. After washing 4 times with 
TBS-T for 5 min each, the blots were incubated with HRP substrates (SuperSignal® West, 
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Pico and Femto mixed at 4:1 ratio; Thermo Scientific, Rockford, IL). The luminescent 
signals from the blots were imaged using ChemiDoc™ XRS+ imaging system (Bio-Rad, 
Hercules, CA), and, analyzed using Image Lab™ software (Version 4.1; Bio-Rad, 
Hercules, CA) for quantification of the relative band intensities. 
4.2.6 Mammalian cell culture 
All cultured mammalian cell lines were maintained at 37 °C and under 5% CO2 
within a humidified environment. AZ-521 cells (3940; RIKEN, Japan) was maintained in 
Minimum Essential Medium (MEM; Corning Life Sciences, Tewksbury, MA) with 10% 
FBS (Atlanta Biologicals Inc., GA). Unless otherwise indicated, cells were seeded in 96 
well plates at a confluency not exceeding 90% (2.5 x 104 cells / well).  
4.2.7 Qualitative and quantitative analysis of vacuole biogenesis on cells.  
  Monolayers of AZ-521 were cultured in 96 well plates and allowed to adhere at 37 
ºC, 5% CO2, in humidified atmosphere. After 16 h, the cells were incubated at 4 °C to 
prevent toxin uptake from the cell surface to occur. The cells then received experimental 
treatment in cell culture medium containing ammonium chloride (5 mM; Sigma-Aldrich, 
MO) with a duplicate experimental set on the same plate, one for vacuolation 
measurement and the other for total protein measurement. Following experimentation, 
cells were imaged for qualitative vacuole biogenesis by light microscopy. Cells with more 
than 4-5 visible vacuoles observed throughout the cytosol of the cells were qualified as 
VacA-mediated vacuolated cells. 
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  After cell imaging, the monolayers were washed twice with PBS (pH 7.4) for 
quantitative analysis. To measure vacuole biogenesis on cells, one experimental set was 
incubated at 37 ºC with Neutral Red solution (Sigma-Aldrich) (100 µL / well, diluted 1:5 
with PBS, pH 7.4). After 4 min, cells were washed three times with PBS (pH 7.4, 4 ºC) to 
remove residual neutral red. The cells within the wells were lysed by adding acid alcohol 
(100 µL / well, 3.7% hydrochloride, 70% ethanol, in diH2O) and the colorimetry of the 
neutral red on the plates was measured at 530 nm and 410 nm using a microplate reader 
(BioTek, Winooski, VT). To measure total protein concentration, another experimental set 
was lysed in RIPA buffer (30 µL / well, Thermo Fisher), followed by incubation at 37 ºC 
with BCA reagent (200 µL / well, Thermo Fisher). After 30 min, total protein was measured 
at 562 nm using a microplate reader (BioTek, Winooski, VT). The total protein 
concentration was determined by BCA assay, using bovine serum albumin (BSA) to 
generate a standard curve (0.025 – 1.5 mg / mL). The neutral red uptake data were 
normalized to the respective total protein measurement under the same experimental 
treatment and relativized to the respective untreated control. 
4.2.8 Qualitative and quantitative analysis of vacuole biogenesis on cells.  
  Monolayers of AZ-521 were cultured in 96 well plates and allowed to adhere at 37 
ºC, 5% CO2, in humidified atmosphere. After 16 h, the cells were incubated at 4 °C to 
prevent toxin uptake from the cell surface to occur. The cells then received experimental 
treatment in cell culture medium containing ammonium chloride (5 mM; Sigma-Aldrich, 
MO) with a duplicate experimental set on the same plate, one for vacuolation 
measurement and the other for total protein measurement. Following experimentation, 
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cells were imaged for qualitative vacuole biogenesis by light microscopy. Cells with more 
than 4-5 visible vacuoles observed throughout the cytosol of the cells were qualified as 
VacA-mediated vacuolated cells. 
  After cell imaging, the monolayers were washed twice with PBS (pH 7.4) for 
quantitative analysis. To measure vacuole biogenesis on cells, one experimental set was 
incubated at 37 ºC with Neutral Red solution (Sigma-Aldrich) (100 µL / well, diluted 1:5 
with PBS, pH 7.4). After 4 min, cells were washed three times with PBS (pH 7.4, 4 ºC) to 
remove residual neutral red. The cells within the wells were lysed by adding acid alcohol 
(100 µL / well, 3.7% hydrochloride, 70% ethanol, in diH2O) and the colorimetry of the 
neutral red on the plates was measured at 530 nm and 410 nm using a microplate reader 
(BioTek, Winooski, VT). To measure total protein concentration, another experimental set 
was lysed in RIPA buffer (30 µL / well, Thermo Fisher), followed by incubation at 37 ºC 
with BCA reagent (200 µL / well, Thermo Fisher). After 30 min, total protein was measured 
at 562 nm using a microplate reader (BioTek, Winooski, VT). The total protein 
concentration was determined by BCA assay, using bovine serum albumin (BSA) to 
generate a standard curve (0.025 – 1.5 mg / mL). The neutral red uptake data were 
normalized to the respective total protein measurement under the same experimental 
treatment and relativized to the respective untreated control. 
4.2.9 Protease sensitivity assay 
  To assess gross structural perturbations of the mutant VacA toxins relative to 
wildtype VacA, the protein’s sensitivity to proteolytic digestion with trypsin 91 was 
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evaluated. Briefly, purified toxins were incubated at room temperature with or without 
trypsin (PBS, pH 7.4; Sigma-Aldrich, MO). After 1 h, trypsin digestion was stopped by 
addition of SDS-polyacrylamide sample buffer (Bio-Rad, Hercules, CA) containing ß-ME 
(Thermo Fisher, IL) and heating at 100 ˚C for 10 min. The samples were analyzed by 
Western blot analysis, using rabbit anti-VacA antibodies prepared as described above 
under “Western blot analysis of VacA.” The resulting dose-dependent banding patterns 
were visually evaluated for gross differences, which would be interpreted to suggested in 
overall VacA structure resulting in altered sensitivity to the protease.   
4.2.10 Glycerol gradient sedimentation assay  
  To distinguish between the monomeric and oligomeric forms of VacA, glycerol 
gradient sedimentation was employed as described previously 20. 3.5-ml 0- 40% glycerol 
gradients were prepared in either a neutral pH buffer (60 mM Tris-HCl, 100 mM NaCl, pH 
7.4) or an acidic pH buffer (100 mM glycine, 100 mM NaCl, pH 3.0). 1 mL of 40% glycerol 
was overlaid with 2 mL of 20% glycerol, which was topped with 0.5 mL of the pH buffers 
without glycerol. Purified toxins were layered on the top of the gradients and centrifuged 
at 4 ˚C at 35, 000 g for 16 hrs. Six fractions (580 µl each) were collected from the top to 
the bottom of the gradient. Each fraction was resolved using SDS-PAGE, and VacA was 
detected by immunoblot analysis employing the polyclonal rabbit a-VacA antibody, as 
described above under “Western blot analysis of VacA.”  
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4.2.11 Statistical analysis 
  Unless otherwise indicated, each experiment consisted of 3 independent 
replicates, each comprise of three technical replicates. Statistical analyses were 
performed using Prism 6.0e (GraphPad Software Inc., La Jolla, CA). Error bars indicate 
standard deviations. All P values were calculated using either the t test with paired, two-
tailed, one-way ANOVA, or two-way ANOVA (corrected using Sidak’s multiple 
comparisons test). A P value of less than 0.05 indicate the statistically significant 




4.3.1 Oligomerization defective mutant does not induce vacuolation 
  Previously two distinct regions have been identified to be important for 
oligomerization: one small region within the p33 domain and one within the p55 domain. 
A two-amino acid deletion mutation (∆ 346-347) is a small alteration within the p55 amino-
terminal subdomain that is known to abrogate vacuolation toxic activity 30. The 
investigation on understanding the molecular basis for the inactivity of the ∆ 346-347 
mutant showed that it has impairment in the assembly into functional oligomeric VacA 
complexes. A nine-amino acid deletion mutation (∆47-59) within the p33 domain was 
identified to be responsible for the oligomerization of VacA 106. Combining the deletion 
VacA with wildtype has a dominant negative effect on vacuolation activity. To evaluate 
whether the two small domains are important for vacuolation activity, deletion mutant form 
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of VacA were generated. Then purified deletion form of VacA was examined for the 
capacity to induce cellular vacuolation relative to wildtype toxin. Monolayers of AZ-521 
cells pre-chilled at 4 °C, so as to prevent membrane uptake from the cell surface, were 
incubated in the absence or presence of a range of concentrations (1, 3.5, 10, 35, 100, 
250 nM) of wildtype VacA or the deletion form of VacA. After 30 min, the monolayers were 
washed to remove unbound VacA, and then further incubated with cell culture medium at 
37 °C. After 16 h, the monolayers were evaluated for cellular vacuolation, both 
qualitatively, using phase contrast microscopy imaging, and quantitatively, by measuring 
the increase cellular uptake of the acidotrophic dye neutral red. Phase contrast 
microscopy revealed visible intracellular vacuoles were significantly reduced with the 
deletion form of VacA. These phase contrast microscopy data were then validated using 
the neutral red uptake assay, in which the lysates from cells that had been incubated with 
deletion VacA and wildtype VacA yielded significantly less absorbance at 520 nm than 
lysates from cells incubated with wild-type VacA and the other nine mutant forms of VacA 
(Figure 4.1). 
 
4.3.2 Characterization of the deletion VacA 
To evaluate the potential effects of the deletion on VacA structure and stability, we 
examined the deletion form of VacA for gross structural perturbations, by comparing the 
protease sensitivity profiles of wildtype VacA and the deletion VacA. Purified wildtype 
VacA and the deletion VacA were incubated separately at 25 °C in the absence or 
presence of trypsin (0.1, 1, 10, 100 nM)(with help of Anna Kim, Blanke Lab). After 1 h, 
each sample was analyzed by immunoblot analysis, for the profile of VacA peptides 
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generated during trypsin digestion, using anti-VacA antibodies. These studies revealed 
that, both wildtype VacA and deletion VacA incubation with trypsin resulted in similar 
dose-dependent patterns of immune-specific bands identified by α-VacA antibodies 
(Figure 4.2). These data indicated that both wildtype VacA and deletion VacA were 
digested in a similar manner by trypsin. These results suggest that deletion mutant on 
VacA do not cause gross structural perturbations in toxin structure. 
  VacA assembles into higher-ordered oligomeric rings, and previous work 
indicating that mutant forms of VacA that cannot assemble into oligomeric structures lack 
cellular activity 104-106, strongly support a model that oligomer assembly is critical for toxin 
activity. Several imaging techniques have revealed that VacA monomers assemble into 
oligomers with the amino-terminal p33 domains forming the inner ring believed to 
ultimately form membrane spanning ion-conducting channels 20,107-110. To evaluate the 
potential effects of the deletion on the capacity to form higher-ordered structures, we 
examined deletion VacA for gross changes in quaternary structures by comparing the 
glycerol density gradient profiles of both wildtype VacA and deletion VacA. Purified 
wildtype VacA or the deletion VacA (1 µM), at either pH 7.4, conditions under which 
wildtype VacA forms soluble oligomeric rings of 6 or seven monomers 20,111, or pH 3.0, 
conditions under which VacA exists as soluble monomers, were fractionated at 4 ˚C by 
glycerol gradient density centrifugation (0 - 40%; 35,000 xg). After 16 h, six fractions of 
equal volumes were collected from the top (0%) to the bottom (40%) of the gradient. The 
collected fractions were analyzed by immunoblot analysis, using α-VacA antibodies, to 
determine the relative levels of VacA in each fraction. These studies revealed that the 
profile of immuno-specific bands corresponding to VacA were dramatically different for 
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both deletion VacA and wildtype VacA (Figure 4.3). These data indicate that the deletion 
on the small region on p33 and the small region on p55 are only localized on the early 
fractions, either in pH7 or pH3, on the glycerol density gradient profiles of VacA, 
suggesting that the deletion on the small regions both in p33 and p55 has dramatic role 
for pH dependent oligomer assembly or disassembly.  
4.3.3 VacA binding of the deletion VacA to SM-coated plates is highly attenuated 
relative to wildtype VacA 
   The results described above indicated that the two regions, the small region on 
p33 and the small region on p55, are important for toxin cellular activity. However, these 
studies did not address the potential importance of these residues for binding of VacA to 
SM. To evaluate whether the two regions are important for VacA-SM interactions, we 
compared the relative binding of wildtype VacA and deletion VacA to SM-coated wells 
using an ELISA binding assay. Individual wells within 96-well Immulon 1B microtiter 
plates, that had been previously coated with SM (500 pmol), were incubated at 4 ˚C in 
the absence or presence of wildtype VacA or the deleted VacA (1-100 nM; 50 µL in each 
well). After 16 h, unbound toxin was washed out of the wells, and VacA retained within 
the wells was quantified by ELISA using α-VacA antibodies. These experiments revealed 
that the ELISA signal at 460 nm, corresponding to bound-VacA, was significantly less for 
deletion VacA than for wildtype VacA (Figure 4.4.). These data indicated that significantly 
less deletion VacA (10%) was bound within SM-coated wells relative to wildtype VacA. 
These results suggested that the two small regions on p33 and p55 together are important 




The preliminary data shown here demonstrated that the two small regions on p33 
and p55 domain are crucial for the oligomerization state of VacA. In addition, the deletion 
on VacA on the two regions is important for vacuolation activity. Interestingly, when the 
oligomerization state is defective, VacA has dramatic reduction on SM interaction. Given 
the fact that the deletion on the oligomerization state do not strongly disturb the overall 
structure and the fact that the receptor binding site is still intact, I am currently 
hypothesizing that the oligomerization state is playing an important role for accessing the 
receptor binding site for SM. For future direction, it is important to investigate how the 
accessibility of the receptor binding site is affected by the oligomerization state of VacA. 
Further investigation of how monomeric VacA behave on the plasma membrane will be 
important to understand how oligomerization state affects the overall membrane 











4.5 Figures and Tables 
 
Figure 4.1. The deletion VacA shows attenuation in cellular vacuolation activity relative 
to wildtype VacA. 
Monolayers of AZ-521 cells were incubated at 37 ˚C in the absence or presence of wildtype VacA 
(1, 10, 35, 100, 250 nM), or the deletion VacA 1, 10, 35, 100, 250 nM) (A) After 16 h, the monolayers 
were imaged using phase contrast microscopy (scale bar, 10 μm). The images are representative 
of those collected during three independent experiments (n = 3), each performed with three 
technical replicates. (B) After 16 h, the relative vacuolation activity was measured using the neutral 
red uptake assay, and the data were normalized according to total protein per well. The data were 
combined from three independent experiments (n = 3), each performed with three technical replicates. 

































Figure 4.2. Proteinase K senstivity of purified wildtype VacA and VacA (∆ 49-57 + 346-347). 
Evaluation of VacA (∆ 49-57 + 346-347) for structural perturbations by comparing trypsin sensitivity relative to 
wildtype VacA. Purified toxin, either wildtype VacA (2 μM) or VacA (W603A/R552A/R647A) (2 μM), was incubated 
at room temperature without or with trypsin (final concentrations : 0, 0.1, 1, 10, 100 nM). After 1 h, the trypsin 
digestion was stopped by addition of SDS-PAGE sample buffer containing β-ME and heating at 95 ˚C for 5 min. 
Immunoblot analysis using α−VacA antibody revealed the trypsin sensitivity profiles of the toxins. The data are 
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Figure 4.3. Examination of the higher structure formation of purified wildtype VacA and 
VacA (∆ 49-57 + 346-347).. 
Evaluation of the monomeric VacA for higher-ordered structure formation by glycerol gradient sedimentation 
relative to wildtype VacA. Purified toxin, either wildtype VacA (1 μM) or VacA (∆ 49-57 + 346-347) (1 μM),
 in two buffers, either at pH 7.4 or at pH 3, was loaded and fractionated at 4 ˚C by glycerol gradient density 
centrifugation (0 - 40%). After 16 h, six fractions were collected from the top (0%) to the bottom (40%) of the
 gradient. Immunoblot analysis of the collected fractions using α−VacA antibody revealed the presence of 
VacA in each fraction. High-molecular mass forms of VacA were detected in higher density fractions, 
while low-molecular mass forms of VacA were detected in lower density fractions. The data are representative 




















Figure 4.4. VacA (∆ 49-57 + 346-347) binding to plates coated with SM is attenuated relative to wildtype VacA. 
96-well Immulon 1B microtiter plates, with individual wells coated with SM (500 pmol) were incubated at 4 ˚C in 
the absence or presence of wildtype VacA, or VacA (∆ 49-57 + 346-347) (1, 3.5, 10, 35, 100 nM in 50 µL for 
each well. After 16 h, unbound toxins were washed out of the wells with PBS (pH 7.4, 4 ˚C), and the extent 
of VacA binding was quantified using ELISA while employing α-VacA antibody. The O.D. values at 460 nm were 
measured in each well using a microplate reader. Relative VacA binding to SM-coated wells was calculated by 
subtracting the O.D. values at 460 nm obtained from wells incubated with VacA in the absence of lipids, from 
the O.D. values at 460 nm obtained from SM-coated wells incubated with VacA. Each of the values was expressed 
relative to values obtained in the absence of VacA which was assigned an arbitrary value of 1. The data were 
combined from three independent experiments (n = 3), each performed with three technical replicates. 
The data were then rendered as a bar graph using Prism 6.0e. Error bars indicate standard deviations. 
Statistical significance (α = 0.05)  was calculated for the differences in binding of VacA (∆ 49-57 + 346-347) 
compared to that of wildtype VacA in SM-coated plates, using two-way ANOVA (and corrected using Sidak’s 
multiple comparisons test). P values less than 0.05 indicate statistical significance.          
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TABLE 4.1. Helicobacter pylori strains used in this study 
Strains Description Reference 
60190 Wildtype H. pylori containing 
s1/m1 vacA gene 
TL Cover 
et al 1992 
JBC 
VM022 vacA gene deletion mutant of 
60190 
AD Vinion-
Dubiel et al 
1999 JBC  
VM022 (∆vacA) VM022 transformed with pHEL2 
plasmid 
This study 
VM022 (∆vacA:: vacA (∆47-59)) VM022 transformed with pHEL2-
vacA (∆47-59) plasmid 
This study 
VM022 (∆vacA:: vacA (∆ 346-347)) VM022 transformed with pHEL2-
vacA (∆ 346-347) plasmid 
This study 
VM022 (∆vacA:: vacA (∆47-59) + (∆ 
346-347)) 
VM022 transformed with pHEL2-






















TABLE 4.2. Primers and templates used for generating amplicon in this study 











1Primers were ordered from Integrated DNT technologies Inc. (www.idtdna.com, Coralville, 
IA) 
2Underlined and bold DNA sequences, on forward primers, or, on reverse primers, were the 
mutagenized sequences to obtain alanine substitution for the amino acid residue indicated, 





































TABLE 4.3. plasmids used in this study 
Plasmid Description reference 
pHEL2 E. coli and H. pylori shuttle vector D 
Heuermann 
and R Haas 
1998 Mol 
Gen Genet. 
pHEL2-vacA (∆ 39-47) Point mutation on pHEL2-vacA to 
generate VacA (∆ 39-47) 
This study 
pHEL2-vacA (∆ 346-347) Point mutation on pHEL2-vacA to 
generate VacA (∆ 346-347) 
This study 
pHEL2-vacA (∆ 39-47) + (∆ 346-
347) 
Point mutation on pHEL2-vacA to 
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Chapter 5: Conclusions and Future Work 
5.1 Conclusions and Future work 
The overall objective of the work described in this dissertation was to identify and 
characterize the molecular details of the interactions of VacA with sphingomyelin and its 
importance in the allelic dependent toxicity. Understanding the toxin receptor 
biochemistry is important since this specific interaction links toxin to the right uptake 
machinery. In addition, since the toxin is still outside of the cells, inhibiting toxin-receptor 
interaction is one of the most targetable steps for drug development. 
In Chapter 2, I identified the novel receptor binding site on VacA. Based on the 
studies on many unrelated SM-interacting proteins, I identified the importance of 
tryptophan residues on SM interactions 49,68. It was evidenced by biochemical 44,48 and 
structural 47,51 observation. While the importance of tryptophan residues for SM interaction 
has been a recurring theme throughout the literature in the SM-interacting proteins 
48,50,68,122-124, additional molecular determinants for sphingomyelin specificity are unique 
to the individual SM-interacting proteins 44-46,67,123-125. Our data suggest that VacA 
incorporates one tryptophan residue, in alignment with previously identified SM-
interacting proteins, along with two adjacent positive-charged arginine residues, for SM 
interaction. 
Our data agrees with previous work of membrane interaction of VacA. Moreover, 
it further explains the membrane interaction at an atomic level. Many previous data 
indicated the importance of C-terminal region of VacA for cell surface binding on human 
epithelial cells 59,61,63-65. Biochemical evidence demonstrated that the C-terminal region of 
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VacA is both sufficient 59 and necessary 65 for membrane binding activity of VacA. In 
agreement with the previous work, the location of the newly identified SM-interacting 
residues on VacA, R552, W603 and R647, are within the C-terminal region of VacA. To 
our knowledge, this report firstly provides an atomic level explanation on VacA-receptor 
interaction.  
My current studies of VacA suggest that SM interaction of VacA plays an important 
role to differentiate the functional VacA-membrane interaction from the non-functional one. 
I demonstrated that three SM-interacting residues of VacA are important to shift the 
membrane-bound VacA population move towards to sphingolipid-enriched microdomain, 
while the three residues did not affect the overall VacA binding to the plasma membrane 
much. The overall VacA binding on the plasma membrane has been shown to be not 
saturating, with the suggestion that VacA membrane interaction is mediated by abundant 
cell surface molecules 30,92,120,121. Agreeing with the previous suggestions, my data also 
showed that the three SM-interacting residues can now differentiate mere VacA-
membrane interaction from the specific VacA interaction towards sphingolipid-enriched 
microdomain. On sphingolipid-enriched microdomain, VacA encounters GEEC/CLIC 
mediated, cdc42-dependent, and clathrin-independent internalization pathway 37,126, 
which conveys VacA to the endo-lysosomal trafficking system 127 for traveling to its target 
organelle, mitochondria 22,113,128.  Our data suggests the importance of SM-interacting 
residues on VacA for its membrane interaction specificity for its functional consequences. 
However, the exact stoichiometry of VacA-SM interaction still needs to be 
addressed. One approach to this problem is to obtain a co-crystal structure with VacA 
and sphingomyelin mimic lipids. A recent report on the co-crystal structure of lysenin with 
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sphingomyelin mimic lipid revealed the confined molar ratio between the two molecules 
interaction, which helped to understand the evolution of this SM-interacting protein and 
its family members 53. Co-crystal structure of VacA and SM can help to understand how 
many lipid molecules are incorporated into the receptor-binding site.  
Another approach to understand the stoichiometry of VacA-SM interaction is to 
examine VacA interaction using a complete controlled nanoscale lipid bilayer systems 
called Nanodiscs. Shaw et al 134,135 demonstrated the number of phospholipid molecules 
required to have an active blood clotting protease, called tissue factor VIIa (TF VIIa), upon 
lipid bilayer interaction, as well as the importance of localized phosphatidylserine, via 
thorough characterization of the Nanodisc bound with TF VIIa. Characterizing VacA-SM 
interaction using a complete controlled nanoscale lipid bilayer system can contribute to 
understand the stoichiometry of VacA-SM interaction on the plasma membrane and how 
the localized concentration of SM is important for VacA-membrane interaction. I hope that, 
given that VacA and plasma membrane interaction is the most targetable step, our data 
can be beneficial for inhibitor design in the future, which can be used in current H. pylori 
eradication strategy of antibiotic treatment. 
In Chapter 3, the key component to understand the cellular mechanism of the 
allelic dependent cytotoxicity of VacA 17 was explored. Within the C-terminal region of 
VacA contains, the highest genetic variation region, named “m region” is known to be 
highly associated with the risk of development of human gastric diseases 17,63,64. 
Biochemical evidence demonstrated the genetic variation on “m region” among different 
H. pylori strains is important for the differences on VacA-mediated cytotoxicity 61 and the 
cell surface binding ability 63. I identified that the location of the three VacA residues are 
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located within the “m region”. In addition, based on protein alignment of VacA among 
different alleles of H. pylori, I identified the three VacA residues, R552, W603 and R647, 
are only conserved in toxic strains of VacA. Examination of the importance of this region 
by generating a chimeric VacA containing less toxic m region on toxic background 
showed significant reduction both on cytotoxicity and SM interaction. My data indicates 
that 175-amino acid region that contains active receptor residues are both necessary and 
sufficient for vacuolation and SM interaction. In addition, my data indicate that 
reconstitution of active SM-interacting residues, R552, W603, and R647, on non-active 
VacA is important for partial restoration of the cytotoxicity. 
Even though there is a restoration, the recovery activity was only partial. There are 
two possible explanation for this partial recovery. One is that there are other contributing 
amino acids that orient the three residues to make them more active configuration for 
optimized SM interaction. The three residues are located on the flexible loops without 
confined secondary structure. By comparing the difference between toxic and less toxic 
alleles on the residues within these loops, I identified that there are several residues that 
are also different between the two. To examine this possibility, it is important to substitute 
the loops that contain the three SM-interaction residues and examine the cytotoxicity. 
Second possibility is that additional part of VacA, other than the SM-interacting region, 
may contribute to the membrane interaction, hence the cytotoxic activity. Even though 
VacA has no homology to any proteins, VacA has very similar characteristic of protectin-
like proteins 28. Many protectin-like proteins utilize multiple loops for its function. VacA 
contains many flexible loops, including the three loops that contain R552, W603, and 
R647. It is possible that additional loops on VacA may play a role in membrane interaction. 
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To examine this possibility, it is important to examine the differences of the loops other 
than those loops that contain SM-interacting residues. Additional examination on the 
multiple loops on VacA may help to see the full recovery of vacuolation activity.  
This study allows us to explore a possible molecular mechanism behind the allelic 
dependent cytotoxicity of VacA. My data supports that while toxic alleles of VacA, 
containing active receptor binding residues within multiple loops, have a strong binding 
ability to its receptor, SM, less-toxic alleles of VacA have a weaker binding ability. For 
future direction, examination of additional multiple loops between the toxic and less toxic 
alleles will be able to help whether there is an additional player that helps VacA-
membrane interaction.  
In summary, these results demonstrate that the receptor interaction of VacA is 
mediated by three VacA residues, W603, R552, and R647. This interactiong is important 
for VacA to be recruited to the SM-enriched microdomains, which eventually lead to the 
interaction of VacA. In addition, I identified that the alleleic dependent activity of VacA is 
dependent on the difference on the receptor binding residues between toxin and less 
toxin alleles. Overall, these studies demonstrated the complexity and dynamic of VacA 
and membrane interaction. Future work will be required to reveal whether other 
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